Mitosis and protein Na-terminal acetylation by Pimenta-Marques, Ana
Mitosis and Protein N-Terminal Acetylation
Ana Rita Marques
Dissertation presented to obtain the Ph.D degree in
Developmental Biology
Instituto de Tecnologia Química e Biológica
Universidade Nova de Lisboa
Research work performed at:
Oeiras,
July, 2011
This dissertation was sponsored by Fundação para
a Ciência e Tecnologia.
“Apoio financeiro da FCT e do FSE no âmbito do
Quadro Comunitário de apoio, BD nº
SFRH/BD/28767/2006 e projecto FCT-POCI-
DG/BIA/82013/06”
ii
iii
List of publications
The work described in this thesis contributed to the following
publications.
1. Pimenta-Marques, A., Tostoes, R., Marty, T., Barbosa, V.,
Lehmann, R. and Martinho, R. G. (2008). Differential
requirements of a mitotic acetyltransferase in somatic and germ line
cells. Dev Biol 323, 197-206.
2. Van Damme, P.#, Hole, K.#, Pimenta-Marques, A.#, Helsens, K.,
Vandekerckhove, J., Martinho, R.G., Gevaert, K., and Arnesen,
T. (2011). NatF contributes to an evolutionary shift in protein N-
terminal acetylation and is important for normal chromosome
segregation. PLoS Genet 7, e1002169.
# - These authors contributed equally to this work.
3. Guilgur, L., Prudêncio, P., Ferreira, T., Pimenta-Marques, A.,
Martinho, R.G. (2011). Drosophila aPKC is required for mitotic
spindle orientation during symmetric division of epithelial cells
(submitted).
This thesis is the result of the work I developed between
January 2007 and December 2010 under the supervision of Dr. Rui
Gonçalo Martinho, at the laboratory of Early Fly Development at
Instituto Gulbenkian de Ciência, Oeiras, Portugal.
Collaborations are indicated in the sections Materials and
Methods.
The original manuscript 1 corresponds to chapter III, where I
performed all experiments descried in the article.
iv
Concerning manuscript 2, I collaborated in the description of
Drosophila Naa60-depleted cell phenotypes. Therefore, I will
incorporate those results in chapter V.
vAcknowledgments / Agradecimentos
First I would like to thank my supervisor Rui Martinho for taking
me in his lab and giving me the opportunity to grow as a scientist. He
made me believing that I was capable of starting and one day finishing
a PhD. It was lots of fun and I will remember this learning process with
care and laughter.
I must also thank Thomas Arnesen and Petra Van Damme for all
the support and enthusiastic discussions we had about my project and
NATs.
To the CCR group I must thank all the support regarding both
scientific discussions and reagents. Particularly, Zita Santos and Inês
Ferreira for introducing me to the cell culture world. Besides being
excellent colleagues, I must also thank them, as well as to Inês Bento
and Ana Martins for their true friendship during these years.
Ao Tostões e ao André tenho a agradecer o facto de terem
tornado as horas infindáveis na sala das moscas em momentos de
autêntica diversão e boa disposição. A amizade deles foi
indispensável neste percurso.
À Tânia, Pedro e Gaston tenho a agradecer a amizade e forte
companheirismo e união que temos entre nós. É de facto um privilégio
acordar de manhã e ir trabalhar com um grupo de pessoas de quem
genuinamente gostamos e com quem nos identificamos. Além disso
ainda nos fartamos de rir juntos.
Ao Paulinho e à Catarina tenho a agradecer por estarem
presentes não só como colegas de trabalho em outros laboratórios
mas principalmente por serem meus grandes amigos.
Tenho sido de facto uma privilegiada por ao longo do
doutoramento ter feito verdadeiros amigos como os que referi. Sem
eles estes anos não teriam sido tão alegres como foram.
vi
Aos meus pais tenho a agradecer do fundo do coração o amor e
apoio incondicional que sempre me deram. Ter partilhado com eles os
melhores e piores momentos fez-me crescer e aprender a valorizar o
que é verdadeiramente importante e a relativizar o dispensável. Se de
alguma forma tenho sido bem sucedida na vida, o devo a eles.
Quanto às minhas irmãs… são as maiores!!! Sou uma sortuda por ter
duas manas destas na minha vida.
Ao meu avô Pimenta agradeço por ser o avô único que é! O meu
avô tem sido uma presença constante e fundamental no meu
processo de crescimento. Desde que sai de Évora que o meu avô me
faz o telefonema da praxe todas as semanas. Essas e outras
demonstrações de carinho fazem-me sentir uma “netinha” menina,
apesar dos 31 anos, e isso é tão bom!
Aos meus tios Chico e São tenho a agradecer o facto de ter
sempre podido contar com eles. Foram também uma presença
constante nos momentos importantes da minha vida.
À Ju, Avô João, D.Virginia, Tio e Ana Catarina, tenho a agradecer
o facto de me terem acolhido como um verdadeiro membro da família
e do pelo forte apoio que me deram nestes últimos anos. Os nossos
almoços de fim de semana são uma lufada de ar fresco.
Claro, ao meu maridão tenho a agradecer o amor, amizade,
companheirismo e paciência que teve comigo nestes últimos cinco
anos. É muito bom para mim ter alguém com a personalidade do
Gonçalo ao meu lado. O facto de partilhar a minha vida com ele faz
com que tudo o que é bom seja “maravilhoso” e tudo o que é mau
seja apenas “menos bom”. É cá uma peça o meu marido.
À minha feijoca linda estou grata por ela ter tornado estes últimos
meses verdadeiramente únicos e maravilhosos. Ela foi sem dúvida
uma força de motivação em momentos mais cinzentos. Tem sido tão
bom estarmos juntas, que já não consigo imaginar os meus dias sem
ela.
vii
Abstract
Protein N-terminal acetylation is a highly conserved and
widespread modification that occurs on approximately 80% of all
soluble, cytoplasmic human proteins. Nevertheless, with few
exceptions, little is known about the biological function of protein N-
acetylation. Recently, it was suggested to act as a general protein
destabilization signal in yeast (Hwang et al., 2010). Yet, other reports
suggest it might act as stabilizer, for instance by blocking protein
degradation (Ciechanover and Ben-Saadon, 2004). This protein
modification is catalyzed by N-terminal acetyltransferases (NATs),
which are highly conserved from yeast to humans both in subunit
composition and substrate specificity (Starheim et al., 2009). Since
NATs enzymatic activity and function has been mostly studied in yeast
and tissue culture cells, our current understanding of the role of these
enzymes during development of multicellular organisms is extremely
poor, being our main goal to understand the role of this ubiquitous
protein modification during development.
In Chapter II of this work, we isolated two genes from a
maternal genetic screen designed to identify genes required for
blastoderm embryonic development. Both genes were required for
syncytial nuclear divisions. One of the isolated genes corresponded to
separation anxiety (san) (Pimenta-Marques et al., 2008). san encoded
a poorly characterized NAT known by Naa50p, which is conserved
from yeast to humans. San/Naa50p was found in a complex with two
other NATs, Naa10p and Naa15p, forming the NatE complex.
Interestingly, in contrast to the previously studied NATs, we and others
showed that dSan/dNaa50-depleted cells showed specific phenotypes
during mitosis (Hou et al., 2007; Pimenta-Marques et al., 2008;
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Williams et al., 2003). dSan/dNaa50 was originally described as being
involved in centromeric sister chromatid cohesion (Williams et al.,
2003). This conclusion came from the observation that san mutant
neuroblasts exhibited premature loss of sister chromatid cohesion
during mitosis accompanied by mislocalization of a subunit of the
cohesin complex from the centromeric region.
Detailed characterization of Drosophila san mutants (chapter
III) revealed striking defects during chromosome segregation in the
syncytial nuclear divisions (Pimenta-Marques et al., 2008). These
included lagging chromosomes and extensive chromosome bridges.
Additionally, we observed that during mitosis a subset of nuclei
showed a dramatic decrease in the levels of a condensin subunit.
Moreover, a subset of chromosome bridges showed reduced levels of
Topoisomerase II. Together, these observations suggested
dSan/dNaa50 was also important for chromosome condensation/
resolution, implying a more general mitotic function of this NAT.
Surprisingly, our work showed that whereas all analyzed somatic
tissues required dSan/dNaa50 for correct cell cycle progression,
during Drosophila oogenesis we failed to detect mitotic defects in the
female germ-line stem cells mutant for dSan/dNaa50, suggesting
there are differential requirements for N-acetylation between the
female germ-line and the soma. We hypothesized that different NATs
are likely to have different tissue-specific functions throughout
development. In order to test this hypothesis we focused on: 1)
defining the mitotic function of dSan/dNaa50, 2) understanding why is
this enzyme not required in the female germ-line.
To understand in which molecular pathway dSan/dNaa50 is
regulating mitosis we decided to identify its in vivo mitotic substrates
(chapter IV). To that end, we took advantage of the N-terminal
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COmbined FRActional Diagonal Chromatography (COFRADIC)
methodology to identify proteins whose N-acetylation levels were
reduced in san mutant embryos. We identified 18 proteins whose N-
acetylation levels were reduced in san mutants. From these 18
proteins, we identified the gamma subunit of the cytosolic chaperonin
containing T-complex polypeptide 1 (CTT) (Cct), which displayed
chromosome segregation defects identical to dSan/dNaa50-depleted
cells. Cct was shown to be required for the metaphase to anaphase
transition by activating the anaphase promoting complex/ cyclosome
complex (Camasses et al., 2003), making this protein an excellent
candidate for a putative mitotic substrate of dSan/dNaa50. Ongoing
complementation experiments in tissue culture cells will allow us to
test if the chromosome segregation defects of San-depleted cells are
Cct-mediated.
In chapter V we addressed why dSan/dNaa50 was not required
in the female germ-line stem cells. Each NAT complex preferentially
acetylates distinct N-termini. However, recent data suggested that
different NAT complexes were partially redundant (Arnesen et al.,
2009b; Van Damme et al., 2001). We therefore hypothesized that
dSan/dNaa50 was not required within the female germ-line because of
redundancy with another NAT specifically on this tissue. To test our
hypothesis we identified the Drosophila NAT paralogues of
dSan/Naa50. Phylogenetic analysis revealed that dNaa60 was the
closest NAT paralogue to dSan/dNaa50. Interestingly, dNaa60-
depleted cultured cells showed chromosome segregation defects
remarkably similar to dSan/dNaa50 (Van Damme et al., 2011),
suggesting this NAT was also required for chromosome segregation in
mitosis. We hypothesize that dNaa60 is redundant with dSan/dNaa50
specifically in the female germ-line. Ongoing analysis of the female
xgerm-line stem cell divisions within san/naa60 double mutants will
clarify this potential redundancy.
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Sumário
A acetilação N-terminal de proteínas é uma modificação muito
comum e conservada que ocorre em cerca de 80% das proteínas
solúveis citoplasmáticas em humanos. Com algumas excepções,
pouco se sabe acerca da função biológica da acetilação N-terminal.
Foi recentemente sugerido em levedura, que esta modificação pode
actuar como um sinal de destabilização de proteínas (Hwang et al.,
2010). Outros trabalhos sugerem que ao invés, possa actuar com
estabilizador, como por exemplo no bloqueio de degradação proteica
(Ciechanover and Ben-Saadon, 2004). Esta modificação é catalisada
por acetiltransferases de N-terminais (NATs). Estas enzimas são
altamente conservados desde as leveduras aos humanos, quer na
composição das suas subunidades quer na especificidade dos seus
substratos (Starheim et al., 2009). Uma vez que a actividade e função
destas enzimas tem sido principalmente estudada em levedura e
sistemas de cultura de células, o conhecimento sobre a função da
acetilação de N-terminais no contexto de um organismo multicelular
é ainda muito limitado. O nosso principal objectivo é o de
compreender a função desta modificação de proteínas durante o
desenvolvimento.
No Capítulo II deste trabalho, isolamos dois grupos de
complementação de um screen materno desenvolvido com o objectivo
de identificar genes necessários para o desenvolvimento da
blastoderme embrionária. Ambos os genes mutados nestes grupos de
complementação são necessários para as divisões nucleares do
sincício. Um dos genes isolados correspondeu ao “separation anxiety”
(san). A San codifica uma NAT pouco caracterizada, conhecida por
Naa50p, conservada de leveduras a humanos. A San/Naa50p foi
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identificada como parte de um complexo com mais duas NATs, a
Naa10p e a Naa15p designado por NatE. Curiosamente, e ao
contrário do que foi observado para as outras NATs, nós e outros
grupos de investigação mostrámos que células onde a actividade da
dSan/dNaa50 foi eliminada, apresentam fenótipos específicos durante
a mitose (Hou et al., 2007; Pimenta-Marques et al., 2008; Williams et
al., 2003). A dSan/dNaa50 foi originalmente descrita como uma
proteína envolvida na coesão centromérica das cromatidias irmãs
(Williams et al., 2003). Esta conclusão veio da observação de que
neuroblastos de mutantes para san exibem perda prematura de
coesão das cromátidias irmãs durante a mitose. Foi igualmente
descrita a deslocalização de uma subunidade do complexo da
coesina na região centromérica dos cromossomas.
A caracterização detalhada de mutantes de Drosophila para o
gene san (capítulo III) revelou defeitos marcantes durante a
segregação dos cromossomas nas divisões nucleares do sincício
(Pimenta-Marques et al., 2008). Estes defeitos incluem pontes
cromossómicas e/ou perda de cromossomas no meio do fuso mitótico
aquando da segregação cromossomática. Observou-se ainda, que
uma percentagem de núcleos mitóticos apresentou uma forte
diminuição dos níveis de uma subunidade do complexo de
condensina. Igualmente, observámos que um subconjunto de pontes
cromossómicas apresentou níveis reduzidos de topoisomerase II.
Estas observações sugerem que a dSan/dNaa50 é importante para a
condensação/resolução cromossómica, o que implica uma função
mais geral desta NAT do que a inicialmente proposta. O nosso
trabalho mostrou que a dSan/dNaa50 é necessária para a progressão
normal do ciclo celular em todos os tecidos somáticos analisados.
Surpreendentemente, durante a oogénese, não fomos capazes de
detectar defeitos mitóticos nas células estaminais da linha germinal
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em mutantes para a dSan/dNaa50. Os nossos dados sugerem que a
linha germinal feminina e as células somáticas apresentam requisitos
diferentes para a acetilação de N-terminais. Com base nos nossos
resultados, hipotetizamos que diferentes NATs poderão ter diferentes
funções reguladoras ao longo do desenvolvimento de diferentes
tecidos. Para testar esta hipótese focámo-nos em 1) definir a função
mitótica da dSan/dNaa50, 2) compreender porque é que a
dSan/dNaa50 não é necessária na linha germinal feminina.
De modo a identificarmos a via molecular em que a
dSan/dNaa50 regula a mitose, decidimos identificar os substratos
mitóticos desta NAT (capítulo IV). Para esse fim, tirámos partido da
cromatografia combinada de fraccionamento de N-terminais, de forma
a identificar proteínas cujos níveis de N-acetilação estão reduzidos
em embriões mutantes para dSan/dNaa50, por comparação com
embriões de estirpe selvagem. Desta análise resultou a identificação
de 18 proteínas cujos níveis de N-acetilação foram reduzidos em
mutantes para dSan/dNaa50. Uma das 18 proteínas identificadas foi a
subunidade gama da chaperonina citosólica contendo o complexo T-
polipeptídeo (CTT) (Cct). A Cct apresentou defeitos de segregação
cromossómica muito semelhantes aos observados para células onde
a dSan/dNaa50 foi eliminada. Esta chaperonina foi descrita como
sendo necessária para a transição metáfase-anáfase por activação do
complexo promotor da anáfase/complexo ciclosoma (Camasses et al.,
2003). As funções associadas à Cct tornam-na numa excelente
candidata a ser um substrato mitótico da dSan/dNaa50. Futuras
experiências de complementação em cultura de células vão permitir-
nos testar se de facto os defeitos de segregação cromossómica
observados em células depletadas de dSan/dNaa50 são mediados
pela Cct.
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No capítulo V investigámos porque é que a dSan/dNaa50 não
é necessária nas células estaminais da linha germinal feminina. Cada
complexo NAT acetila preferencialmente distintos N-terminais.
Contudo, dados recentes sugerem que diferentes complexos NAT
podem ser parcialmente redundantes (Arnesen e tal., 2009b; Van
Damme e tal., 2011). Com base nestes estudos hipotetizámos que a
dSan/dNaa50 não é necessária na linha germinal feminina devido à
redundância com outra NAT especificamente neste tecido. Para testar
esta hipótese identificámos os parálogos da dSan/Naa50 em
Drosophila. A análise filogenética revelou que a dNaa60 é a NAT
paráloga mais próxima da dSan/dNaa50. Após a depleção da dNaa60
em células em cultura observámos defeitos de segregação
cromossómica muito semelhantes aos associados a células
depletadas para dSan/dNaa50 (Van Damme et al., 2011 ), indicando
que esta NAT é necessária para a segregação de cromossomas na
mitose. Tendo em conta estes resultados, a nossa hipótese actual é a
de que a dNaa60 é a NAT redundante com a dSan/dNaa50 na linha
germinal feminina. A análise de duplos mutantes em Drosophila para
san/naa60 irá clarificar esta possível redundância.
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1. Cell cycle
The cell cycle is a series of events that takes place in a
eukaryotic cell leading to its division and replication. Numerous
proteins regulate the correct progression of the cell cycle, which
ensures the accurate transmission of genetic information from a
mother cell to its daughter cells. The eukaryotic cell cycle is typically
divided on basis of chromosomal events: interphase and M phase
(mitosis) (fig. 1). Interphase is comprised by G1 phase followed by S
phase and G2 phase. The G1 and G2 phases represent “gaps” in the
cell cycle that occur between the two landmark events – DNA
synthesis (S phase) and mitosis (M phase). In these stages, the cells
grow and pass through regulatory transitions in which progression to
the next phase is controlled by a variety of signals. In G1, cells
become committed to either continue or exit from the cell cycle into a
quiescent state. The M phase is composed by two events: nuclear
division (mitosis) and cell division (cytokinesis).
Figure 1: Schematic representation of the cell cycle. The main events of the cell
cycle are DNA replication (S phase), chromosome segregation and consequent
nuclear division (M phase or mitosis). Between these main events exist the gap
phases (G1 and G2). Cells may also enter a G0 phase that is characterized by a more
or less prolonged stage of nondividing cells.
G0
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1.1. Cell cycle regulation
Cell cycle regulation involves crucial steps such as detection
and repair of genetic damage and the provision of various checkpoints
that ensure correct segregation of genetic information and prevent
uncontrolled cell division. The molecular events that control the cell
cycle are ordered and directional. Two key classes of regulatory
proteins, cyclins and cyclin-dependent kinases (Cdks) are central
players in regulating the cell cycle through its different stages. Cdks
are specific serine/threonine protein kinases that are activated at
specific points of the cell cycle. Cyclins assure activation of Cdks, as
they interact with distinct Cdks providing them with substrate
specificity. Cyclins are named from their cyclic expression over the cell
cycle, which ensures each Cdk can only be activated at specific stages
of the cell cycle. Thus, different cell cycle stages are associated with
the presence of specific cyclins and activation of specific Cdks
(Revised by Murray A.W., 2004).
1.2. Mitosis
Mitosis results in the production of two daughter cells
containing identical genetic information and is subdivided into five
successive phases: prophase, prometaphase, metaphase, anaphase
and telophase (fig. 2).
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Figure 2: Mitosis in the animal cell. (a) Interphase, where chromosomes are
dispersed and not visible as distinct structures. (b) As prophase is initiated
centrosomes move towards opposite sides of the cell and chromosome condensation
starts to be visible. (c) Prometaphase starts when the nuclear envelope breaks down
and chromosome condensation is completed. Each chromosome can be visualized as
a structure composed of two sister chromatids held together at the centromeric region.
During prometaphase chromosomes are captured by microtubules growing from
opposite poles, a process that contributes to chromosome congression and alignment
at the metaphase plate (d). (e) At anaphase onset, each chromatid pair separates and
segregates to opposite poles of the cell. (f) By the end of mitosis, in telophase,
chromosomes decondense and the nuclear membrane re-forms around the daughter
nuclei. Cytoplasm division, or cytokinesis, occurs concomitantly as the later stages of
mitosis, giving rise to two daughter cells. (Adapted from Lodish, 2003).
During prophase (fig. 2b) two major events can be easily
visualized including overall reorganization of the cytoskeleton and
condensation of chromatin into compact mitotic chromosomes.
Reorganization of cytoskeleton microtubules (MTs) is conducted by
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separation and migration to opposite sides of the cell of the two
previously duplicated microtubule organizing centers (MTOCs), which
in animal cells are called centrosomes. Centrosomal maturation occurs
during G2 and plays a major role in promoting the conversion of the
highly stable MTs found in interphase to highly dynamic MTs present
in mitosis.
Prometaphase (fig. 2c) starts with nuclear envelope break-
down (NEBD). This allows MTs, nucleated by centrosomes, to invade
the nuclear space and marks the initiation of assembly of the mitotic
spindle. MTs are polymers composed of tubulin subunits that exist as
heterodimers of - and -tubulin. MTs will eventually form the mitotic
spindle. Stable interactions between MTs and chromosomes take
place at a very specific chromosomal structure called the kinetochore.
The kinetochore is a multiprotein complex located at the surface of
each sister chromatid at a region called the centromere that
corresponds to the primary constriction of condensed chromosomes.
As a result of the interaction with the spindle MTs, the chromosomes
will eventually move towards the cell center, a process known as
chromosome congression.
Metaphase (fig. 2d) occurs when all chromosomes are aligned
at the equatorial plane of the mitotic spindle so that each sister
chromatid of each chromosome is attached to MTs emanating from
opposite poles of the spindle. Chromosome segregation can only
occur when all chromosomes are correctly aligned at the spindle
equator and are under tension as a result of their attachments to the
MTs. In the next stage, which is known by anaphase (fig. 2e), sister
chromatids migrate to opposite sides of the spindle. Finally during
telophase (fig. 2f), the nuclear envelope reassembles and surrounds
each group of segregated chromatids, which then decondense giving
rise to two daughter nuclei. At the same time, the cell cytoplasm
divides by cytokinesis. This is initiated with the ingression of the
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cleavage furrow normally at the center of the cell perpendicular to the
long axis of the mitotic spindle and terminates when the two daughter
cells finally separate (reviewed by Lodish 2003, Morgan 2007).
1.3. The spindle assembly checkpoint and the metaphase to
anaphase transition
The spindle assembly checkpoint (SAC) is a molecular system
that ensures the accurate segregation of mitotic chromosomes by
delaying anaphase onset until each kinetochore is properly attached to
the mitotic spindle (Kops et al., 2005; Rieder et al., 1995; Rieder et al.,
1994). The SAC is activated by kinetochores that are not yet attached
to mitotic spindle MTs and chromosome pairs that lack tension across
sister chromatids generated by spindle forces (Rieder and Maiato,
2004; Yu, 2002). The established concept is that a group of mitotic
checkpoint proteins such as budding uninhibited by benzimidazole 3
(Bub3), budding uninhibited by benzimidazole 3 related 1 (BubR1) and
mitotic arrest-deficient 2 (Mad2) bind to kinetochores that lack tension
or MT attachment leading to a delay in chromosome segregation
(Kops et al., 2005). As each pair of sister kinetochores attaches to
MTs, they become under tension leading to their stretching. This
allows checkpoint proteins to diffuse from the kinetochore silencing the
SAC. Silencing the SAC leads to activation of the Anaphase Promoting
Complex/Cyclosome (APC/C).
The APC/C regulates the metaphase to anaphase transition
through recognition and destruction of ubiquitinated proteins (fig. 3).
Ubiquitination by the APC/C is mainly controlled by activator subunits
that bind the core components at different points in the cell cycle and
promote ubiquitination of specific substrates. Of these, cell-division-
cycle 20 homologue (Cdc20) and cdc20-homologue 1(Cdh1) are the
most important. Cdc20 activates the APC/C at the metaphase to
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anaphase transition allowing further degradation of securin which is an
inhibitor of the protease separase. Once securin is degraded,
separase will be active and will cleave cohesin, the complex that keeps
sister chromatids together. Also, at this stage the mitotic cyclin B is
prompted for degradation leading to the subsequent inactivation of its
binding partner Cdk1, the major mitotic cyclin dependent kinase. Cdh1
activates the APC/C at the end of mitosis to maintain cyclin destruction
(Li and Zhang, 2009).
Figure 3: Regulation of anaphase and mitotic exit by APC/C. During
prometaphase, SAC proteins such as Mad2 and BubR1 are activated at kinetochores
that are not (or not fully) attached with MTs. Activated Mad2 and BubR1 inhibit the
capability of the APC/C to ubiquitinate securin and cyclin B and thereby prevent
anaphase and mitotic exit. In metaphase, when all kinetochores are attached to MTs,
APC/C ubiquitinates securin and cyclin B and thereby activates the protease separase
and inactivates Cdk1. Separase then cleaves cohesin complexes which hold sister
chromatids together and thereby initiates sister-chromatid separation. Cdk1
inactivation leads to the dephosphorylation of Cdk1 substrates by protein
phosphatases, and thereby enables exit from mitosis. (Adapted from Peters, 2006).
1.4. Chromosome cohesion and condensation
Both cohesin and condensin complexes are essential for
faithful segregation of chromosomes during the mitotic cell cycle.
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Cohesin establishes sister chromatid cohesion between duplicating
DNAs in S phase. In prophase, a large structural reorganization of
chromosomes is started, with initial release of cohesin and progressive
loading of condensins, culminating with the formation of metaphase
chromosomes with well-resolved sister chromatids. Sister chromatid
resolution, is a prerequisite of the final separation of sister chromatids
that is triggered by proteolytic cleavage of cohesin at the onset of
anaphase. The dynamic behavior of cohesin and condensins must be
tightly regulated under the control of the cell cycle machinery.
1.4.1. Sister chromatid cohesion
To ensure the faithful transmission of chromosomes in mitosis,
replicated chromatids remain paired until both sister kinetochores
attach to opposite poles of the mitotic spindle, a state known as
biorientation. This pairing requires cohesin, a multiprotein complex that
ensures proper sister chromatid pairing until anaphase onset.
The cohesin complex contains a pair of structural maintenance
of chromosomes (SMC) subunits and ancillary non-SMC subunits.
Mitotic cohesion complexes contain a heterodimer of SMC1 and
SMC3, the non-SMC subunit Scc3 (also known as SA), and the -
kleisin subunit Mcd1/Scc1/Rad21 (fig. 4). Subunit-subunit interaction
assays have shown that cohesin forms a tripartite ring in which the
open-V structure of the SMC heterodimer is closed by simultaneous
binding of the N- and C-terminal regions of Scc1 to the head domains
of SMC3 and SMC1, respectively (fig. 4) (Haering et al., 2002). It has
been proposed that the ring-like structure of cohesin holds sister
chromatids together by embracing two DNA duplexes within the SMC
subunits coiled-coil arms (Haering et al., 2002) (fig 4). In agreement
with this model, cohesin dissociates from chromatin upon disruption of
the integrity of the ring by cleavage of one of its subunits or, in the
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case of circular minichromosomes, upon DNA linearization (Gruber et
al., 2003; Ivanov and Nasmyth, 2007; Uhlmann et al., 1999).
In most organisms, meiotic cohesin complexes contain the
alternative Rec8 instead of the -kleisin Drad21. There is no obvious
Rec8 orthologue in D.melanogaster. Instead, crossover suppressor on
2 of Manheim (C(2)M) encodes a distant -kleisin member that
associates with DmSMC3 and has a role in synaptonemal complex
(Heidmann et al., 2004), a regulator the overall process of homologous
recombination.
Conserved orthologues of the cohesin proteins are found in
metazoans (Darwiche et al., 1999; Losada et al., 1998; Rollins et al.,
1999; Sumara et al., 2000), suggesting cohesin is very likely the
universal mechanism of sister-chromatid cohesion.
Figure 4: (a) Composition of the cohesin complex. The head domains of cohesin’s
SMC1/SMC3 dimer are bound by different ends of the Scc1/Rad21 -kleisin subunit,
which also recruits the HEAT repeat-containing Scc3/SA subunit to the complex. (b)
The ring model. Both sister chromatids (blue cylinders) pass through the same
cohesin ring structure, and the major DNA-cohesin interaction is topological.
Loading of cohesin on chromatin requires a heteromeric
complex composed of the Scc2 and Scc4 proteins. These proteins are
conserved from yeast to humans (Watrin et al., 2006). Scc2 and Scc4
are required to load cohesin onto DNA during the G1 phase of the cell
cycle in yeast (Ciosk et al., 2000; Tomonaga et al., 2000), and
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telophase in vertebrates, prior to DNA replication (Gillespie and
Hirano, 2004; Takahashi et al., 2004). Further establishment of
cohesion only occurs during or after DNA replication. Indeed,
establishment of sister chromatid cohesion is tightly coupled to
replication and some, if not all, cohesion is generated at replication
forks (Unal et al., 2007). Cohesion is established by the
acetyltransferase Eco1. This protein associates with the DNA
polymerase processivity factor PCNA and with components of the
clamp loader replication factor C (RF-C) (Kenna and Skibbens, 2003;
Moldovan et al., 2006). Deco is the name for the orthologous
acetyltransferase needed for centromeric cohesion in flies (Williams et
al., 2003). In humans, there are two paralogs of Eco1 known as
ESCO1 and ESCO2. Cohesion establishment was shown to be
dependent upon Eco1-mediated acetylation of at least two lysine
residues of SMC3 at the head region of the protein (Rolef Ben-Shahar
et al., 2008; Rowland et al., 2009; Unal et al., 2008; Zhang et al.,
2008).
There are at least three proteins which are important for
cohesin maintenance following S phase (fig. 5). These proteins include
Pds5, Sororin and Wpl1. They interact closely with cohesin and
modulate its chromatin association dynamics, although they are not
required for cohesion loading. The exact mechanism by which the
Pds5 protein modulates cohesion is not well understood. Pds5 is a
HEAT-repeat protein conserved from fungi to vertebrates. It interacts
with Eco1 and through this interaction is believed to contribute to the
dynamic association of cohesion with chromatin (Noble et al., 2006;
Tanaka et al., 2001). The phenotypes observed in Pds5 deficient cells
are somewhat variable among different organisms. PDS5 is an
essential gene in budding yeast, required during G2/M phase for
maintenance of cohesion (Hartman et al., 2000; Panizza et al., 2000).
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In Drosophila, pds5 mutants display premature sister chromatid
cohesion in brain neuroblasts (Dorsett et al., 2005). Vertebrate cells
have two Pds5-like proteins, and mild cohesion defects were observed
with decreased levels of these proteins (Losada et al., 2005). Sororin
is a vertebrate-specific component of the cohesin network (Rankin et
al., 2005; Schmitz et al., 2007). Depletion of Sororin in HeLa cells
decreased the fraction of stable chromatin-bound cohesin, causing
cohesion defects already in interphase (Schmitz et al., 2007). In
contrast to Pds5 and Sororin, Wpl1 promotes dissociation of cohesin
from chromosome arms. Drosophila mutants of the Wpl1 orthologue
(wapI) prevented separation of sister chromatids in mitosis (Verni et
al., 2000). Consistently, in mammalian cells depleted of Wpl1, cohesin
remains associated with chromatids during mitosis, resulting in a
mitotic delay (Gandhi et al., 2006; Kueng et al., 2006) (fig. 5).
In metazoans dissolution of most cohesin from chromosome
arms is performed during prophase in what has been called the
“prophase pathway”. Only a small population, enriched at the
pericentromeric region remains on chromosomes until metaphase.
Cohesin dissociation from chromosome arms requires phosphorylation
of the cohesin subunit, SA, by the mitotic kinase Polo-like kinase 1
(Plk1) (Hauf et al., 2005; Sumara et al., 2002). In addition to Plk1,
Aurora B may contribute to this process by phosphorylation of other
targets. Xenopus cell-free extracts depleted of Aurora B approached
metaphase with condensed sister chromatids, but the axes failed to
resolve (Losada et al., 2002; Sumara et al., 2002). Most of the cohesin
dissociated by the prophase pathway is not cleaved at anaphase, but
instead relocates to chromatin in telophase to function in the next cell
cycle. During the prophase pathway, centromeric cohesin is protected
from dissociation by Shugoshin (Sgo/Mei-S332) (Watanabe and
Kitajima, 2005). In Drosophila or yeast, the contribution of Sgo/Mei-
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S332 to mitotic chromosome segregation is modest. In contrast, HeLa
cells depleted of Sgo1, one of the two human members of this family,
causes premature sister chromatid separation during mitosis (Kitajima
et al., 2005; Salic et al., 2004; Tang et al., 2004) Sgo acts in concert
with protein phosphatase 2A (PP2A), where it is likely to counteract
Plk1-dependent phosphorylation of cohesin and thereby prevent
dissociation of cohesion from the centromeres (Kitajima et al., 2006;
McGuinness et al., 2005; Riedel et al., 2006; Salic et al., 2004; Tang et
al., 2006).
Centromeric cohesin is essential for chromosome segregation
in mitosis. For proper chromosome segregation, the sister
kinetochores must attach spindle MTs emanating from opposite poles,
and centromeric sister chromatid cohesion is essential in antagonizing
the pulling force of the spindle microtubules. Centromeric sister
chromatid cohesion is dissolved at the metaphase to anaphase
transition. Once the SAC is satisfied, the APC/C is activated and
promotes the ubiquitin dependent-destruction of the sequestering
chaperone securin, which leads to the activation of the protease
separase. Cohesin release results from site-specific cleavage of the
Scc1 subunit by separase (Uhlmann, 2001). Scc1 phosphorylation by
polo is not essential but enhances in vitro cleavage by separase
(Alexandru et al., 2001; Hauf et al., 2005; Hornig and Uhlmann, 2004).
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Figure 5: The cohesin network. The Scc2-Scc4 loading complex deposits the
cohesin complex onto chromatin in the G1 phase of the cell cycle. Cohesion is
established between sister chromatids concomitantly with DNA replication in an Eco1-
dependent manner. Upon entry into G2/M phase cohesion is maintained by the
proteins Pds5, Sororin and WpI1. Mammalian cells remove cohesin along
chromosome arms during prophase via phosphorylation of Scc1/Rad21 by Polo-like
kinase. During metaphase centromeric cohesin is protected from removal by Sgo and
PP2A. At the onset of anaphase, separase cleaves Scc1/Rad21 leading to the opening
of the cohesin ring and the separation of sister chromatids. (Adapted from Xiong and
Gerton, 2010).
1.4.2. Chromosome condensation
Chromosome condensation is essential for correct
chromosome segregation and therefore faithful transmission of genetic
information to daughter cells. One important player of the process of
chromosome compaction is the condensin complex. There are two
condensin complexes in vertebrate cells: condensin I and II. Both
complexes are pentameric composed by two SMC ATPase subunits
(SMC2 and SMC4) and three auxiliary subunits (CAP-G/G2, CAP-
D2/D3 and CAP-H/H2) (Hirano, 2005; Ono et al., 2003) (fig. 6).
Drosophila appears to have both complexes but no homologue has
been identified for CAP-G2. The condensin complex is highly
conserved and is found ubiquitously among eukaryotes, while
prokaryotes have a condensin-like complex.
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Figure 6: Composition of the condensin complexes. Condensin’s SMC2/SMC4
dimer associates with a CAP-H -kleisin or with a CAP-H2 -kleisin in condensin I or II
complexes, respectively. Separate pairs of HEAT repeat-containing proteins associate
with condensin I (CAP-D2 and CAP-G) or II (CAP-D3 and CAP-G2).
The two condensin complexes have different localization
patterns in the cell cycle and on chromosomes. In vertebrates,
condensin I is thought to localize to the cytoplasm during interphase
and gain access to chromosomes only at the end of prophase after
NEBD. It then dissociates again from chromosomes at the end of
telophase. Condensin II is nuclear during interphase but only
associates with chromatin until prophase, where it remains until the
end of telophase (Gerlich et al., 2006; Hirota et al., 2004; Ono et al.,
2004). Both complexes are present at centromeres and along
chromosome arms. They bind to different places along chromosome
axes and are both necessary for mitotic chromosome segregation
(Ono et al., 2004).
Recent data in yeast suggests that like cohesin, the condensin
complex might be loaded onto chromosomes by the Scc2-Scc4
complex. Budding yeast scc2 and scc4 mutants displayed
chromosome compaction defects and reduced condensin binding
(D'Ambrosio et al., 2008).
Condensin’s loading on chromosomes during early mitosis is
accompanied by the compaction of sister DNAs into largely separate
linear rod-shaped structures. Several studies showed condensin has a
role in organizing mitotic chromatids that is essential for their
successful segregation during anaphase. However the mechanism of
action and its contribution to chromosome condensation is poorly
understood. Although in vitro studies suggested condensin to be a key
player in chromosome condensation (Hagstrom et al., 2002; Hirano,
2005; Hudson et al., 2003; Strunnikov et al., 1995), several studies
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showed that chromosomes depleted of condensin do condense. The
first defect observed in cells depleted of condensin is associated with a
delay in the timing of prophase compaction. Elimination of both
condensin complexes in chicken DT40 cells revealed no appreciable
chromosome condensation in G2/M cells with intact nuclear envelopes
(Hudson et al., 2003). However, after NEBD, chromosomes were able
to undergo a nearly normal condensation process (Hudson et al.,
2003; Kaitna et al., 2002).   Depletion of condensin II-specific subunits,
but not in those depleted of condensin I-specific subunits, leads to a
delay in chromosome condensation within prophase (Hirota et al.,
2004; Ono et al., 2004). By metaphase, depletion of condensin I- or
condensin II-specific subunits produces distinct, highly characteristic
defects in chromosome architecture, i.e., swollen or curly
chromosomes, respectively. These data are consistent with distinct
contributions of condensin I and II to mitotic chromosome structure.
Depletion of the SMC core subunits causes the severest defects
revealing cloud-like chromosomes with a very fuzzy appearance (Ono
et al., 2003). Condensin depletion was also shown to lead to the
mislocalization of a number of non-histone chromosomal proteins,
including topoisomerase II (TopoII), inner centromere protein
(INCENP) and KIF4A/chromokinesin (Hudson et al., 2008; Hudson et
al., 2003).
TopoII is an evolutionarily conserved protein, and removes
catenation between sister chromatids that remains after completion of
DNA replication (Wang, 2002). Indeed, it is thought that sister
chromatid resolution is achieved by the cooperation between
topoisomerase II and condensins (Coelho et al., 2003; Steffensen et
al., 2001). DmSMC4-depleted cultured cells failed to localize TopoII to
a clearly defined chromatid axial structure and protein extracts from
DmSMC4-depleted cells exhibited a significant decrease in TopoII-
mediated DNA decatenation activity (Coelho et al., 2003).
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In condensin mutants, mitotic chromosomes interact normally
with spindle MTs and chromosomes congress to the metaphase plate
with rare defects (Gerlich et al., 2006; Hagstrom et al., 2002). Upon
anaphase onset, severe defects are observed in condensin mutants
and condensin depleted cells. Chromosome segregation at anaphase
almost always fails, leading to the formation of prominent chromatin
bridges and cytokinesis failure (Hagstrom et al., 2002; Hirota et al.,
2004; Hudson et al., 2003; Kaitna et al., 2002; Ono et al., 2003; Saka
et al., 1994; Savvidou et al., 2005; Steffensen et al., 2001).  Premature
loss of chromosome compaction is apparently the cause of these
chromosome segregation defects in early anaphase (Gerlich et al.,
2006; Vagnarelli et al., 2006), and not due to the failure of TopoII
decatenation activity (Vagnarelli et al., 2006). On the other hand, it has
also been suggested that condensins have additional and distinct roles
during anaphase to achieve proper chromosome segregation (Wignall
et al., 2003; Yanagida, 2009). The potential roles of condensins during
anaphase remain elusive. Different studies have shown an extent of
defects observed in condensin depleted cells. The observed defects
seem however to vary among different organisms and different
conditions, thereby leaving room for different interpretations (Losada
and Hirano, 2005).
2. Posttranslational modifications
One of the most significant conclusions of the Human genome
project was the small number of annotated genes, which was
approximately twice of the number of genes annotated in Drosophila
melanogaster (2004; Adams et al., 2000). This suggested that an
increase in biological complexity does not necessarily translate in a
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proportional increase in gene number. Indeed proteomes may be
orders of magnitude more complex than the encoding genomes would
predict. The first route of diversification of proteins is at the level of
alternative transcriptional start sites and pre-mRNA alternative splicing.
The second route of proteome expansion is by covalent
posttranslational modification (PTM) of proteins at one or more sites.
As the name implies, PTMs are covalent modifications that occur on
protein side chains or their backbones by the addition of a chemical
group either during or after assembly of the polypeptide chain (Walsh
et al., 2005). PTMs can regulate protein function, by causing changes
in protein activity, protein cellular locations and dynamic interactions
with other proteins (fig.7). Proving the relevance of these modifications
in protein processing, about 5% of the genomes of higher eukaryotic
can be dedicated to enzymes that carry out PTMs of their proteomes.
Figure 7: Schematic representation of protein modifications related to the
regulation of downstream biological processes. (Adapted from Seo and Lee,
2004).
Most common PTMs include phosphorylation (Burnett and
Kennedy, 1954), acetylation (Glozak et al., 2005), methylation (Grewal
and Rice, 2004), glycosylation (Spiro, 2002), sumoylation (Gareau and
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Lima, 2010), and ubiquitination (Pickart and Eddins, 2004). These
modifications regulate a variety of different cellular processes,
including cell cycle progression and its regulation.
2.1. Posttranslational modifications and the cell
2.1.1. Phosphorylation
Phosphorylation of Serine (Ser), Threonine (Thr), Tyrosine
(Tyr) and Histidine (His) residues is the best known and most
ubiquitous PTM. Because the phosphate group (-O-PO32-) carries a
large negative charge at neutral pH, phosphorylation of neutral amino
acids induces altered conformations in local protein microenvironments
(Johnson and Lewis, 2001). Phosphorylation can therefore modulate
protein function by altering protein stability, cellular localization,
substrate affinity, complex formation and activity.
The addition of a phosphate group on a substrate protein is
catalyzed by protein kinases, while hydrolyses of the phosphate group
is achieved by protein phosphatases. Eukaryotes express a large
variety of protein kinases (Manning et al., 2002) and phosphatases
(Moorhead et al., 2007; Virshup and Shenolikar, 2009), each with a
unique substrate specificity and regulation. The expansion of the
protein kinase families in higher metazoans accounts for the observed
cellular and functional diversity between these organisms. Due to its
reversible and transient nature, phosphorylation allows signal
transduction pathways to carry out diverse cellular functions. Moreover
it also allows essential events such as cell cycle and growth to occur at
precise times and locations.
The eukaryotic cell cycle is an example of cellular decision-
making based on reversible phosphorylation and dephosphorylation of
proteins. One third of the Drosophila kinome was shown to affect cell
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cycle progression (Bettencourt-Dias et al., 2004). Cdks regulate the
G1, S and G2 phases of the cell cycle ensuring DNA duplication and
segregation of chromosomes into daughter cells (fig. 8). Cdks are
themselves regulated and cooperate with other protein kinases.
Figure 8: Mitotic phosphoregulation in animal cells. Upper panel shows the
different mitotic stages and highlights major events known to be regulated by
reversible protein phosphorylation. Middle panel indicates the activity phases of the
major mitotic kinases. Lower panel shows known mitotic phosphatases with respect to
the depicted mitotic events. Exact timing of activation and inactivation of most mitotic
phosphatases is not known as depicted by open bars. (Adapted from Bollen et al.,
2009).
Among the different kinases, Cdk1 has an essential role in
mitotic entry and progression until all chromosomes are properly
aligned along the metaphase plate (Morgan, 2007). Entry into
anaphase and subsequent mitotic exit requires inactivation of Cdk1
and other mitotic regulators (Sullivan and Morgan, 2007). This
inactivation is primarily mediated by proteosome-dependent
degradation of proteins by the APC/C and also by controlled removal
CHAPTER I
20
of mitotic phosphorylations by different phosphatases. Mitosis relies
therefore in a delicate balance between the activities of kinases and
their counteracting phosphatases.
2.1.2. Acetylation
The role of acetylation has been suggested to be analogous to
that of phosphorylation (Kouzarides, 2000). Many proteins are
posttranslationally acetylated, and at least for eukaryotic proteins,
acetylation is the most common covalent modification out of over 200
reported types. Protein acetylation is catalyzed by a variety of different
acetyltransferases. These enzymes catalyze the transfer of an acetyl
group from acetyl-coenzyme A (Acetyl-CoA) to either the -amino
group of amino-terminal residues (N-terminal acetylation, revised in
Chpater I, section 3.) or to the -amino group of lysine (Lys) residues
at various positions. The -amino group designates the position of the
central carbon atom of amino acids, whereas the -amino group of
lysine residues designates the position of a carbon atom on the side
chain.
The introduction of acetyl groups on Lys side chains potentially
converts cationic side chains into neutralized surfaces influencing
protein function or its association with other proteins. Acetylation of -
Lys residues occurs on histones, high mobility group (HMG) proteins,
transcription factors, nuclear receptors (Bannister et al., 2000; Imhof et
al., 1997; Roth et al., 2001) and -tubulin (MacRae, 1997).
Most studied acetylated proteins include N-acetylation of Lys
side chains on the N-terminal tail of histones (Yang, 2004). Two
groups of enzymes responsible for regulating the reversible and
dynamic state of histone acetylation are histone acetyltransferases
(HATs) and histone deacetylases (HDACs). Acetylation of histones, in
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general, leads to transcriptional activation by inducing the unpacking of
the nucleosomes from the tight 30nm chromatin fibers. This allows
manipulating the tightly packed heterochromatin to more relaxed
euchromatin state (fig. 9), which in turn allows other transcriptional
regulatory proteins to gain access to promoter elements on DNA. The
acetylation state of different promoters is maintained by specific
combinations of HATs and HDACs. Not surprisingly, histone
acetylation appears to influence other processes including cell cycle
progression, chromosome dynamics, DNA replication, recombination
and repair, silencing and apoptosis (Kouzarides, 1999).
Figure 9: Histone acetylation and transition of heterochromatin to euchromatin.
Representation of the molecular structure of acetylated and deacetylated lysine
residues and resultant chromatin state. (adapted from Khan and Khan, 2010).
2.1.3. Methylation
Although there are known examples of protein side chain
methylation, histone N-terminal tail methylation draws most research
attention. Since methyl groups are relatively small, addition of these
groups to Lys and Arginine (Arg) residues does not neutralize their
charges, having little effect on histone conformation. Instead,
methylation has been associated with the creation of binding sites for
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specific regulatory proteins (Bannister and Kouzarides, 2005).
Therefore, unlike acetylation, which generally correlates with
transcriptional activation, histone lysine methylation can signal either
activation or repression, depending on the sites of methylation
(Cuthbert et al., 2004). The -amino group of Lys can accept up to
three methyl groups and hence can be mono-, di- or trimethylated
(Martin and Zhang, 2005). For certain processes, methylation on the
same site can lead to different outcomes depending on the number of
methyl groups added.
2.1.4. Ubiquitination
Ubiquitination is likely to affect all proteins at some point in their
life cycle. Ubiquitin (Ub) a highly conserved 8.5 kDa protein that
becomes covalently attached to Lys residues of target proteins in an
inducible and reversible manner. This attachment occurs through a 3
step process involving 3 different types of enzymes, E1, E2 and E3
ligases (Pickart and Eddins, 2004). According to the number of Ubs
added, substrate proteins can be monoubiquitinated or
polyubiquitinated. Monoubiquitination is believed to serve as a
regulatory modification of a target protein in much the same way
phosphorylation regulates protein activity (Weissman, 2001). However,
the most common role associated to ubiquitination is the tagging of
proteins for degradation. The vast majority of proteins (80-90%) tagged
by Ub polypeptides are then degraded via the 26 S proteasome (Craiu
et al., 1997; Rock et al., 1994). This degradation signal usually
involves protein polyubiquitination. One example where ubiquitination
plays a central role is in cell cycle progression. The characteristic
temporal control of proteins destroyed during the cell cycle, such as
the cyclin subunits of cdks, is performed by the E1-E2-E3 ubiquitin
ligase machinery of the APC/C (Nakayama and Nakayama, 2006).
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3. N-terminal acetylation
Besides -amino acetylation of side chain residues, acetylation
can also occur at the -amino group of protein N-terminals. This
modification is an enzyme catalyzed reaction in which the protein -
amino group accepts an acetyl group from Acetyl-CoA. N-acetylation
neutralizes positive charges that can influence protein function,
stability, interaction with other molecules, or other subsequent
modifications, such as phosphorylation.
N-acetylation is one of the most common protein modifications
in eukaryotes. Indeed, different studies revealed N-acetylation of
approximately 85% of soluble cytosolic human proteins (Arnesen et al.,
2009b; Jornvall, 1975; Persson et al., 1985) and approximately 50% in
yeast (Arnesen et al., 2009b; Lee et al., 1989).
N-acetylation often occurs in two consecutive events
(Bradshaw et al., 1998; Polevoda and Sherman, 2002). In the first
step, the initiator methionine (iMet; fig. 10), is removed from the
nascent polypeptide by methionine aminopeptidases (MAP). This
event is not obligatory in protein biosynthesis and has been shown to
only take place if the second amino acid is small and uncharged
(Boissel et al., 1988; Sherman et al., 1985). Larger amino acids at this
position prevent removal of iMet by sterical hindrance (Lowther and
Matthews, 2000). In the second step, the acetylation of the amino-
terminus is catalyzed by N-terminal acetyltransferases (NATs; fig.10).
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Figure 10: Schematic representation of initial methionine removal followed by
N-terminal acetylation. During translation of a protein, when the iMet is followed by
a small and uncharged amino acid residue, it will be removed by a methionine
aminopeptidase (MAP, orange). Following iMet removal, the processed amino-
terminus will be acetylated at the -amine of the following amino acid residue by a
NAT (green).
NATs form a subfamily within the Gcn5-related N-
acetyltransferases (GNAT) superfamily (Polevoda et al., 1999). GNATs
are one of the largest known protein superfamilies, with more than 10
000 members in all kingdoms of life (Vetting et al., 2005). Accordingly,
NATs have been found in all kingdoms: prokaryotes, archaeal, and
eukaryotes (Polevoda and Sherman, 2000; Polevoda and Sherman,
2003b). In humans, as in yeast, three NAT complexes are believed to
perform most N-acetylation events, namely the human NatA, NatB
and NatC complexes (Arnesen et al., 2005a; Asaumi et al., 2005;
Starheim et al., 2008; Starheim et al., 2009a). Each NAT acts on
different groups of amino acid sequences, whose specificity is
determined by two or more residues at the amino-terminal positions
(table 1). However, for some proteins, acetylation does not occur even
if the appropriate amino acid sequences are present, suggesting that
additional unknown amino acid sequence patterns or other
determinants like secondary structure of the protein N-terminus may
play a role (Polevoda and Sherman, 2003b).
All eukaryotic NATs so far identified were shown to interact with
ribosomes and N-acetylation is believed to take place during protein
synthesis (Gautschi et al., 2003; Polevoda et al., 2008; Starheim et al.,
2008; Starheim et al., 2009a). In vitro studies demonstrated that
cotranslational N-acetylation takes place when the nascent
polypeptide extrudes 20 to 50 amino acids from the ribosome
(Driessen et al., 1985; Kendall et al., 1990).
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Type NatA NatB NatC NatD NatE
Catalytic
subunit
Naa10p
(Ard1p)
Naa11p
(Ard2p)
Naa20p
(Nat3p)
Naa30p
(Mak3p)
Naa40p
(Nat4p) Naa50p
Auxiliary
subunit
Naa15p
(Nat1p)
Naa16p
(Nat2p)
HYPK*
Naa25p
(Mdm20p)
Naa35p
(Mak10p)
Naa38p
(Mak31p)
-
Naa15p?
(Nat1p)
Naa10p?
(Ard1p)
Substrates
Ser-
Ala-
Thr-
Val-
Gly-
Cys-
Met-Glu-
Met-Asp-
Met-Asn-
Met-Leu-
Met-Ile-
Met-Trp-
Met-Phe-
Ser-Gly-
(H2A/H4) Met-Leu-
Table 1: Eukaryotic N-terminal acetyltransferases and there substrates. N-termini
of which the iMet is followed by one of the small amino acids, Ser-, Ala-, Thr-, Val-,
Gly-, Cys-, and Pro- undergo iMet cleavage performed by a methionine
aminopeptidase (MAP). These N-termini, with the exception of Pro-, are often further
acetylated by NatA (Arnesen et al., 2009b; Polevoda et al., 1999), or in the case of
Histone H2A and H4, by NatD (Song et al., 2003). Met-Asp-, Met-Glu-, Met-Asn- and
Met-Gln- are acetylated by NatB (Polevoda et al., 1999; Polevoda and Sherman,
2003b). Hydrophobic Met-Leu-, Met-Ile-, Met-Phe- and Met-Tyr- are acetylated by
NatC (Kimura et al., 2000; Polevoda et al., 1999; Tercero et al., 1993). Met-Leu- N-
termini have been demonstrated to be acetylated by Naa50p in vitro (Evjenth et al.,
2009) *HYPK is an interactor partner of NatA in humans and may modulate NAT-
activity (Arnesen et al. 2010).
In contrast to other PTMs, very little is known about the
biological relevance of N-acetylation in the context of a developing
multicellular organism. Nevertheless, multiple evidences suggest it is
essential for development and is likely to play an important role during
carcinogenesis (Starheim et al., 2009b). Work in yeast and mammalian
cell culture described NATs in vivo substrate specificities (table 1) and
knockdown phenotypes, yet the N-acetylated substrates associated to
the observed phenotypes are mostly unknown.
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3.1. The NatA acetyltransferase complex
Among the three major NAT complexes, NatA acetyltransferase
complex is the most studied one. This complex is conserved from
yeast to humans in respect to subunit composition (Arnesen et al.,
2005a) and substrate specificity (Arnesen et al., 2009b). Functional
complementation studies demonstrated that expression of the human
NatA complex (hNAA10-hNAA15) rescued the phenotypes observed in
a yeast NatA-deletion strain. Furthermore, when expressed in yeast
the hNatA complex could N-acetylate the same set of substrates as
the yeast NatA complex in vivo (Arnesen et al., 2009b).
The NatA complex acetylates N-termini in which the initial iMet
was removed by MAPs. It also seems to be the most degenerate NAT
complex, including a wide range of sequences, although N-terminal
residues of Ser and alanine (Ala) are the most common ones (Arnesen
et al., 2009b; Polevoda et al., 1999) (table 1).
NatA is believed to be the major NAT complex both in yeast and
humans having a higher amount of potential substrates in comparison
to the NatB and NatC complexes (Arnesen et al., 2009b; Polevoda and
Sherman, 2003b). Based on the substrate specificity of this complex
and the N-terminal sequences of all known human proteins, it was
estimated that more than 8.000 (from a total of 20.000) unique human
proteins are hNatA substrates. Indeed, a large number of NatA
substrates were identified in vivo by analysis of the N-terminal
acetylation levels of protein extracts from control and downregulated
NatA subunits in HeLa cells (Arnesen et al., 2009b). Surprisingly,
downregulation of the hNatA complex only led to a significant change
in the acetylation status of 6% of the identified hNatA substrates. The
authors attributed this to a residual presence of the hNatA complex
being able to acetylate most of its substrates (Arnesen et al., 2009b).
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Another possibility is a partial redundancy of other NATs with the NatA
complex.
The NatA complex is composed by the catalytic subunit
Naa10p (Ard1p) and the auxiliary subunit Naa15p (Nat1p; Table 1)
(Arnesen et al., 2005a; Mullen et al., 1989). Both human subunits were
found to be associated with ribosomes, suggesting Naa10p performs
cotranslational acetylation of nascent polypeptides (Arnesen et al.,
2005a). However, a significant proportion of these subunits were also
found to be non-ribosomal (Arnesen et al., 2005a), suggesting these
proteins might have other functions independent of the NatA complex.
Naa10p protein levels are dependent on Naa15p; depletion of Naa15p
significantly diminished Naa10p protein levels on ribossomes,
suggesting Naa15p is likely to anchor Naa10p to the ribosome (Hou et
al., 2007; Polevoda et al., 2008).
Interestingly, humans contain paralogues of the hNaa10p and
hNaa15p proteins, hNaa11p and hNaa16p, respectively (Arnesen et
al., 2006b; Arnesen et al., 2009a). These were suggested to form less
abundant functional NatA complexes, allowing for four possible
combinations of the different NatA subunits (Arnesen et al., 2006b;
Arnesen et al., 2009a).
The hNatA complex was recently described to interact with the
Huntingtin (Htt) yeast two-hybrid protein K (HYPK). HYPK has
chaperone-like properties preventing Htt polyglutamine (polyQ)
aggregation. The NatA complex was essential for the proper
expression of the HYPK protein and for the modulation of Htt polyQ
aggregation. Moreover, the interaction of HYPK with the NatA complex
was shown to be required for normal in vivo and in vitro acetylation of
a known NatA substrate (Arnesen et al. 2010). It is not clear in human
cells however, if HYPK influences NatA acetylation activity in general
or the acetylation of specific substrates. If further studies confirm the
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latter hypothesis, it opens a window to hypothesize that the NatA
activity might be modulated by different cofactor proteins to modulate
different substrate acetylation events.
Another subunit, San/Naa50p (Nat5p), was shown to physically
associate with the NatA complex (Gautschi et al., 2003) and form a
complex known by NatE. Since San/Naa50p is central for this
dissertation, I will further focus on this NAT in more detail on section
3.5. of this chapter.
3.1.1. Naa10/ Ard1 acetyltransferase
Naa10p is the catalytic subunit of the NatA acetyltransferase
complex. Different mammalian Naa10p isoforms have been identified.
These include mouse variants mNaa10p198, mNaap10225 and
mNaa10p235, and the human variants hNaa10p131 and hNaa10p235.
Mouse and human Naa10p235 are orthologs and are considered the
wild-type protein (Chun et al., 2007; Jeong et al., 2002). hNaa10p235
localizes at the nucleus and cytoplasm (Arnesen et al., 2005a), while
mNaa10p225 and mNaa10p235 are present at the cytoplasm and the
nucleus, respectively (Chun et al., 2007), suggesting Naa10p may
have different functions according to its localization. These Naa10p
isoforms share a conserved N-acetyltrasferase domain but contain
different sequences and lengths at their C-terminal region (Bilton et al.,
2006). The C-terminal region is unstructured and flexible (Sanchez-
Puig and Fersht, 2006), and was shown to be phosphorylated at
several sites (Beausoleil et al., 2006; Olsen et al., 2006), suggesting a
possible regulation of this NAT by different phosphorylation states.
Indeed hNaa10p was shown to be phosphorilated at Ser209 by IkB
kinase  (IKK), leading to the destabilization and induction of
proteasome-mediated degradation (Kuo et al., 2009). Some of the
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phosphorylation events were also shown to be mediated by Glycogen
synthase kinase 3 (GSK-3) kinase (Malen et al., 2009).
Interestingly, mammalian Naa10p was suggested to have -
amino acetyltransferase activity. mNaa10p225 was shown to N-
acetylate the transcription factor hypoxia-inducible factor 1 (HIF-1),
at Lys532, enhancing its ubiquitination and further proteasomal
mediated destruction (Jeong et al., 2002). However mNaa10p235 and
hNaa10p did not destabilize HIF-1 (Kim et al., 2006), reinforcing the
idea that different Naa10p isoforms might have distinct biological
functions. Furthermore, a recent study showed hNaa10p is
autoacetylated in vivo at the internal lysine, K136. Autoacetylation of
hNaa10p was required for binding and activation of -catenin, which is
a transcription factor for cyclin D1 expression in human lung cancer
cells (Seo et al.). These results suggested that autoacetylation of
hNaa10 is required for its enzymatic activity and reinforced the -amino
acetyltransferase activity of mammalian Naa10p.
hNAA10 seems to be ubiquitously expressed in most human
tissues and several human cancer cells lines (Arnesen et al., 2005b;
Bilton et al., 2005; Jeong et al., 2002; Starheim et al., 2009b). hNAA10
was shown to be expressed at higher levels in the brain, heart, liver
and skeletal muscle (Jeong et al., 2002).
A mammalian specific gene duplication event of hNAA10 gave
rise to a paralogue known by hNAA11. Like hNaa10p, hNaa11p
localizes both at the nucleus and the cytoplasm and was shown to be
expressed in several human cell lines. In contrast with hNAA10 which
is broadly expressed, expressed sequence tag (EST) data shows that
hNAA11 expression is confined to certain tissues (liver, placenta, skin,
testis) (Starheim et al., 2009b). Similar to Naa10p, mouse and human
Naa11p interacts with Naa15p and exhibits N-acetyltransferase
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activity (Arnesen et al., 2006b; Pang et al., 2009), suggesting this
complex may be responsible for protein N-acetylation in mammalian
cells. Interestingly, in NB4 cells undergoing retinoic acid-mediated
differentiation, the levels of endogenous hNaa10p and hNaa15p
proteins decreased while the level of hNaa11p was maintained stable,
suggesting differences in the function of these proteins (Arnesen et al.,
2006b).
mNAA11 was shown to be upregulated in testis during male
spermatogenesis. No mNAA11 expression was found in somatic
tissues, except for a trace amount in the ovary (Pang et al., 2009).
Since mNAA10 is located on the X chromosome it is not expressed
during expermatogenesis, which was confirmed by RT-PCR. The
authors proposed that the upregulation of mNAA11 in the testis was to
complement the function of mNaa10p during male meiosis (Pang et
al., 2009).
3.1.2. Naa15 /NatH acetyltransferase
hNaa15p is the auxiliary subunit of the NatA complex. It was
described to be localized to the cytoplasm (Arnesen et al., 2005a).
Protein sequence analysis revealed yeast Naa15p contains 4 or 5
tetratrico-peptide repeat (TPR) motifs (Polevoda and Sherman,
2003a). TPR motifs are usually associated with protein-protein
interactions. The authors suggested these domains could be involved
in the interaction of yNaa15p with nascent polypeptides or with other
NatA subunits (Polevoda and Sherman, 2003a).
Naa15p expression seems to correlate with cell proliferation.
hNAA15 is normally expressed at low levels in most adult tissues, with
the exception of parts of the human brain, heart, testis, ovaries,
spleen, colon and stomach (Line et al., 2002). High levels of
expression were also detected in Burkitt lymphoma cell lines,
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colorectal carcinoma SW480 cell lines, and in papillary thyroid
carcinomas (Fluge et al., 2002; Line et al., 2002). Expression of this
NAT seems to correlate with especially aggressive and
undifferentiated tumors (Fluge et al., 2002). These data suggest that
Naa15p is involved in cell proliferation, however its exogenous
expression in embryonic kidney and papillary thyroid carcinoma cell
lines did not significantly alter the cellular proliferation rate (Fluge et
al., 2002).
The mouse Naa15p, also known as the NMDA receptor-
regulated gene 1 (NARG1) was significantly expressed in the
developing brain. mNAA15/NARG1 was shown to be regulated in vivo
by physiological levels of NMDA receptor function in developing
neurons (Sugiura et al., 2001). NMDA receptors are highly expressed
in the neonatal brain in regions of neuronal proliferation and migration,
but downregulated during early postnatal development.
A mouse splice variant of mNaa15p, also designated by
tubedown-1 (tbdn-1) was shown to be expressed in different tissues
during development. Tbdn-1 was shown to be highly expressed in the
developing embryo and placenta, and in unstimulated mouse
embryonic cell lines during blood vessel development. The protein was
also downregulated in myeloid leukemia cells after differentiation
induction (Gendron et al., 2000). In adult tissues Tbdn-1 expression
was generally low or undetected with the exception of the arterial
endocardium, endothelium of retinal vessels, bone marrow tissue, and
ovaries (Gendron et al., 2000).
hNaa15p (Tbdn100) was also proposed to mediate the stable
assembly of the Ku-transcriptional complex at the Osteocalcin
promoter of in human osteosarcoma cells. Chromatin
immunoprecipitation experiments indeed revealed that both Ku and
hNaa15 were associated with the Osteocalcin promoter (Willis et al.,
2002). Indeed, both the knockdown of Naa15p in animal models and
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the suppression of Naa15p expression in human retinal-disease
specimens have been associated with increased angiogenesis and
pathological neovascular retinopathies (Gendron et al., 2001; Gendron
et al., 2006; Paradis et al., 2008; Paradis et al., 2002; Wall et al.,
2004).
An orthologue of hNaa15p, hNaa16p, was recently identified.
This NAT resulted from an early vertebrate duplication event from the
common ancestor of hNAA15 and hNAA16. Immunoprecepitation
assays confirmed the presence of the endogenous hNaa10-hNaa16
complex. hNAA16 was shown to be expressed in a variety of human
cell lines. This NAT was shown to be ribosome and non-ribossome
associated and to exhibited acetyltransferase activity in vitro.
Knockdown of hNaa16p lead to cell death suggesting an essential
function of this NAT (Arnesen et al., 2009a). In contrast to hNaa15p,
hNAA16 expression does not seem to correlate with cell proliferation.
hNAA15 was shown to be the dominant variant in most tissues, with
few exceptions (Arnesen et al., 2009a).
3.1.3. Knockout studies demonstrate that the NatA complex is
involved in several biological processes
According to knockout studies, NatA seems to play an
important role in cell cycle and cell growth. Yeast mutants of both
subunits of the NatA complex are viable but exhibit a wide range of
defects including slower growth, temperature sensitivity, salt
sensitivity, defects in sporulation, derepression of the silent mating
type gene HML and failure to enter G0 (Mullen et al., 1989; Park and
Szostak, 1992). Both yNaa10p and yNaa15p were shown to influence
transcriptional silencing at telomeres (Longtine et al., 1993; Stone et
al., 1991). Indeed, overexpression of SIR1, which is known to be
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involved in silencing transcription of the silent mating-type genes,
suppressed the yNatA mutant defects in mating due to derepression of
the silent loci. yNaa15/yNat1 was also identified in a yeast genome-
wide search to affect chromosome stability. Both deletion and
overexpression of yNaa15p led to chromosome loss (Ouspenski et al.,
1999).
In contrast to yeast, orthologues of yNaa10p/yArd1p in higher
eukaryotes such as Trypanosoma brucei and Drosophila melanogaster
are essential genes (Ingram et al., 2000; Wang et al. 2010).
Knockdown of both Naa10p and Naa15p in Caenorhabditis elegans
are embryonically lethal (Sonnichsen et al., 2005). Loss-of-function
mutations of the gene variable nurse cells (vnc), which encodes the
Drosophila Naa10p led to several defects during oogenesis. These
defects included abnormal cyst encapsulation, desynchronized
cystocyte division, disrupted nurse cell chromosome dispersion and
abnormal chorion patterning (Wang et al. 2010). These pleiotropic
defects are consistent with the wide range of predicted NatA
substrates.
Depletion of hNAA10-hNAA15 in human cell lines resulted in
reduced cell viability by induction of apoptosis and cell cycle arrest
(Arnesen et al., 2009a; Arnesen et al., 2006c). Consistently,
knockdown of hNAA10 in HepG2 cells influenced genes involved in
cell proliferation and energy metabolism. Genes involved in cell
growth, survival and metabolism were down regulated, while
antiproliferative genes were upregulated (Fisher et al., 2005).
Moreover, over-expression of hNAA10 led to upregulation of genes
involved in cell cycle, growth and survival such as CDC2 (cell division
cycle 2), CCNA2 (Cyclin A2) and BIRC5 (apoptosis inhibitor surviving)
(Fisher et al., 2005). Indeed, another study suggested hNaa10 could
participate in cell proliferation as an activator of the -catenin pathway
(Lim et al., 2006). The authors attributed inhibition of cell proliferation
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and induction of G1 arrest in lung cancer cell lines depleted of hNaa10
to the transcriptional repression of the cyclin D1 gene (Lim et al.,
2006). hNaa10p knockdown inhibited the activity of the -catenin/TCF,
which is a transcription factor for cyclin D1. The same study showed
hNaa10p associated and acetylated -catenin, which in turn induced
the binding of TCF4 to cyclin D1 promoter (Lim et al., 2006).
The NatA complex was also implicated in neuronal dentritic
development. Both mNAA15 and mNAA10 were found to be
expressed postnatally in the cerebellum during Purkinje neuron
development. Purkinje cells exhibit highly complicated dentritic
branching patterns. mNaa10p activity was shown to regulate the
fraction of acetylated tubulin and overexpression of a mutant mNaa10p
form limited dentritic development.
3.1.4. The NatA complex is associated with tumor development
An increasing amount of data has associated tumor
development to the expression of NatA subunits. hNAA10 was shown
to be highly expressed in hepatocellular carcinoma. Its expression was
associated with the dedifferentiation step in liver cancer progression
(Midorikawa et al., 2002). hNaa10p was also found to be
overexpressed in colorectal cancer tissues and breast cancers (Ren et
al., 2008; Yu et al., 2009).
hNAA15 was shown to be overexpressed in papillary thyroid
carcinoma especially in clinically aggressive and undifferentiated
tumors (Fluge et al., 2002). Furthermore, hNaa15p levels were shown
to be overexpressed in human thyroid papillary neoplastic versus non-
neoplastic tissues (Arnesen et al., 2005b). hNAA15 was also
upregulated in gastric cancer (Line et al., 2002). Consistently, in vitro,
retinoic acid-induced neuronal differentiation responses of
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neuroblastoma cells were associated with a significant decrease in
hNaa15p expression (Martin et al., 2007).
Altogether these data strongly suggests a strong correlation
between NatA complex and carcinogenesis, the specific molecular
mechanisms underlying the role of this complex in cancer development
remains mostly unknown.
3.2. The NatB complex
The NatB complex is composed of two subunits, the catalytic
subunit Naa20p (Nat3p) and the auxiliary subunit Naa25p (Mdmp) as
has been observed in yeast and human cells (Polevoda et al., 2003;
Singer and Shaw, 2003; Starheim et al., 2008). Depletion of hNaa25p
significantly diminished hNaa20p levels, indicating hNaa25p is
required for hNaa20p stability (Starheim et al., 2008). Both hNaa20p
and hNaa25p were found at the cytoplasm and present in both
ribosome and non-ribosome bond forms. However these proteins were
shown to be generally higher in the non-polyribosomal fraction
(Starheim et al., 2008), suggesting additional functions than the ones
related with the ribosomal-bound ones. The hNaa20p subunit but not
hNaa25p, was also found at the nucleus, suggesting hNaa20p might
have other functions independent of the NatB complex (Starheim et al.,
2008).
The yeast NatB complex was shown to potentially acetylate the
N-terminal methionine residue of substrates with the N-terminal
sequence Met-Glu-, Met-Asp- and Met-Asn- (table 1) in a highly
sequence-specific manner (Polevoda et al., 1999; Polevoda and
Sherman, 2003b). Recent studies have shown that the predicted NatB
substrates are completely acetylated in yeast and are almost
completely acetylated in Drosophila and humans (Arnesen et al.,
2009b; Goetze et al., 2009). Supporting the conservation of NatB
CHAPTER I
36
substrate specificity, hNatB was shown to acetylate a peptide with a
Met-Asp- N-terminus in vitro (Starheim et al., 2008). This N-terminus
corresponds to the NF-kB subunit p65, which is known to be
acetylated in vivo (Arnesen et al., 2009b).
3.2.1. NatB known substrates and knockdown studies
Deletion of either yNaa20p or yNaa25p genes resulted in the
reduction of cell growth and mating, and increased sensitivity to DNA-
damaging agents. yNaa20 mutants were defective in actin cable
formation (Hermann et al., 1997; Polevoda et al., 2003). This
phenotype was linked to the loss of acetylation of actin and
tropomyosin 1 (Tpm1), which are known NatB substrates. NatB-
dependent N-terminal acetylation of Tpm1 was shown to be required
for its normal interaction with actin (Singer and Shaw, 2003).
Another substrate of the NatB complex is the conserved
inhibitor of protease carboxypeptidase Y, Tfs1p. Inhibitor activity of
Tfs1p was shown to be N-acetylation dependent. Interestingly, Tfs1p
inhibits Ira2p which is a Ras-GTPase-activating protein in the protein
kinase A (PKA) pathway. These data suggest that N-terminal
acetylation of Tfs1p is essential in the regulation of the PKA pathway
(Caesar and Blomberg, 2004).
Proteins involved in DNA processing and cell cycle progression
were shown to be overrepresented among the yeast predicted
substrates of NatB, suggesting the yeast NatB complex might have an
important function in cellular proliferation (Caesar et al., 2006).
Consistently, knockdown of hNatB subunits inhibited cell growth and
proliferation, and disturbed cell cycle progression. One study
demonstrated that hNaa20p knockdown led to a G0/G1 arrest and an
increase in the levels of the inhibitor of cyclin-dependent kinases p21
(Starheim et al., 2008). Another study found that hNaa20p knockdown
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led to a reduction of cells in G0/G1 but an increase of cells in S phase
and an accumulation of cells in G2/M phase. Furthermore, this later
study showed a strong increase of the tumor suppressor protein 53
(p53) as well as p21 in hNaa20p-inhibited cells (Ametzazurra et al.,
2008). On the other hand, hNaa20p knockdown led to downregulation
of genes that promote cell proliferation (Ametzazurra et al., 2008).
Upregulation of p53 is associated with induction of growth arrest. p21
is a known inhibitor of cyclin dependent kinases and thus functions as
a regulator of cell cycle progression at G1. The expression of p21 is
tightly controlled by tumor suppressor protein p53. These results
strongly suggest the observed growth arrest is linked to p53 and p21
upregulation.
Knockdown of hNaa25p leaded to cell death, a decrease in
G0/G1 cells and a decrease in p21 levels. Since hNaa20p protein levels
are dependent on hNaa25p levels, knockdown phenotypes of
hNaa25p are most likely a combination of the phenotypes of both NatB
subunits. The different effects observed by knockdown of hNaa20p
and hNaa25p can be attributed to downstream mechanisms of this
complex. On the other hand they might also be a result of individual
functions of these subunits from those related to the NatB complex
(Starheim et al., 2008).
The NatB complex has also been suggested to play a role in
neoplastic growth. hNaa20p was found upregulated in tumor tissues of
mouse models of hepatocellular carcinoma. Moreover, hNaa20p was
shown to be increased in malignant tissue of patients with
hepatocellular carcinoma (Ametzazurra et al., 2008).
3.3. The NatC complex
As with the NatA and NatB complexes, the NatC complex is
conserved form yeast to humans. It is composed of the Naa30p
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(Makp) catalytic subunit, and the auxiliary subunits Naa35p (Mak10p)
and Naa38p (Mak31p). In yeast all tree subunits are required for NatC
acetyltransferase activity (Polevoda and Sherman, 2001). hNaa30p
and hNaa35p localize almost exclusively at the cytoplasm, while
hNaa38p also localizes to the nucleus. hNAA38p (Lsmd1) shares
sequence similarity with the Sm-like proteins. The Sm-like proteins are
small ribonucleproteins (snRNP), which are involved in RNA
processing (Mattaj et al., 1993). Therefore, consistent with its nuclear
localization, hNAA38p might have a role in RNA processing
independent of the NatC complex.
All subunits of the NatC complex were found to be ribosomal
and non-ribosomal bound (Starheim et al., 2009a). This suggests that
these proteins might have other functions than the ones related with
co-translational acetylation at ribosomes.
yNatC was shown to acetylate the N-terminal of proteins
containing large hydrophobic amino acids such as isoleucine, leucine,
tryptophan, or phenylanine adjacent to the iMet (Polevoda et al., 1999;
Polevoda and Sherman, 2003a). In vitro assays with hNaa30p
revealed similar substrate specificity supporting conservation of the
NatC complex in eukaryotes (Starheim et al., 2009a).
3.3.1. NatC known substrates and knockdown studies
Mutant yeast strains of all subunits of the NatC complex display
similar phenotypes: diminished growth at 37ºC in medium without
fermentable sources (Polevoda and Sherman, 2001), defective L-A
virus propagation (Wickner and Toh-e, 1982) and loss of telomere
elongation (Askree et al., 2004). A screen for conserved genetic
interactions in yeast identified Naa30p as part of a core genetic
interaction network, suggesting that NatC activity is required for DNA
replication in eukaryotes (Dixon et al., 2008).
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NatC is an essential NAT in higher eukaryotes. Deficient
Zebrafish for Embryonic Growth-Associated factor (EGAF), which is a
homologue of hNaa30p, fail to develop due to decreased cell
proliferation, increased apoptosis and poor blood vessel development
contributing to embryonic lethality. Interestingly, TOR expression and
signaling is significantly reduced in EGAP/zNaa30p morphans
(Wenzlau et al., 2006). mTOR complex is involved in regulation of cell
growth, proliferation and survival (Corradetti and Guan, 2006; Foster
and Fingar, 2010; Wullschleger et al., 2006) Inhibition of zTOR
phenocopied zNaa30 morpholino defects and overexpression of active
TOR rescued zNaa30 morphans, suggesting TOR is a direct substrate
of the NatC complex (Wenzlau et al., 2006).
Consistent with the zebrafish data, hNatC is required for cell
proliferation.  NatC knockdown studies in human cells resulted in
diminished DNA synthesis, reduced cell viability with an increase in the
G1/G0 fraction and p53 induction of apoptosis. hNaa30 knockdown led
to an increase in p53 serine 37 phosphorylation, and an increase of
the pro-apoptotic p53 downstream genes KILLER, NOXA and FAS
(Starheim et al., 2009a).
A known substrate of the NatC complex in vivo, is the yeast
small Arf-like GTPase Arl3p, which is important for membrane
trafficking and organelle structure in eukaryotic cells. Crosslinking
experiments demonstrated that Sysp and Arl3p (Setty et al., 2004) in
yeast, and the respective homologues hSys1 and ARFRP1 in
mammalian cells (Behnia et al., 2004), interact physically, an
interaction which requires N-acetylation of Arl3p, showing this process
is conserved. Another potential substrate of the NatC complex is the
hArl8b Arf-like GTPase. hArl8b needs to be N-acetylated for proper
lysosomal association (Hofmann and Munro, 2006). Indeed hNaa30
was shown in vitro to acetylate an MLAL- N-terminus which
correspond to the N-terminal sequence of hArl8b and matches the
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substrate specificity of the NatC complex. Consistently, hNaa30p
knockdown leaded to aberrant localization of hArl8b (Starheim et al.,
2009a).
3.4. The NatD complex
The NatD complex composed by the Naa40p acetyltransferase
is well conserved from yeast to humans. Recombinant yNaa40p was
shown in vitro to acetylate a Ser- N-terminal peptide corresponding to
Histone H4. Moreover, yeast H4 and H2A were shown to be
unacetylated in yNaa40p mutants (Song et al., 2003). These histones
are known to be N-terminally acetylated in all species from yeast to
mammals, suggesting Naa40p-mediated acetylation is conserved.
Surprisingly, yeast Naa40p mutants did not exhibit any observable
phenotype under all conditions tested (Song et al., 2003).
3.5. San and the NatE complex
The NatE complex is composed of the previously described
Naa10p and Naa15p subunits of the NatA complex and a third subunit
known by Naa50p. This complex has been identified in yeast,
Drosophila melanogaster and human cells, therefore hNaa50 and
dNaa50 are believed to be homologues of the yNaa50 (yNat5p)
(Arnesen et al., 2006a; Gautschi et al., 2003; Williams et al., 2003). In
higher eukaryotes Naa50p was first identified in Drosophila
melanogaster where it was named Separation Anxiety (San) (Williams
et al., 2003).
yNaa50 was found in equimolar concentrations with yNaa10
and yNaa15. Combined with previous data on the size of the yNatA
complex (Lee et al., 1988; Park and Szostak, 1992), the authors
suggested the complex was trimeric (Gautschi et al., 2003). Gel
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exclusion chromatography of Drosophila embryo protein extracts failed
to identify fractions of dSan/dNaa50 corresponding to its monomeric
size (Williams et al., 2003). This suggested dSan/dNaa50 only existed
in a complex with dNaa10 and dNaa15 proteins. However, in contrast
to dSan/dNaa50, 80% of hSan/hNaa50 was found in fractions
excluding the NatA complex, suggesting the majority of human
San/hNaa50 was either not associated or weakly associated with the
NatA complex (Hou et al., 2007).
San/Naa50p is localized at the cytoplasm (Hou et al., 2007;
Williams et al., 2003). Stable association of yNaa50p to the ribosome
was shown to be dependent on yNatA subunits (Gautschi et al., 2003).
Accordingly, optimal protein levels of hSan were also shown to depend
on the NatA complex (Arnesen et al., 2006a; Hou et al., 2007).
However, a dependency of the NatA complex on hSan was not
observed. In contrast to yNatA mutants, knockouts of yNaa50 did not
result in any detectable phenotypes neither affected NatA type
acetylations (Gautschi et al., 2003). Also yNaa50 was demonstrated to
be dispensable for the acetylation of yNaa10p and yNaa15p substrates
(Polevoda and Sherman, 2003b). Moreover, knockdown phenotypes of
hSan/hNaa50 were distinct from those of the NatA complex,
suggesting hSan/hNaa50 functions separately from the NatA complex
(Hou et al., 2007).
As with the previously described acetyltransferases,
San/Naa50p contains a GNAT domain. Regarding substrate
specificity, hSan/hNaa50 preferentially acetylated in vitro peptides
started by ML- (Evjenth et al., 2009). hSan/hNaa50 was also shown to
have both N- and N-acetyltransferase activity in vitro (Chu et al.
2010; Evjenth et al., 2009). In vitro, hSan/hNaa50 is autoacetylated by
an N-acetylation event and this autoacetylation led to an increase in
its N- but not N-acetyltransferase activity, suggesting autoacetylation
is of physiological relevance (Evjenth et al., 2009).
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3.5.1. San is required for centromeric sister chromatid cohesion
San/Naa50p seems to share conserved functions in higher
eukaryotes. Attempts in yeast failed to detect yNaa50 substrates by
two-dimensional gel electrophoresis. The authors (Polevoda and
Sherman, 2003b) suggested this could be a reflection of yNaa50
acetylating a small subset of proteins. Consistent with this, depletion of
San/Naa50p in higher eukaryotic cells leads to specific phenotypes
regarding mitosis.
dSan/dNaa50 was identified in a genetic screen for mitotic
mutants causing late larval and pupal lethality. Indeed mitotic
progression was severely disrupted in san homozygous mutants. san
mutant neuroblasts exhibited a strong mitotic arrest dependent on the
SAC. Moreover, cells which progressed into anaphase revealed
chromosome segregation defects which included lagging
chromosomes and chromosome bridges. In a wild type cell, sister
chromatids do not separate from each other until anaphase onset.
Instead, dsan mutant centromeric connections were already abolished
by prometaphase resulting in premature sister chromatid separation
(PSCS) (Williams et al., 2003). Also, the cohesin subunit,
Drad21/Scc1, was shown to be absent from chromosomal centromeric
regions, suggesting PSCS in san mutants is due to mislocalization of
the cohesin complex from the centromeres (Williams et al., 2003).
During the metaphase to anaphase transition separase degrades
centromeric cohesion to allow disjunction of sister chromatids.
dSan/dNaa50 was shown to act upstream of separase in ensuring
sister chromatid cohesion (Williams et al., 2003).
Depletion of hSan/hNaa50 in cell culture also led to PSCS with
loss of the cohesin subunit, SMC1, at the centromeric region (Hou et
al., 2007). Depletion of both Plk1 and hSan/hNaa50 rescued sister
chromatid cohesion at chromosome arms, but not at the centromeres,
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reinforcing the previous observations that San/Naa50p is specifically
required for centromeric cohesion. Moreover, the acetyltransferase
activity of hSan/hNaa50 was shown to be required for its function in
sister chromatid cohesion. A hSan/hNaa50 Y124F mutant form, which
abolished acetyltransferase activity, was not able to rescue the
cohesion defects when expressed near the physiological levels (Hou et
al., 2007). However, this mutant form does not discriminate between
the N- and N-acetyltransferase activities.  Depletion of hSan/hNaa50
in HeLa cells also lead to mitotic defects which include multipolar
spindles and scattered chromosomes along the mitotic spindle (Hou et
al., 2007).
San/Naa50p function in centromeric cohesion is apparently
conserved in metazoans. Yet, since there are no known in vivo
substrates of this NAT, the exact molecular mechanism by which it is
involved in centromeric sister chromatid cohesion is not known.
Identification of San/Naa50p substrates will ultimately shed light on the
mechanism by which San/Naa50p regulates centromeric cohesion.
CHAPTER I
44
CHAPTER II
Identification of new genes required for syncytial
nuclear divisions
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1. Introduction
Upon Drosophila egg fertilization, embryogenesis starts with 13
synchronous nuclear divisions without cytokinesis. The first 9 divisions
occur in the interior of the embryo. After cycle 9, most nuclei move
outward towards the periphery, to form the so-called syncytial
blastoderm (Foe and Alberts, 1983). This is followed by 4 nuclei
divisions (Foe et al., 2000; Karr and Alberts, 1986; Sullivan and
Theurkauf, 1995) leading to the formation of a multicellular syncytial
blastoderm. Cycles 9/10 are accompanied by the formation of
primordial germ cells (PGCs), also known as pole cells, at the posterior
end of the embryo. After the initial 13 divisions, the cell cycle pauses at
interphase. During interphase of cell cycle 14 the somatic nuclei of the
syncytial blastoderm, that are arranged as a cortical monolayer, are
enclosed into cells by invagination of the plasma membrane in a
process called blastoderm cellularization (Mazumdar and Mazumdar,
2002) (fig. 1). Blastoderm cellularization is a cytokinesis based process
leading to the de novo formation of a polarized epithelium. The
ingrowth of plasma membrane during cellularization requires a number
of proteins and membrane materials, which are recruited by a
microtubule-dependent pathway. Although some mechanisms may be
specific to cellularization, others may share some features with other
cellular processes. Therefore, cellularization is a particularly interesting
system to study cell polarization during development.
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Figure 1: Drosophila melanogaster nuclear cycles during early embryogenesis.
A. In the preblastoderm stage nuclei divide in the interior of the embryo. Nuclear
migration towards the cortex occurs during cycles 8 and 9 and nuclei reach the cortex
by cycle 10. B. Pole cells form at the posterior end of the embryo during cycles 9/10.
At the cortex, nuclei divide three times (cycles 10-13) forming the syncytial blastoderm.
C-D. Cellularization begins during cycle 14 where the plasma membrane invaginates
between the nuclei to form ~6000 blastoderm cells (Adapted from Mazumdar and
Mazumdar, 2002).
In this chapter we have identified 2 complementation groups
defective for syncytial nuclear divisions. One complementation group
was allelic to the separation anxiety (san) gene while the other group
was mapped to a genomic region containing two uncharacterized
coding genes. Interestingly these alleles do not display egg laying
defects, suggesting the mutated genes are not required for germ-line
stem cell divisions. Therefore, we hypothesize the activity of these
genes is mainly required for cell division in somatic tissues. We
speculate that germ-line stem cell mitosis is differentially regulated
when compared to the soma.
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2. Materials and Methods
2.1. Fly husbandry
Unless otherwise stated, flies were raised at 25ºC under
standard procedures (Roberts, 1998). Embryos were collected on
apple juice plates with fresh yeast for further analysis.
2.2. 2R maternal screen
In order to identify new genes required for blastoderm
cellularization we took advantage of a collection of maternal mutants
previously isolated in the laboratory of Dr. Ruth Lehmann (Barbosa et
al., 2007). Due to methodological constraints related to the induction of
germ-line clones all mutants mapped to the right arm of the second
chromosome (2R).
A primary screen isolated 137 independent mutant lines with
abnormal blastoderm cellularization and/or germ-band extension
defects, but normal formation of PGCs. Mutant lines with egg-laying
defects were discarded to avoid mutations in housekeeping genes. A
secondary screen isolated 47 lines from the previous 137. These
mutant lines showed absence or “scraps” of embryonic cuticle. This
phenotype is frequently associated with loss of embryonic ectoderm
integrity.
The FLP/FRT ovoD system (Chou and Perrimon, 1992) allows
the generation of germ-line clones and the isolation of maternal mutant
embryos. Mutagenized P[FRT 42B] / CyO virgin females were crossed
with P[hs-FLP22]/Y; P[FRT42B] P[w+ ovoD]/ CyO hs-hid males. F1
progeny was heat shocked for 1h at 37°C during the second and third
larval instar stages. Since induction of hs-hid expression in larvae is
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lethal, and since ovoD is a dominant mutation that inhibits oogenesis,
only the germ-line stem cells that induced FRT-mediated mitotic
recombination after induction of the flipase (hs-FLP) will produce
mature eggs. Mature eggs were necessarily homozygous for isolated
maternal mutations.
2.3. Mapping and isolation of complementation groups
Different alleles of the same gene (complementation group)
were identified by crossing the mutant lines with each other. We
assumed the isolated mutations were recessive and intragenic
complementation was unlikely. Lethal and female sterile
complementation groups were directly mapped using the Bloomington
2R deficiency kit (Bloomington Drosophila Stock Center). All together
these deficiencies (deletions) are known to cover ~80% of the 2R
chromosome-arm. To avoid secondary site lethal mutations not related
with the isolated phenotypes, deficiency mapping was always
performed using at least two different alleles of each complementation
group. Any non-complementation result was confirmed with all alleles
of each complementation group and with the reciprocal crosses. Once
a complementation group was mapped to a given cytological (genetic)
interval, a candidate gene approach was taken for all available lethal
and sterile mutations known to map to that relevant cytological interval.
2.4. DNA sequencing of candidate genes
To molecularly characterize the isolated mutations on a given
complementation group, genomic polymerase chain reaction (PCR)
was carried out from mutant males of each isolated allele. An allele
from a different complementation group but also isolated on the 2R
screen (similar genetic background) was used as a control in order to
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identify DNA polymorphisms when compared to the published
Drosophila genome sequence (Flybase). Two independent genomic
PCR fragments from each allele were sequenced and compared with
each other and with the control.
2.5. Molecular biology and generation of transgenic lines
2.5.1. UAS-san generation
To generate UAS-san, san open reading frame (ORF) was
amplified by PCR with a forward primer containing an XbaI restriction
site and a reverse primer containing a KpnI restriction site. The
Amplified PCR product was subcloned into pGEM-T Easy vector
(Promega). After verification by digestion and DNA sequencing, san
cDNA was subcloned into a P[UAST] vector (Brand and Perrimon,
1993). Transgenic san-UAS lines were generated by microinjecting the
P[UAST-san] construct into w1118 embryos. UAS-san transgenic lines
were created at BestGene Inc. (Chino Hills, CA, USA).
Fly lines with the genotypes w; B16-79/CyO; Actin5C-
Gal4/TM6B and w; B50-26/CyO; san-UAST/TM6B were generated to
perform rescue experiment. Rescue of complementation group 2
mutation alleles was performed by crossing w; B50-26/CyO; san-
UAST/TM6B virgin females with w; B16-79/CyO; Actin5C-Gal4/TM6B
males. B50-26 and B16-79 are two mutant alleles of san isolated in the
maternal screen.
2.5.2. Genomic fragments for complementation group 3
The bacterial artificial chromosome BACR25I01 (Berkeley
Drosophila Genome Project) containing the entire interval to which the
complementation group 3 was mapped, was partially digested with the
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restriction endonuclease XbaI. The larger DNA fragments (between
approximately 8 and 15Kb) were subcloned in bulk into the XbaI site of
the pCasper 2 vector. Size of the subcloned fragments were identified
by digestion and identification was performed by DNA sequencing
using the flanking primers pCasperFw 5’-
CGCAAAGCTTGGGCTGCAGGTCGA-3’ and pCasperRev 5’-
TACTAGAATTCGTTAACAGATCT-3’. Six non-overlapping clones
were used to generate transgenic flies (table 1, fig. 6). Given the
difficulty of cloning the gene affected in complementation group 3 and
to facilitate our work, these clones were given names of deserts.
Clone Clonename
Clone
size
(bp)
Cloned region of Drosophila genome
Beginning sequence End of sequence
1 Kalahari 17 494 CTAGAAGCGCCACCGGGC… …ATTAGCAAATATGTAGCT
2 Sonora 15 400 CTAGAGAACGAAAGCGAG… …AATTAAACATAAATATAT
3 Libya 15 555 CTAGATGGAAATTGAAAT… …TCGCCATTTTCTGCTCAT
4 Sahara 12 922 CTAGAGCGGACCAAGTAA… …CACGCTTATCGGAGCTGT
5 Atacama 6 671 CTAGATTTATATGTTGAT… …TCTATAGGAAATTCAACT
6 Mojave 6 528 CTAGAAAAGGTAGTATGT… …ATCGCGGCATTCTCTGGT
Table 1: Genomic DNA fragments used to map complementation group 3.
2.6. DNA staining of complementation group 3 embryos
For primary phenotypic analysis of complementation group 3
mutants, embryos at 4-5 hours of age were collected and fixed (after
dechorionation in 50% bleach for 5 min) by gentle shaking for 1 hour in
4 mL heptane, 0.125 mL 37% formaldehyde and 0.875 mL PBS.
Fixation was followed of devitellinization by addition of 4 mL methanol
and shaking vigorously during 1 minute. Following rehydration,
embryos were three times 5-min washed with phosphate buffered
saline (PBS, pH 7.4) containing 0.1% Tween-20. DNA was stained
with OliGreen at 1:5000 (Invitrogen) with the addition of 5 μg/mL
RNAse A.
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Embryos were mounted in Fluorescent Mounting Medium
(DakoCytomation, Inc) and immunostainings were visualized using a
Leica SP5 confocal microscope. All images are confocal sections.
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3. Results
3.1. Right-arm of 2R maternal screen allowed the identification of
six complementation groups
The maternal forward genetic screen (Barbosa et al., 2007)
allowed the isolation of 47 mutant strains defective for early embryonic
development. From our complementation analysis, we identified six
complementation groups (table 2), which were zygotically lethal or
female sterile (fig. 2). All complementation groups were maternally
lethal (e.g., embryos whose maternal contribution was mutant were not
viable).
Figure 2: Complementation tests. (A) F0 represents the crosses between all mutant lines
obtained from the screen. All lines were in trans with the CyO balancer containing the Cy
dominant marker (curly wings). (B) Representation of possible F1 genotypes. F1 progeny flies
could have two possible phenotypes Cy and Cy+ (Cy = curly wings; Cy+ = normal wings). (C) If F1
progeny only contained Cy flies, both mutant lines were likely to be lethal alleles of the same
gene. If F1 progeny contained fertile Cy+ flies (wild-type wings), there was complementation and
A
B
C
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most likely they were alleles of different genes. If F1 progeny contained female sterile Cy+ flies
(wild-type wings), both mutant lines were likely to be alleles of the same gene. We assumed the
isolated mutations were recessive and intragenic complementation was rare. If Cy males in F0
correspond to a deficiency, then this scheme applies to the cytological mapping of the mutant
lines obtained from the screen.
Complementation group 6 was previously shown to be allelic to
scraps. This gene encodes the Anilin protein, which was previously
shown to be essential for syncytial nuclear divisions and blastoderm
cellularization (Field et al., 2005).
A primary phenotypic characterization of the six
complementation groups allowed us to observe that both
complementation groups 2 and 3 revealed syncytial nuclear defects
(Chapter II, section 3.4.). Interestingly, we failed to detect any egg
laying defects in these mutants, which suggested the mutated genes
were not needed for germ-line stem cells mitotic divisions and they
were likely to be differentially required between the soma and the
female germ-line. We therefore decided to pursue these two
complementation groups for further analysis.
Complementation
Groups Alleles Cuticle
Complementation
test
1
A56-12
B12-22
B42-1
B43-36
No cuticle
No cuticle
No cuticle
No cuticle
Lethal
Lethal
Lethal
Lethal
2 B16-79B50-26
No cuticle
No cuticle
Lethal
Lethal
3
A10-42
B16-2
B43-36
No cuticle
No cuticle
No cuticle
Sterile
Sterile
Sterile
4
B12-43
C2-32
C50-47
Scraps
Scraps
Scraps
Lethal
Lethal
Lethal
5 C50-20C50-61
Scraps
Scraps
Sterile
Sterile
Scra B26-35C82-45
Scraps
Scraps
Sterile
Sterile
Table 2: 2R screen complementation groups.
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3.2. Mapping of complementation group 2
3.2.1. Complementation group 2 is allelic to the gene separation
anxiety (san)
When crossed with each other B16-79 and B50-26 mutant lines
failed to complement zygotic lethality, giving rise to complementation
group 2 (table 2). To identify the gene mutated in complementation
group 2, both alleles were mapped using the Bloomington 2R
deficiency kit (see Materials and methods). The following seven
deficiencies failed to complement both alleles (B16-79 and B50-26):
Df(2R)en-A, Df(2R)en-B, Df(2R)E3363, Df(2R)Exel6060,
Df(2R)ix[87i3], Df(2R)ED2219 and Df(2R)ED2155. Whereas,
Df(2R)En28 complemented both alleles. Since the breakpoints of each
of the deficiencies were cytologically mapped within the 2R
chromosome-arm, this allowed mapping group 2 alleles to the
cytological interval 47E3 – 47F8, which is comprised of 53 annotated
genes (fig. 3). By a candidate gene approach, we concluded that both
alleles failed to complement a known lethal mutation (san2) of the
separation anxiety (san) gene (Williams et al., 2003), which is
annotated within the cytological band 47F5.
Sequencing both alleles of complementation group 2 confirmed
they are allelic to san, as both alleles contained two distinct nonsense
mutations within san ORF. These two nonsense mutations are
predicted to cause severe truncations of the San protein (Chapter III).
CHAPTER II
56
Figure 3: Complementation group 2 cytological interval. Red and green bars represent
deleted genomic portions of the corresponding indicated deficiency. Deficiencies that did not
complement group 2 are indicated by red. Deficiencies that complemented group 2 are indicated
by green. The right limit of deficiency E3363 is not well defined.
3.2.2. san cDNA rescues the viability san mutants
Both isolated alleles of san are recessive lethal. To confirm the
lethality was exclusively associated with the san locus, rescue
experiments were carried out using a UAS-san cDNA transgene. The
lethality of the transheterozygous flies B16-79/B50-26 was rescued by
UAS-san driven by a ubiquitous Gal4 driver (Act5c-Gal4). This
demonstrated the lethality associated to these alleles was caused by
loss of san gene activity.
3.3. Mapping of complementation group 3
3.3.1. Cytological mapping of complementation group 3
When crossed with each other A10-42, B16-2 and B43-36
mutant lines failed to complement female sterility, giving rise to
complementation group 3 (table 2). As with group 2, all alleles of
complementation group 3 (table 2) were mapped using the
Bloomington 2R deficiency kit. Deficiencies Df(2R)bw-HB132,FrdHB132
and Df(2R)Vir130 did not complement both alleles A10-42 and B43-36
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by sterility, nor allele B16-2 by lethality. This suggested that allele B16-
2 was a stronger allele than the other two alleles. This allowed
mapping of the three mutant alleles to the cytological interval 59D11 -
59E1 (fig. 4).
Figure 4: Complementation group 3 cytological interval. Red and green bars represent
deleted genomic portions of the corresponding indicated deficiency/ deletion. Deficiencies that did
not complement group 3 are indicated in red. Deficiencies that complemented group 3 are
indicated in green.
Since there were no additional deficiencies that could narrow
this region to a smaller portion of the 2R chromosome, we crossed the
deficiencies Df(2R)Vir130 and Df(2R)bw-HB132 to lethal mutations
known to map to this interval. Transheterozygous between
Df(2R)Vir130 and Df(2R)bw-HB132 were lethal. These deficiencies
were crossed with lethal alleles of the virilizer (vir) and brown (bw)
genes. vir was annotated within the cytological bands 59D8-9 and bw
was annotated within the cytological bands 59E2-3. Df(2R)Vir130
complemented the bw mutant, but did not complement the vir mutant.
Similarly, Df(2R)bw-HB132 did not complement the bw mutant, but
complemented the vir mutant. Complementation group 3 mutations
were therefore localized in the interval between the vir and the bw
genes. The genomic region between these two genes corresponded to
the annotated base pairs 19247786 to 19426016. This region was
178,23 Kb long and included 25 annotated genes. Since for most
genes there were no available mutants, we could not pursue a
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candidate gene approach as previously performed for
complementation group 2.
3.3.2. A genomic DNA fragment containing 2 genes rescues the
sterility of complementation group 3 mutants
Complementation group 3 mutations were likely to be within the
transcribed regions of one of the 25 annotated genes within the
previously mapped interval. 20 out of the 25 annotated genes were
sequenced in alleles A10-42 and B16-2, but we failed to detect any
mutation within these genes (fig. 5) (Rui Tostões, unpublished data).
The remaining 5 unsequenced genes included yellow-d, yellow-d2,
odorant receptor 59A (or59a), odorant receptor 59B (or59b) and
odorant receptor 59C (or59c). Both yellow-d and yellow-d2 genes are
yellow (y) related genes (Drapeau, 2001). The or59a, or59b, and or59c
genes belong to the larval odor receptor genes. Or59a was described
to be expressed in larval olfactory receptor neurons (Kreher et al.,
2005). Furthermore, according to Affymetrix data
(http://www.flyatlas.org/) these 5 genes are not expressed during
oogenesis, suggesting they are not maternally provided. Therefore,
these genes are unlikely to be associated with the observed cell cycle
phenotypes.
Figure 5: Complementation group 3 alleles did not contain mutations within 20 out of 25
genes annotated between vir and bw. Representation of the sequenced genes within the
genomic region between the vir and bw genes (red boxes). Sequenced genes are highlighted in
yellow. Non sequenced genes are highlighted in gray.
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We decided to pursue an alternative experimental approach
and use genomic DNA complementation. Transgenic flies carrying
non-overlapping genomic DNA fragments mapped to the region
between vir and bw were used to complement female sterility or
lethality of complementation group 3 alleles. Six different transgenic
lines were generated (see Materials and methods), containing the
genomic fragments represented in figure 5. These transgenic lines
were called names of different deserts given the difficulty of cloning the
affected gene and to facilitate their identification (Table 1; fig. 6).
Figure 6: Representation of the genomic regions used for complementation of group 3.
Yellow boxes correspond to the regions of DNA that were used to create transgenic flies. Each
transgenic line was named after a desert. vir and bw genes are highlighted in red boxes.
The Mojave transgenic line complemented both the sterility and
viability of all complementation group 3 alleles. The Mojave transgenic
line contained a genomic region of 6528 bp long. We decided to
sequence this region in complementation group 3 mutants and search
for possible mutations there. Figure 7 represents the regions
corresponding to the Mojave fragment already sequenced in both
alleles A10-42 and B43-36 of complementation group 3. Although we
have failed to find any mutation, close to 1Kb of genomic DNA still
needs to be sequenced. Since both annotated genes within this region
lacked 5´and 3´UTRs (Flybase), it was likely the proposed gene
structure was incomplete.
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Figure 7: Sequenced genomic regions within the Mojave genomic fragment. Blue
area represents the genomic region of the Mojave fragment which complemented
complementation group 3 alleles. Orange areas represent the regions already
sequenced within this fragment in complementation group 3 mutants.
3.4. san and complementation group 3 alleles showed dramatic
defects during syncytial nuclei divisions
Although two of the maternal screen criteria were , normal egg
laying (a proxy for normal germ-line stem cells mitosis) and normal
formation of primordial germ cells (a proxy for posterior migration of
syncytial nuclei), complementation groups 2 (Chapter III) and 3
maternal mutant embryos showed clear defects in syncytial nuclear
divisions (fig. 8). Although unexpected we decided to pursue analysis
of these mutants since they could uncover interesting differences
between the soma and the germ-line.
Preliminary phenotypic characterization of complementation
group 3 demonstrated that maternal mutant embryos showed defects
during syncytial blastoderm divisions. During wild-type syncytial
blastoderm development, the nuclei divided synchronously with an
even distribution along the embryo (fig. 8A). Maternal mutant embryos
for complementation group 3 alleles, however, showed abnormal
nuclear divisions with loss of nuclear division synchrony and uneven
distribution of nuclei throughout the embryo (fig. 8B).
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Figure 8: Complementation group 3 mutants showed nuclear division defects during
syncytial blastoderm. (A) Wild-type syncytial blastoderm embryo showing synchronous mitosis
and evenly spaced nuclei. (B) Maternal mutants of allele A10-42 of group 3 showed abnormal
nuclear divisions during syncytial blastoderm. Interestingly, while some nuclei were already
decondensed, others were still in telophase (white arrows) connected by a chromosome bridge.
All mutant alleles of complementation group 3 showed abnormal nuclear syncytial divisions (data
not shown).
A B
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4. Discussion
This chapter described the isolation and mapping of two novel
complementation groups required for syncytial nuclei divisions.
Interestingly, both mutants showed normal egg-laying (data not
shown), which suggested the germ-line stem cell mitotic divisions were
normal. We hypothesized that the activity of the affected genes was
mainly required in somatic tissues, and we speculated that female
germ-line stem cells mitosis was differentially regulated when
compared to the soma. We isolated two mutant alleles for separation
anxiety (san) (complementation group 2; Chapter III). Since the
following chapters of this dissertation will focus on the san gene I will
focus the discussion of this chapter on complementation group 3
alleles.
Complementation group 3 maternal mutants displayed nuclear
division defects during syncytial blastoderm that included uneven
nuclear distribution and asynchronous mitosis (fig. 8; Rui Tostões,
unpublished data). Complementation group 3 mutants were not further
characterized since we failed so far to identify the affected gene.
Nevertheless, we mapped this complementation group to a 7Kb
genomic interval (Fig. 7).
The 7kb genomic DNA fragment that complemented the group
3 mutants contained two annotated genes, CG13558 and CG13559.
According to available DNA arrays and RNAseq expression data
(modENCODE project), these genes were the only genomic locus
clearly expressed within this region. Nevertheless, we failed to detect
any mutation within the transcribed region of these two genes. Yet,
since both CG13558 and CG13559 were annotated without 5’ and
3’UTRs it was likely the gene structure annotation was incomplete and
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suggested the existence of additional unsequenced exons. All mutant
alleles isolated in this screen were generated by ethylmethane
sulfonate (EMS) treatment. The most common effect of EMS is to
generate point mutations by G/C-A/T transitions. Although we cannot
exclude the possibility of a point mutation affecting an enhancer or the
structure of a non-coding RNA, this is unlikely to occur in three
different alleles.
The putative protein encoded by the CG13558 gene is well
conserved within insects. BlastP analysis revealed that the putative
protein encoded by CG13558 shares some degree of similarity with a
putative guanine nucleotide exchange factor (GEF) from the Pediculus
humanus corporis. GEFs are directly responsible for the activation of
Rho-family GTPases by catalyzing the exchange of GDP for GTP.
RhoGTPases regulate many aspects of the actin cytoskeleton and
membrane organization and thus control cell polarity, behavior,
morphology and division (Jaffe and Hall, 2005). Although Rho
activation is spatially and temporally regulated, the molecular
mechanisms that underlie this tight control are still poorly understood.
Rho1 locally regulated activation plays a fundamental role within
cytokinesis of animal cells (D'Avino et al., 2005). Separation of the two
newly formed daughter cells is achieved by assembly of a contractile
ring in the cleavage plane of the mother cell followed by constriction
and subsequent abscission. Rho activation is a prerequisite for the
assembly of the actomyosin filaments that drive constriction (Bement
et al., 2005; Kamijo et al., 2006; Lee et al., 2004; Somers and Saint,
2003; Tatsumoto et al., 1999). Rho1 RNA interference (RNAi) in
Drosophila cultured cells, results in failure of cytokinesis leading to
binucleated cells (Somma et al., 2002).
Inhibition of Rho1 function by drugs or expression of dominant-
negative alleles in Drosophila embryos leaded to disruption of the actin
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cytoskeleton and caused severe defects in membrane invagination
during blastoderm cellularization (Crawford et al., 1998). RhoGEF2
was shown to be required for activation of Rho1 during cellularization
(Padash Barmchi et al., 2005). Accordingly, Drosophila RhoGEF2
mutants showed dramatic defects during blastoderm cellularization,
with furrow canals often incorrectly formed and sometimes missing
(Afshar et al., 2000; Grosshans et al., 2005; Padash Barmchi et al.,
2005).
Despite the absence of cell boundaries, the first 13 nuclear
divisions within Drosophila embryos require an intact F-actin network
(Mavrakis et al., 2009). In cycles 10–13, metaphase furrows, which are
invaginations of the plasma membrane, form during metaphase to
create mitotic domains and prevent adjacent mitotic figures from
interacting or “colliding” with one another. Inhibition of Rho1 at mitotic
stages 10-13 lead to disruption of metaphase furrows and failure to
proceed into cellularization (Crawford et al., 1998). In contrast to Rho1
inhibition, RhoGEF2 loss of function mutants did not show defects in
the syncytial blastoderm (Grosshans et al., 2005), which suggests
another GEF is regulating the activity of Rho1 in these earlier nuclear
divisions. If CG13588 is the affected gene in group 3 mutants we
hypothesize it might encode a new GEF required for activation of Rho1
in the syncytial blastoderm.
CG13559 encodes a protein closely related with the human
LITAF-like protein, named cell death involved p53-target (CDIP)
(Brown et al., 2007). CDIP was shown to be a transcriptional target of
p53, capable of upregulating the tumor necrosis factor alpha (TNF)
(Brown et al., 2007). Work done in human cells suggested that under
genotoxic stress TNF was up-regulated by p53 in a CDIP dependent
manner to induce apoptosis. Many factors that induce apoptosis are
conserved between mammals and Drosophila (Igaki et al., 2002;
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Moreno et al., 2002; Song, 2005). Drosophila Eiger was shown to be
the sole member of the TNF superfamily (Igaki et al., 2002; Moreno et
al., 2002). If CG13559 was the gene affected in group 3 mutants, we
could expect CG13559 would be playing a role in the activation of the
Eiger. It has been suggested that Eiger is a ligand for the Drosophila
JNK pathway, and its overexpression induces JNK-dependent cell
death in imaginal epithelia (Igaki et al., 2002; Moreno et al., 2002).
However, eiger loss-of-function mutants show no morphological or cell
death defects during normal development (Igaki et al., 2002). In
contrast to complementation group 3 alleles, where mutant females
were sterile due to the syncytial nuclei division defects, eiger loss-of-
function mutants were viable and fertile (Brodsky et al., 2004; Igaki et
al., 2002). However, we cannot exclude the possibility of CG13559
being involved in a pathway other then TNF activation that would
justify the observed mitotic phenotypes.
In summary, complementation group 3 is most likely bearing
mutant alleles of the either the CG13558 or the CG13559 gene.
Identification of the mutated gene will allow a better understanding of
the molecular mechanisms regulating syncytial nuclear divisions and
possibly will uncover interesting differences between the soma and the
germ-line.
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CHAPTER III
Differential requirements of a mitotic
acetyltransferase in somatic and germ line cells
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Sister chromatid cohesion
Separation anxietyes of cells can have differential requirements for chromosome segregation. We
isolated two new alleles of the separation anxiety gene (san). sanwas previously described in both Drosophila
and in humans to be required for centromeric sister chromatid cohesion (Hou et al., 2007; Williams et al.,
2003). Our work confirms and expands the observation that san is required in vivo for normal mitosis of
different types of somatic cells. In addition, we suggest that san is also important for the correct resolution of
chromosomes, implying a more general function of this acetyltransferase. Surprisingly, during oogenesis we
cannot detect mitotic defects in germ line cells mutant for san. We hypothesize the female germ line stem
cells have differential requirements for mitotic sister chromatid cohesion.
© 2008 Elsevier Inc. All rights reserved.IntroductionDrosophila embryonic development starts with thirteen nuclear
divisions without cytokinesis (Foe et al., 1993). The nuclei migrate
outward to the egg periphery during nuclear division 8 and 9, with
most nuclei arriving at the surface of the embryo during interphase 10.
After four additional nuclear divisions, the cortical nuclei arrest
mitosis during interphase 14. Once arrested, the nuclei become
synchronously encased by polarized invaginations of the plasma
membrane and a monolayer of epithelial cells is formed de novo.
Sister chromatid cohesion is crucial for chromosome alignment
during metaphase (Losada, 2007; Nasmyth and Haering, 2005). The
evolutionarily conservedmultisubunit cohesin complex is required for
sister chromatid cohesion. This complex contains four core subunits:
Smc1, Smc3, Scc3, and Scc1/Mcd1/Rad21 (Losada, 2007). In verte-
brates, Scc3 has two isoforms: SA1 and SA2 (Losada et al., 2000;
Sumara et al., 2000). Another protein, Pds5, is weakly associated with
the cohesin complex and may regulate the dynamic interaction of
cohesin with chromatin (Hartman et al., 2000; Panizza et al., 2000).
In yeast cohesion is established in multiple steps: before S-phase
the Scc2 and Scc4 proteins regulate the chromosomal loading of
cohesin at centromeres and at regularly spaced intergenic regions
along chromosome arms (Ciosk et al., 2000; Glynn et al., 2004;
Tomonaga et al., 2000). During ensuing DNA replication, sister
chromatid cohesion is established (Uhlmann and Nasmyth, 1998).ncia, Rua da Quinta Grande 6,
artinho).
l rights reserved.The Eco1/Ctf7 protein is the main regulator of this event (Skibbens et
al., 1999; Toth et al., 1999). Yeast mutants lacking the acetyltransferase
Eco1/Ctf7 (or Eso1 in fission yeast) exhibit defective cohesion despite
cohesins continuing to localize to the chromosomes (Skibbens et al.,
1999; Tanaka et al., 2000; Toth et al., 1999). Recent studies support the
idea that this protein makes a direct connection with the replication
fork when establishing cohesion (Lengronne et al., 2006; Moldovan et
al., 2006). The cohesin linkswill then remain until anaphasewhen they
are removed through proteolytic cleavage of Scc1 (Uhlmann et al.,
1999).
Meiotic and mitotic sister chromatid cohesion are distinct. Meiotic
cells contain specific cohesin subunits, including the α-kleisin Rec8
(Nasmyth and Haering, 2005). Rec8 is crucial for meiotic cohesion and
for synaptonemal complex (SC) formation in all organisms studied
(Klein et al., 1999; Molnar et al., 1995; Pasierbek et al., 2001). In Dro-
sophila, meiotic cohesion depends on the protein Orientation
Disruptor (Ord) (Bickel et al., 1996, 1997; Miyazaki and Orr-Weaver,
1992). In ord mutants, sister chromatids segregate randomly through
both meiotic divisions (Bickel et al., 1997; Webber et al., 2004). Ord is
enriched at the centromeres of meiotic chromosomes in both males
and females (Bickel et al., 1997; Webber et al., 2004). Smc1 and Smc3
subunits colocalize with Ord at centromeres of ovarian germ line cells
and in flies lacking Ord activity, cohesin SMCs fail to accumulate at
oocyte centromeres (Khetani and Bickel, 2007).
In Drosophila, the separation anxiety (san) gene encodes an
acetyltransferase known to be required for mitotic sister chromatid
cohesion in neuroblasts and S2 cells (Williams et al., 2003). san
function was associated with sister chromatid cohesion since mutant
cells showed loss of the cohesin Scc1 specifically at the centromeres.
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al., 2006). RNAi experiments depleting SAN in HeLa cells caused
defects in sister chromatid cohesion and cohesin SMC1 was no longer
detected at the centromeres (Hou et al., 2007).
In this studywe isolated two new loss-of-function alleles of san in a
forward genetic screen for maternal mutants defective in blastoderm
cellularization. We confirm and expand the observation that during
mitosis san is required in vivo and in different types of somatic cells for
chromosome segregation. In addition, our work suggests that san is
also important for chromosome resolution. This implies amore general
function of this acetyltransferase and a possible interplay between
cohesion and chromosome condensation/resolution. Surprisingly,
during oogenesis we cannot detect mitotic defects in germ line cells
mutant for san. We hypothesize the female germ line stem cells have
differential requirements for mitotic sister chromatid cohesion.
Results
atado is required maternally for the correct segregation of chromosomes
during syncytial blastoderm
To identify new genes involved in Drosophila blastoderm cellulariza-
tion and germ-band extension, we took advantage of a previouslyFig. 1. atado is required maternally for chromosome segregation during syncytial blastoderm
chromosome bridges (A–C, G–I) and chromosome lagging (F). All panels show syncytial blast
clones (maternal mutants). All embryos were stained for DNA (green) and pSer10 Histone H3
Shows a detail of the atado2 embryo shown in panel B. Highmagnification of awild type (D) a
panel E. High magnification of a wild type (G) and atado2 (H) embryo during late anaphase/
staining marks condensed chromosomes. For quantitative data on the observed chromosomreportedmaternal screen (Barbosa et al., 2007). This screen used the FLP-
FRT/ovoD system(ChouandPerrimon,1992) togenerate germ linemutant
clones. The screen was carried out in the right-arm of the second
chromosome (2R) and 137 independent mutant lines within the “germ
cells only” class of mutants were isolated on the basis of an extremely
abnormal soma but where the germ cells were formed normally at the
posterior pole of the embryo. The secondary screen involved isolation of
mutants defective in cuticle production. Absence of cuticle is a good
marker for defects in apicobasal polarization of epithelial cells. Secondary
screening allowed the isolation of 47 of the initial 137 lines. Comple-
mentation studies of thesemutants identified9complementationgroups
by zygotic lethality or sterility. Complementation group 2 contained two
alleles, which we will initially refer to as atado1 and atado2. These two
alleles will later be renamed san3 and san4, respectively.
To characterize the role of the atado gene during Drosophila early
embryonic development, we examined germ line clone embryos of
both alleles of atado. Both mutant alleles had similar maternal
phenotypes, with 87% (n=39) of atado2 embryos exhibiting nuclear
division abnormalities during syncytial blastoderm (2.5%, n=40, in
wild-type embryos) (Supplementary Fig. 1). During syncytial blas-
toderm development wild-type nuclei divide synchronously and are
evenly distributed throughout the embryo (Figs. 1A, D, G). We
observed that the atado embryos frequently showed nuclei division. Embryos mutant for atado2 show abnormal anaphases (D, E), with a high frequency of
oderm embryos. atado2 mutant embryos were obtained after the induction of germ line
(red). Lowmagnification of a wild type (A) and atado2 (B) embryo during interphase. (C)
nd atado2 (E) embryo during anaphase. (F) Shows a detail of the atado2 embryo shown in
telophase. (I) Shows a detail of the atado2 embryo shown in panel H. pSer10 histone H3
e bridges, refer to Figure S1. Scale bars equals 10 μm.
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(Fig. 1B). Yet, the most striking phenotype in atado embryos was
chromosome segregation defects during mitosis (Fig. 1). Anaphase,
whilst being mainly bipolar in atado embryos, appeared significantly
more disorganized in atado than in wild-type embryos (Figs. 1D, E).
atado embryos showed a high frequency of chromosome lagging
(Fig. 1F) and formation of chromosome bridges (Figs. 1H, I). We also
observed interphase nuclei fused together or attached by chromo-
some bridges (Fig. 1C, Supplementary Fig. 1). Due to these chromatin
bridges we refer to our mutant as atado, “tied-up” in Portuguese.
Chromosome lagging in atado embryos may be explained by
kinetochore abnormalities, but we failed to detect any obvious defects
in the localization of Centromere identifier (Cid) during metaphase or
anaphase (SupplementaryFigs. 2A,B). Chromosome lagging couldalsobe
explained by centrosome/mitotic spindle defects. Yet, we did not detect
any obvious defects in the localization of Centrosomin (Cnn) (Supple-
mentary Figs. 2C–F), and the mitotic spindle was bipolar and correctly
attached to chromosomes and centrosomes (Supplementary Figs. 2E, F).
atado is necessary zygotically for neuroblasts mitosis and imaginal discs
development
atado mutations were zygotically lethal. To better characterize
the zygotic lethality of atado alleles, we followed the developmentFig. 2. atado is required zygotically for normal mitosis of larvae neuroblasts and imaginal d
Figure S3) and the neuroblasts showmitotic defects (A–F). Neuroblasts mutant for atado2 sh
during anaphase (D, E). In larvae imaginal discs, clones with two copies of GFP (control clone
(G–H). In control imaginal discs both types of clones have equivalent sizes (I). (A–F) Neurobla
were stained for DNA (red). Scale bars equals (A–F) 5 μm, (G–H) 50 μm, and (I) 30 μm.of transheterozygote atado1/atado2 mutants. All isolated transheter-
ozygote atado larvae reached the third instar larval stage, pupated
and died at the pupa stage (n=14). All isolated heterozygous larvae
(atado/+) were viable (n=16). Therefore, the maternal contribution
of atado was sufficient for development to larval stage, but not for
pupa and metamorphosis to the adult.
We expected the lethality to be associated with mitotic defects,
and hence we analyzed the brains and imaginal discs of
transheterozygote third instar larvae. We observed that atado
mutant larvae had smaller brains and extremely small imaginal
discs (Supplementary Fig. 3, data not shown). This is the typical
zygotic phenotype of several cell cycle mutants (Gatti and Baker,
1989; Krause et al., 2001). atado neuroblasts showed chromosome
congression defects during metaphase (Figs. 2A, B) and abnormal
segregation of chromosomes during anaphase (Figs. 2D, E). To
further confirm that atado is important for cell proliferation, we
induced atado mutant clones in imaginal discs of an otherwise
heterozygote larva (one copy GFP). Imaginal disc clones mutant for
atado2 (marked by the absence of GFP) were absent or significantly
smaller than the twin-spot wild-type clones (marked by two copies
of GFP) (Figs. 2G, H). In contrast, control clones also marked by
absence of GFP had a similar size to the twin-spot clones (Fig. 2I).
This suggested that atado is required for normal development of
larvae imaginal discs.iscs development. Larvae zygotically mutant for atado2 contain smaller brains (refer to
ow chromosome congression defects during metaphase (A, B) and chromosome lagging
s) are significantly bigger than the twin-clones without GFP (clones mutant for atado2)
sts were stained for α-Tubulin (green) and pSer10 Histone H3 (red). (G–I) Imaginal discs
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sister chromatid cohesion
To identify the gene responsible for the atado mutant phenotypes,
wemapped both atado alleles using the Bloomington 2R deficiency kit
(see Materials and methods), defining a cytological interval compris-
ing 47 genes. By a candidate gene approach we concluded that atado
was most likely allelic to the gene separation anxiety (san) since both
atado alleles failed to complement san2 (Fig. 3A), a lethal P-element
of the san gene (Williams et al., 2003). Furthermore, san2 germ line
clones produced mutant embryos phenotypically indistinguishable
from atado1 and atado2 (Supplementary Fig. 4). The san gene was
previously predicted to encode an acetyltransferase, which transfers
acetyl groups to the N-terminus of other proteins (Williams et al.,
2003). San protein contains 184 amino acids and analysis of San
primary sequence revealed an acetyltransferase domain composed by
two acetyltransferase subdomains from amino acids 74–94 and 117–
129, respectively (Fig. 3B) (Williams et al., 2003). Sequencing both
alleles of atado confirmed that atado was allelic to san, as both alleles
contained distinct nonsense mutations within san open reading frame
(ORF). These two nonsense mutations were predicted to cause severe
truncations of the San protein (Fig. 3B). We failed to detect San from
embryonic total protein extracts (Fig. 3C). The San antibody is
polyclonal and it was raised against most of San protein (Williams et
al., 2003). It was nevertheless possible that it did not recognize the
truncate proteins encoded by the atado alleles. We expressed in
bacteria the smallest truncated protein, which was predicted to be
encoded by atado2/san4. The San antibody used in this work was able
to recognize the recombinant protein in total extracts from bacteria
(Supplementary Fig. 5). We concluded that the isolated atado alleles
are loss-of-function alleles of san. We therefore renamed atado1 and
atado2, respectively to san3 and san4 alleles.
san is required for chromosome resolution
Syncytial blastoderm embryos mutant for san showed dramatic
chromosome segregation defects during anaphase (Fig. 1). WeFig. 3. atado is allelic to separation anxiety (san). Both alleles of atado contain nonsense
mutations within san open-reading frame and are protein null for San. The mutations of
both alleles ofatadoweremapped to a small cytological interval using the 2Rdeficiencykit.
Using a candidate gene approach it was observed that both alleles of atado failed to
complement a loss-of-function allele of the gene separation anxiety (san2) (A). The atado
alleles (atado1 and atado2) were therefore respectively renamed as san3 and san4. Both
isolated alleles of san contain nonsense mutations within san open-reading frame, which
will putatively lead to the truncation of Sanprotein (B). Total protein extracts fromembryos
mutant for both alleles of san show absence or undetectable levels of San protein (C).observed that during metaphase the defects in chromosome congres-
sion and alignment were comparatively mild (Figs. 4A–C and
Supplementary Fig. 4). This is in contrast to the dramatic defects in
chromosome congression and alignment recently reported in Scc1-
depleted embryos (Pauli et al., 2008). Additionally, we only detected a
minor separation of the sister chromatid kinetochores (due to the loss
of centromeric cohesion) in san mutant embryos arrested in
metaphase (Figs. 4D, E). Given this evidence we decided to investigate
if San had additional functions that could explain the observed
phenotypes.
Cohesion defects can explain the lagging chromosomes and the
high frequency of chromosome bridges observed in san mutant
embryos, but we noticed that a large proportion of these bridges did
not involve centromeric regions of the chromosome (negative for
Cid staining). Of the scored bridges between nuclei in late-mitosis/
interphase, 55.6%±18.2 were negative for Cid staining, 32%±11.5
were positive for Cid staining, and in 12.4%±10 of the cases the
result was inconclusive (n=104 bridges) (Supplementary Fig. 6).
Bridges involving distal chromosome regions were previously
described in mutants defective in chromosome condensation and/
or resolution (Bhat et al., 1996; Steffensen et al., 2001). Consistent
with the hypothesis that san could be involved in chromosome
resolution/condensation; we observed that during mitosis a subset
of nuclei showed a dramatic decrease in the levels of Barren (Figs.
4F–J) (number of cortical nuclei with a detectable reduction of
Barren localization, wild-type: 0±0 nuclei, n=780, 11 embryos, san4:
19.7%±12.9 nuclei, n=980,11 embryos; Student's t test, 95% confidence
interval, pb3×10−5). Embryos mutant for barren are defective in
chromosome segregation with the formation of chromosome bridges
(Bhat et al., 1996). Although the reduction of Barren localization
suggests defects in chromosome resolution and/or condensation, we
did not detect reduced levels of this condensin specifically at
chromosome bridges (data not shown). Consistent with chromosome
resolution defects, during interphase we observed a subset of
chromosome bridges showing reduced levels of Topoisomerase II
(Figs. 4K, L). TopoII is important for DNA decatenation and chromo-
some resolution (Holm et al., 1989; Uemura et al., 1987). Chromosomal
localization of TopoII is condensin-dependent (Coelho et al., 2003).We
did not detect any change in the levels of TopoII in embryo total
extracts (data not shown).
During oogenesis san is not required for germ line mitosis
Our data implied san as being important for mitosis of distinct
types of somatic cells. This is consistent with previous published
work that showed that san is required in vivo in neuroblasts, ex vivo
in S2 cells and human HeLa cells, for mitotic sister chromatid
cohesion (Hou et al., 2007; Williams et al., 2003). At this point it is
important to emphasize that the maternal screen from which we
isolated both san3 and san4 alleles was designed to exclude mutants
with mitotic defects during oogenesis as egg laying had to be normal.
To investigate if egg laying from females with a germ line mutant for
sanwas normal, we induced germ line clones using the FLP-FRT/ovoD
system (Chou and Perrimon, 1992). We compared the number of eggs
laid by san and control females (with an identical FRT chromosome),
and concluded that egg laying between these females was identical
for more than 15 days after pupa eclosion (Supplementary Fig. 7) (see
Materials and methods). Since clones were induced at larvae stages
by heat-shock, this suggested that san and control germ line stem
cells divided continuously and at similar rates for almost 20 days
after clone induction.
To test the hypothesis that san mitotic function is not required
during oogenesis, we generated females with genetically mosaic
ovaries using the FLP-FRT-mediated mitotic recombination and a
nuclear GFP clone marker. Absence of GFP (green) indicates that the
cells are homozygous for san mutations. After the induction of clones
Fig. 4. A subset of nuclei from syncytial blastoderm embryos mutant for san show reduced levels of Barren and Topoisomerase II. Embryos mutant for san4 show mild defects in
chromosome congression and alignment during metaphase (A–C). san4 embryos incubated with colchicine arrest the cell cycle with condensed chromosomes and show a minor
separation of the sister chromatid kinetochores (D, E). Subsets of mitotic nuclei in san4 embryos show a dramatic reduction in Barren localization (F–J; asterisks indicates reduction in
Barren localization; see text for quantification). Subsets of interphasic nuclei in san4 embryos show reduced levels of TopoII localization specifically in the chromosome bridges (K, L;
asterisk indicates reduction of TopoII). All panels show syncytial blastoderm embryos. (A–E) Embryos were stained for Cid (green) and pSer10 Histone H3 (red). (F–J) Embryos were
stained for Barren (red) and pSer10 Histone H3 (blue). (K, L) Embryos were stained for Topoisomerase II (green) and DNA (red). (D, E) Embryos were incubated with colchicine for
15 min at room temperature. Scale bar equals 10 μm.
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clones in the adult ovaries (data not shown). This suggested that the
proliferating larvae primordial germ cells mutant for san could
efficiently compete for the adult germ line stem cell niche.
Confirming that san is not required during oogenesis for germ line
mitosis, egg chambers mutant for san from females with 7/8 or 15
days old after pupa eclosion showed a normal determination of the
oocyte (Figs. 5B–D), a normal condensed karyosome (Fig. 5E—
asterisks indicates a condensed karyosome), a normal number of
nurse cells (15 nurse cells, n=16), a normal fusome (Fig. 5F), and a
normal eggshell without fused dorsal appendages (spindle pheno-type) (data not shown). Similar results were obtained with a
previously isolated loss-of-function allele of san (san2) (Supplemen-
tary Figs. 8A–E).
Since germ line clones mutant for san did not showmitotic defects
during oogenesis, we investigated if San is requiredwithin the somatic
follicle cells. Each Drosophila egg chamber contains 16 germ line cells
surrounded by a follicle cell epithelium of somatic origin. Follicle cell
clones were induced by heat-shock at larvae stages (as described for
germ line clones— SeeMaterials andmethods).Whereas wewere able
to isolate large clones (negative for GFP) using a control chromosome
(Supplementary Figs. 8G–L), in the case of san mutants (FRT san2 and
Fig. 5. During oogenesis san is not required for germ line mitosis. Absence of endogenous GFP (green) indicates that the cells are homozygous for san mutations. Germ line mutant
clones of san4 were induced at larvae stages using heat-shock-controlled flipase. Ovaries were dissected from adult females that were 7/8 (A–C, F, G, I–O) or 15 days (D, E) old after
hatching (pupal eclosion). Drosophila germariumwhose germ line is mutant for san4 develops normally (A). Germ line stem cells mutant for san4 divide normally since egg-laying is
identical to the one observed in control females (refer to Figure S7) and egg-chambers mutant for san4 develop normally (A–D), with a normal condensed karyosome (E; asterisk
indicates karyosome) and a normal fusome (F). San is expressed in the ovaries (H) and no obvious difference in the expression levels of San could be detected between young (3 days)
and older females (8 days). San is expressed within the ovaries germ line (G, I). Germarium whose germ line is mutant for san4 (L–O) show Smc1 expression identical to the one
observed in wild-type germarium (J, K). Absence of GFP indicates that the germ-line is mutant for san4. (A–E) Ovaries were stained for DNA (red). (F) Ovary was stained for fusome
marker Hts (red). (G, I) Ovary was stained for San (gray). (J–O) Ovaries were stained for Smc1 (blue or gray). (H) Total ovaries and embryonic protein extracts were analyzed by SDS-
PAGE and western blot using an anti-San polyclonal antibody. An anti-α-tubulin antibody was used as a loading control. Scale bars equals (A–C) 10 μm, (D, G, I) 50 μm. (E) Is a detailed
view of the image shown in panel D.
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frequent (Supplementary Figs. 8A–F); suggesting a requirement of san
function within follicle cells.
We were able to recover san clones within the follicle cells if they
were induced in adult flies and if the ovaries were dissected two/three
days after induction (data not shown). This was most likely due to San
protein perdurance within the follicle cells.
We also tested whether San was expressed in wild-type ovaries.
Western blots of total protein extracts showed that Sanwas expressed
in the ovaries (Fig. 5H), with no obvious differences in the expressionlevels detected between younger (3 days) and older females (8 days).
Additionally, San immunostaining of mosaic ovaries confirmed San
expression within the ovaries germ line, as we detected a specific
cytoplasmic staining between the control (presence of GFP) and
mutant egg chambers (absence of GFP) (Figs. 5G, I).
Previous studies with san homologue in HeLa cells showed that
the inactivation of san expression by RNAi induced an abnormal
expression of cohesin SMC1 (Hou et al., 2007). To check if integrity of
the cohesin complex during oogenesis was affected in san mutants,
mosaic ovaries were stained for Smc1. Consistent with the absence of
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Smc1 localization in germaria whose germ-line was mutant for san
(Figs. 5J–O), with bright foci and a diffuse staining present as was
previously described for wild-type germarium (Khetani and Bickel,
2007). We failed to detect specific immunostaining for Scc1 in wild-
type germarium (data not shown). We also did not detect specific
immunostaining for Scc1 and Smc1 in the syncytial blastoderm
embryo (data not shown).
Discussion
We isolated two new alleles of the san gene: san3 and san4. sanwas
previously described to be required for centromeric sister chromatid
cohesion in Drosophila (neuroblasts and ex vivo in S2 cells) and in
humans (ex vivo in HeLa cells) (Hou et al., 2007; Williams et al., 2003).
Our work confirms and extends the observation that san is
required in vivo for mitosis of different types of somatic cells. It also
suggests that in addition to the previously described role in sister
chromatid cohesion, san is also important for chromosome resolution.
We also propose that female germ line stem cells have differential
requirements for sister chromatid cohesion, since we could not detect
mitotic defects when they were mutant for san.
san is required in vivo for mitosis of different types of somatic cells
Since the mitotic function of san had only been studied in vivo in
Drosophila neuroblasts (Williams et al., 2003), we decided to
characterize its function during different stages of Drosophila devel-
opment. Our analysis shows that san is important for chromosome
segregation during syncytial blastoderm nuclei division (maternal
phenotype) and, as previously shown, in larvae neuroblast mitosis
(zygotic phenotype). We also observe that imaginal discs from larvae
mutant for san are extremely small. Clonal analysis confirms san
function is required within larvae imaginal discs and adult ovary
follicle cells.
san is required for chromosome resolution
Defects in mitotic sister chromatid cohesion in yeast and higher
eukaryotes have similar defects in chromosome alignment during
metaphase and chromosome lagging during anaphase (Dorsett et al.,
2005; Sonoda et al., 2001; Toyoda and Yanagida, 2006; Vass et al.,
2003). Drosophila embryos depleted for Scc1 have dramatic defects in
chromosome congression and alignment during metaphase (Pauli et
al., 2008). In contrast, san mutant embryos have clear defects in
chromosome segregation, but only show remarkably mild abnormal-
ities during metaphase. These phenotypic discrepancies suggest that
loss of san function causes other problems beyond sister chromatid
cohesion defects.
Embryos mutant for san show a high frequency of chromosome
bridges during anaphase. Sister chromatid cohesion defects can cause
a high frequency of anaphase bridging (Pauli et al., 2008; Vass et al.,
2003). Yet a large proportion of chromosome bridges in san embryos
are negative for Cid staining. Bridges involving distal regions of the
chromosomes were previously described in mutants with chromo-
some condensation and/or resolution defects (Bhat et al., 1996; Cobbe
et al., 2006; Dej et al., 2004; Steffensen et al., 2001).
Chromosome condensation during mitosis relies on the con-
densin multisubunit protein complex (Hirano, 2005). Together with
topoisomerase II, this complex has an important role in organizing
the individual axes of sister chromatids prior to their segregation
during anaphase (Hirano, 2006). Mutants for the condensin complex
SMC4 or gluon and Barren show chromosome segregation defects
with the formation of chromosome bridges during anaphase. After
depletion of SMC4, TopoII fails to localize to a clearly defined
chromatid axial structure and there is a significant decrease in TopoIIDNA decatenation activity (Coelho et al., 2003). TopoII is important
for chromosome resolution, and inactivation of topoII in Drosophila
embryos and S2 cells results in chromosome bridges (Buchenau et
al., 1993; Chang et al., 2003).
Given the phenotypic similarities between san, topoII, and barren
mutant embryos we investigated if Barren and TopoII expression was
abnormal in san mutant embryos. In san mutant embryos a subset of
mitotic nuclei show a dramatic decrease in Barren levels, suggesting
defects in chromosome condensation. Interestingly, we also observe a
subset of the chromosome bridges connecting the interphase nuclei
showing reduced levels of TopoII. We hypothesize that san is
important not only for sister chromatid cohesion but also for
chromosome resolution, which implies a more general function of
this acetyltransferase.
Several lines of evidence argue against a cross talk between the
cohesin and condensin complexes: 1) cohesins and condensins were
isolated as separate complexes in solution (Losada et al., 1998). 2)
Condensin DmSMC4 depletion did not alter the localization or
removal of cohesins from mitotic chromatin in Drosophila S2 cells
(Coelho et al., 2003). 3) In yeast has been shown that although sister
chromatid separation did not occur normally in condensin Ycs4
mutants (Cap-D2 in Drosophila), cohesin MCD1/SCC1 was released
normally from chromosomes at the metaphase–anaphase transition
(Bhalla et al., 2002). 4) In higher eukaryotes cohesion depletion did
not appear to affect chromosome condensation (Losada et al., 1998;
Sonoda et al., 2001; Vass et al., 2003).
Nevertheless, previous reports in budding yeast have suggested
mechanistic interactions between cohesins and condensins (Castano
et al., 1996; Lavoie et al., 2002). We show that san is genetically
upstream of both sister chromatid cohesion and chromosome
resolution/condensation. Our current interpretation is that San
acetyltransferase activity is necessary for sister chromatid cohesion
and chromosome resolution/condensation without being a core
component of these processes. To what extent we are uncovering a
cross talk is still unclear, but this is a plausible possibility.
During oogenesis san is not required for germ line mitosis
The female ovary is composed of 16–20 ovarioles (Gilboa and
Lehmann, 2004; Spradling, 1993). The germarium is at the anterior tip
of each ovariole and is responsible for egg chamber formation. Two to
three germ line stem cells are positioned at the anterior tip of each
germarium. These cells divide asymmetrically: the most anterior
daughter cell keeps a germ line stem cell fate whereas the most
posterior daughter cell (the cystoblast) starts a differentiationprogram
that ultimately produces an egg. The cystoblast dividesmitotically four
times in order to form a cyst of 16 cells connected by ring-canals and a
highly branched cytoskeletal structure called fusome. One of these
cells becomes the oocyte, the other 15 nurse cells.
In accordance with previously published work (Williams et al.,
2003), we clearly demonstrate that san is necessary in vivo for
normal mitosis in Drosophila melanogaster. It was therefore surpris-
ing that analysis of germ line clones mutant for san did not detect
any obvious mitotic defects during oogenesis. 1) The mitotic
divisions of the germ line stem cells and cysts mutant for san are
normal based on morphological analysis of the DNA, number of
nurse cells, and fusome organization. 2) Egg-laying from females
whose germ line is mutant for san is equivalent to the control
females, even two weeks after pupa eclosion (hatching). This
suggests that loss of san function does not reduce the mitotic rate
or impair the viability of the germ line stem cells. 3) Egg chambers
mutant for san show a normal determination and positioning of the
oocyte, and a normal condensed karyosome. 4) Drosophila eggs
mutant for san have a normal size and a normal dorsal ventral (DV)
patterning (absence of spindle phenotype). If san activity were
necessary within the germ line for chromosome segregation we
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Consistent with this expectation, defects in the repair of DNA
double strand breaks (DSB) during meiosis activates the DNA
damage checkpoint (Ghabrial and Schupbach, 1999), delaying
meiosis, inhibiting karyosome condensation, and mutant females
lay eggs with DV patterning defects.
A possible explanation for the lack of mitotic abnormalities in
females whose germ line is mutant for san is that San protein is
extremely stable. We do not favor this hypothesis for four separate
reasons: 1) we induce germ line clones for san during larvae
development (2nd and 3rd instar larvae) and analyze their effect at
least 12 days later in adult females that were 7/8 and 15 days old
(after pupa eclosion). 2) We consistently detect mitotic defects in
embryos laid by females whose germ line is mutant for san. 3) san
zygotic mutants reaching larvae stage is a typical phenotype
associated with several previously characterized cell cycle mutants
(Gatti and Baker, 1989; Krause et al., 2001). 4) san mutant clones in
larvae imaginal discs show defects only three days after clone
induction.
The isolated alleles of san contain nonsense mutations within the
open reading frame (ORF) and since they are protein-null alleles, the
lack of oogenesis defects is not the result of a putative hypomorphic
nature of the isolated alleles. Similar results were also obtained with
san2, a previously isolated loss-of-function allele of san (Williams et
al., 2003). We conclude that during oogenesis san is not required for
germ line mitosis.
san is possibly not required during oogenesis due to a functional
redundancy with deco acetyltransferase. This is improbable since
these two proteins are thought to have different substrates: San was
predicted to be an N-acetyltransferase (Williams et al., 2003), and
Deco was predicted to acetylate internal lysines (Ivanov et al., 2002).
Additionally, San was shown to localize to the cytoplasm during the
interphase of Drosophila Kc cells and human HeLa cells (Hou et al.,
2007; Williams et al., 2003), whereas members Eco1/Ctf7 family
(that includes Drosophila Deco) localize to the nucleus (Hou and Zou,
2005; Skibbens et al., 1999; Toth et al., 1999). Nevertheless, even if
the observed results are a consequence of a redundancy between
san and deco specifically within the germ line, this is consistent
with the hypothesis that during oogenesis female germ line cells
have differential requirements for mitotic sister chromatid cohesion
(see bellow).
Female germ line cells have differential requirements for mitotic sister
chromatid cohesion
Herewe have shown that duringmitosis different types of cells can
have differential requirements for chromosome segregation. We
cannot discard the possibility that some somatic cells might not
require the mitotic function of san, but our data suggest that female
germ line cells have differential requirements for mitotic sister
chromatid cohesion. Consistent with this hypothesis a previous
analysis of Smc1 germ line clones (focused primarily on prophase I
cysts) has not reported mitotic defects during oogenesis (Khetani and
Bickel, 2007). Identification of the in vivo substrates of san acetyl-
transferase should help a better understanding of the molecular
nature of these differences.
Materials and methods
Fly work and genetics
atado/san alleles were isolated from a maternal screen previously
done in the laboratory of Ruth Lehmann (Barbosa et al., 2007). From
this screen we identified 9 complementation groups on the right arm
of the second chromosome. These mutants fail to form embryonic
cuticle or have scraps of cuticle, however the primordial germ cellsare formed properly at the posterior pole of the embryo. Comple-
mentation Group 2 contained two alleles that initially were named
atado1 and atado2. Later on these alleles were respectively renamed
to san3 and san4. All flies were raised at 25 °C unless otherwise
indicated, using standard techniques.
Germ line clones were induced using the FLP/FRT ovoD system (Chou
and Perrimon, 1992). Germ line clones of san3 and san4 were made by
crossing FRT42B san/CyO virgins to hs flp; FRT42B ovoD/Cyohshid males
and heat shocking the progeny once at 37 °C for 1 h during second and
third larval instar.
Mosaic ovaries with the nuclear GFP clone marker were generated
by FLP-FRT-mediatedmitotic recombination as described (Caceres and
Nilson, 2005; Chou and Perrimon, 1992). FRT42B san4/CyO virgins
were crossed with yw P[w+, hsFLP]1; P[mini-w+, FRT42B] P[w+; ubi-
nls-GFP]/CyOhshid males. The P[w+; ubi-nls-GFP] FRT chromosomes
bear a polyubiquitin promoter that drives ubiquitous nuclear green
fluorescent protein (GFP) expression. Recombinationwas induced by a
1 h heat shock at 37 °C during the second and third instar stage. Adult
ovaries were harvested from females with 7–8 days and 15 days old,
and were subsequently processed for immunofluorescence. Germ line
and follicle cell clones were identified by the absence of nuclear
endogenous GFP.
To generate clones marked by the absence of GFP in imaginal
discs, FRT42B san4/CyOhshid males were crossed with yw P[w+,
hsFLP]1; P[mini-w+, FRT42B] P[w+; ubi-nls-GFP]/CyOhshid virgins.
The offspring were heat-shocked for 2 h at 37 °C at both 24 and 48 h
after a 24 h egg collection, corresponding to the first and second
larval instar.
To test the egg laying, 1 to 3 days old females from both hs flp; FRT
42B san4/FRT42B ovoD germ line clones and control hs flp; FRT42B/
ovoD FRT 42B, where germ line clones had been induced by heat-shock
during the second and third larval instar, were mated in parallel to 30
wild-type (Oregon R) males. Egg layingwas counted every 24 h during
15 days.
Both san3 and san4 alleles were balanced over a CyO Actin-GFP to
enable isolation of transheterozygous mutant larvae. Mutant larvae
were harvested on the basis of lack of GFP and transferred to fresh
tubes. Development was followed until pupae stagewhere sanmutant
larvae died.
In order to compare san mutant phenotypes with a known lethal
P-element insertion on the separation anxiety gene (san) (Williams et
al., 2003), we recombined san2 allele with a FRT42B chromosome. This
allowed us to generate san2 germ line clones and confirm that they are
phenotypically indistinguishable from san3 and san4 germ line clones.
Cloning atado
Both alleles of atado/san geneweremapped using the Bloomington
2R deficiency kit. Deficiencies were crossed with both atado/san
alleles and F1 progeny scored for zygotic lethality. The following seven
deficiencies failed to complement atado alleles: Df(2R)en-A, Df(2R)
en-B, Df(2R)E3363, Df(2R)Exel6060, Df(2R)ix[87i3], Df(2R)ED2219
and Df(2R)ED2155. This allowed us to map atado/san mutation to
the cytological interval 47E3–47F5, comprising 47 genes. By a
candidate gene approach we concluded that both alleles of atado/
san failed to complement a known lethal P-element of the san gene,
san2 (Williams et al., 2003).
To molecularly characterize the isolated san mutations, genomic
PCRwas carried out from heterozygousmutants of san gene (san/Cyo).
As a control, and in order to detect DNA polymorphisms, we used a
mutant from a different complementation group isolated in the same
screen. Two independent genomic PCR fragments from each allele
were sequenced and compared with each other, and with the control.
Both san alleles have distinct nonsense mutations within san open
reading frame that are predicted to cause a truncation of the San
protein.
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For phenotypic analysis of san embryos, at 2–3 h of age, embryos
were collected and fixed (after dechorionation in 50% bleach for
5 min) by gentle shaking for 1 h in 4 mL heptane, 0.125 mL 37%
formaldehyde and 0.875 mL PEMS. Fixation was followed of
devitellinization by addition of 4 mL methanol and shaking
vigorously during 1 min. Following rehydration, embryos were
blocked in phosphate buffered saline (PBS, pH 7.4) containing 0.1%
Tween-20, 0.1% bovine serum albumin and 5% serum (BBS), at 4 °C
overnight. To analyze nuclei arrested in metaphase, san embryos
were incubated 15 min with 250 μM colchicine, PBS and heptane,
prior to fixation.
Primary antibody incubations were carried in BBS at 4 °C over-
night. Antibodies used were anti-Cid at 1:500 kindly provided by
David Glover's laboratory, anti-Neurotactin at 1:133 (BP106 Hybri-
doma Bank), anti-pSer10-Histone H3 at 1:1000 (Upstate Biotechnol-
ogy), anti-Topoisomerase II at 1:400 (Buchenau et al., 1993), anti-
Barren at (1:2000) (Bhat et al., 1996), anti-Cnn at 1:1000 kindly
provided by Jordan Raff, Anti-αTubulin clone YL1/2 at 1:50 (Serotec
UK). The embryos were washed extensively in PBS containing 0.1%
Tween-20 (PBT), reblocked in BBS and incubated with the appro-
priate secondary antibody for 2 h at room temperature (RT).
Secondary antibodies were Cy3- and Cy5-conjugated at 1:1000
(Jackson ImmunoResearch Laboratories, West Grove, PA). After
extensively washed in PBT, DNA was stained with OliGreen
(Molecular Probes, Eugene, OR) at 1:5000 with the addition of 5 μg/
mL RNAse A. For scoring the number of cortical nuclei with reduced
levels of Barren we focused in embryos where the remaining nuclei
(positive for Barren) were at metaphase or early anaphase stages.
These are the stages when Barren localization in the chromosomes is
the highest.
Ovaries were processed for immunofluorescence as described
(Navarro et al., 2004), with exception of DNA staining. Primary
antibody was rabbit polyclonal anti-San (Williams et al., 2003) at
1:1000 and secondary antibody was Cy5-conjugated at 1:1000. For
DNA staining, ovaries were incubated with 100 μg of RNAse/mL for
30 min following incubation with 0.17 μg/mL propidium iodide.
Ovaries were 2 times 5-min washed in PBT and 2 rinses in PBS,
following mounting. Endogenous GFP was used to distinguish
mutant clone egg chambers from chambers that did not have
clones.
For ovary staining with anti-Smc1 antibody, ovaries were pro-
cessed as described (Song et al., 2002). Primary antibody was anti-
Smc1 at 1:2000 (Khetani and Bickel, 2007) and anti-Hts at 1:50 (1B1
Hybridoma Bank). Secondary detectionwas done using rodamin red at
1:1000 (Jackson ImmunoResearch Laboratories) and Cy5-conjugated
at 1:1000.
Imaginal discs were dissected in PBS from crawling late third
instar larvae. Discs were fixed in 4% formaldehyde with PEMS
during 30 min on ice, following a 15 min wash in PBS with 0,2%
Triton X-100. DNA was stained with propidium iodide as previously
described.
Whole brains from transheterozygous mutants of san (san3/san4)
were dissected from third instar larvae in PBS and fixed for 20 min in
3.7% formaldehyde, 2 mM EGTA in PBS. Briefly, brains were three
times 5-min washed with PBS, permeabilized for 10 min in PBS+0,3%
Triton X-100 and blocked in PBS containing 0.1% Triton X-100 and 1%
BSA for 1 h at RT. Anti-αTubulin at 1:50 and anti-pSer10 Histone H3 at
1:300 were incubated with PBS+0.1% Triton X-100 and 1% BSA
overnight at 4 °C. After three 5-min washes, Cy3- and Cy5-conjugated
secondary antibodies were incubated for 4 h at RT. Brains were rinsed
with PBS and DNA was stained with propidium iodide as previously
described.
Embryos and all tissues were mounted in Fluorescent Mounting
Medium (DakoCytomation, Inc) and immunostainings were visualizedusing a Leica SP5 confocal microscope. All images are confocal
sections, with the exception of Figs. 5J–O, Sup. Fig. 4, and Sup. Fig. 6,
which are Z-stacks. The Z-stacks projections were obtained using
Image J program (Grouped ZProjector, maximum pixel intensity).
Western blotting
Embryos were collected on apple juice agar after 3 h egg laying.
Each protein sample was collected by lysing 10 embryos in SDS-PAGE
sample buffer. Samples were boiled for 5 min and loaded on 5×8 cm
12.5% polyacrylamide gels.
Ovaries were dissected from 3-to 8-day-old Oregon females.
Ovaries were homogenized in buffer containing 50 mM Tris–HCl
(pH 7.5), 150 mM NaCl, 2 mM EDTA, 0,1% NP-40, 2 mM DTT,
10 mM NaF and protease inhibitor (Roche). A Bio-Rad™ Bradford
protein microassay ensured loading of 5, 10 and 15 μg of protein
onto 12% SDS polyacrylamide gels. As for embryo extracts,
samples were boiled for 5 min in SDS-PAGE sample buffer before
loading.
Proteins were then transferred onto Hybond-ECL membranes
(Amersham) and western blotting was performed with standard
procedure. Briefly, the membrane was blocked in 5% non-fat milk/
PBT (0,1% Tween-20, 1× PBS) overnight at 4 °C. Primary antibodies
were incubated with the membrane overnight at 4 °C. Following
washes with PBT secondary antibodies were incubated for 4 h at RT.
After washes with PBT, the membranes were detected with an ECL
Plus western blotting detection system (GE Healthcare). Primary
antibodies used were anti-Cid (1:2000), rabbit polyclonal anti-San
(1:1000), rabbit anti-Smc4 (1:1000) (Steffensen et al., 2001), rat anti-
Tubulin (1:250). Secondary detection was performed with rabbit and
rat HRP-conjugated antibodies used at a final concentration of
1:5000.
Recombinant San4 protein expression and detection
We expressed in bacteria a recombinant C-terminal polyhisti-
dine (6xHis)-tagged fragment of San corresponding to residues 1–
113 by cloning a cDNA EcoRI–XhoI fragment into the pET22b vector
(Novagene) and expressing it in E. coli BL21. This is the truncated
protein predicted to be encoded by atado2/san4. Since the San
antibody was generated against a GST-San fusion protein, we
cloned san4 cDNA in a His-tag expression vector to avoid cross-
reactivity with GST. The San4-6xHis protein was induced with
10 mM IPTG in E. coli BL21. Bacterial samples were collected at 90,
120 and 180 min from both induced and non-induced cultures. The
bacterial pellets from each time point were ressuspended in SDS-
sample buffer, boiled for 5 min and loaded on two 15%
polyacrylamide gels. One gel was stained with brilliant coomassie
and the other gel was used for western blotting using the San
antibody.
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Supplementary figure 1
Embryos mutant for atado2 show high frequency of chromosome
bridges during syncytial blastoderm. (A) Syncytial blastoderm is
abnormal in 87% of the embryos mutant for atado2 and 2.5% of the
control embryos. (B) Chromosome bridges during late-mitosis and
interphase can be observed in 12.3% ± 20.5 of the nuclei mutant for
atado2 (n= 1033 nuclei, 12 embryos) and only 0.7%±1.8 of the control
nuclei (n=2081 nuclei, 12 embryos) (Student’s t test, 95% confidence
interval, p<0.03). Nuclei were only scored when pSer10 histone H3
staining was absent (or almost absent) from the syncytial nuclei. This
allows the exclusion of most nuclei going through mitosis.
Supplementary figure 2
Embryos mutant for atado2 apparently have normal kinetochores,
centrosomes, and mitotic spindles. Embryos mutant for atado2
show normal localization of Cid (A, B), Cnn (C, D), and α-Tubulin (E,
F). All panels show syncytial blastoderm embryos. (A, B) Embryos
were stained for Cid (green), DNA (red), and pSer10 H3 (blue). (C, D)
Embryos were stained for DNA (green) and Cnn (red). (E, F) Embryos
were stained for α-Tubulin (green), DNA (red), Cnn (blue). Scale bars
equals (A, B) 10μm and (C, D) 5μm.
Supplementary figure 3
Larvae mutant for atado (zygotic mutants) show smaller and
morphological abnormal brains. Transheterozygotic atado1/atado2
third-instar larvae show smaller and morphologically abnormal brains
(br) when compared to the ones from control larvae (atado/Cyo Actin-
GFP). Control larvae were identified using an Actin-GFP transgene.
Central ganglia (gl) from atado and control larvae have similar sizes.
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Supplementary figure 4
Embryos mutant for san2 (germ-line clones) are phenotypically
indistinguishable from atado mutant embryos. Embryos mutant for
san2 show abnormal anaphases (C, D), with a high frequency of
chromosome bridges (E). Chromosome congression during
metaphase occurs normally, yet a subset of chromosomes although
positive for pSer10 H3 (B) appear to have chromosome condensation
problems (A). All panels show syncytial blastoderm embryos. The
same embryo was stained for DNA (A) and pSer10 H3 (B). Embryos
(C–F) were stained for DNA (green) and pSer10 Histone H3 (red). (D,
E) show details of the embryo shown in C. Embryo shown in (F) is wild
type. Embryos shown in (A–E) are mutant for san2 (germ-line clones
crossed with wild type males). Images shown are Z-stacks obtained
using Image J program (Grouped ZProjector, maximum pixel intensity).
Supplementary figure 5
San antibody is able to recognize a truncated protein predicted to
be encoded by atado2/san4. Western blot from bacteria protein
extracts from induced (with IPTG) and mock induced (no IPTG)
bacteria show that San antibody is able to recognize a truncated
protein predicted to be encoded by atado2/san4. An embryonic extract
from wild type embryos is used as a positive control. Since the San
antibody was raised against a GST-San recombinant protein, the
truncate protein was tagged with a 6xHis-tag in order to avoid GST
cross-reactivity.
Supplementary figure 6
In san2 embryos, a large proportion of the bridges between
interphase nuclei are negative for Cid staining. All panels show
interphase nuclei from syncytial blastoderm embryos mutant for san2.
A large proportion of bridges were negative for Cid staining (C–F). Yet
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some were positive for Cid (G, H). Of the scored bridges between
nuclei in late-mitosis/interphase: 55.6% ± 18.2 were negative for Cid
staining, 32% ± 11.5 were positive for Cid staining, and in 12.4% ± 10
of the cases the result was inconclusive (n= 104 bridges). All embryos
were stained for DNA (green) and Cid (red). Panels (C–I) show details
of the embryos shown in (A, B). Images shown are Z-stacks obtained
using Image J program (Grouped ZProjector, maximum pixel intensity).
Supplementary figure 7
san is not required within the germ line for normal egg laying. The
egg-laying of san4 and control females (with an identical FRT
chromosome) is identical. Germ line clones using the FRT-ovoD
system were induced by heat-shock at larvae stages. For more
experimental information please see MATERIALS AND METHODS.
Supplementary figure 8
During oogenesis san is required within somatic follicle cells but
is not required within the germ line for normal mitosis. san2 is a
previously characterized loss-of-function allele of san. Absence of
endogenous GFP (green) indicates that the cells are homozygous for
san2 (A–F) or control FRT chromosome (G-L). Germ line and follicle
cell clones of san2 (A–F) or control FRT chromosome (G–L) were
induced at larvae stages using heat-shock-controlled flipase and the
ovaries were dissected from adult females that were 7/8 old after
hatching (pupal eclosion). Drosophila germarium whose germ line is
mutant for san2 developed normally (A–F). Follicle cell clones mutant
for san2 were rare and small (B, D, E, F). Follicle cell clones from
control FRT chromosome were more frequent and significantly larger
than the ones observed for san2 (G–L). Ovaries are stained for DNA
(red). Scale bars equal (A, C) 25μm, (E) 50μm, (G) 40μm, and (J)
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50μm. The images shown in (A, B), (C, D), (E, F), (G–I), and (J, K)
correspond to the same egg chambers.
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dSan/dNaa50 in vivo Nα-acetylates multiple targets
and shares partial redundancy with other
N-terminal acetyltransferases
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1. Introduction
N-terminal acetylation is a highly conserved and widespread
modification occurring on approximately 80% of all soluble,
cytoplasmic human proteins (Arnesen et al., 2009). With few
exceptions, little is known about the biological function of protein N-
terminal acetylation. Recently, it was suggested to act as a general
destabilization signal for some yeast proteins (Hwang et al., 2010).
Other reports suggest it might act as stabilizer, for instance by blocking
protein degradation (Ciechanover and Ben-Saadon, 2004). Since it’s
such a conserved and widespread modification, protein N-acetylation
can be envisioned as a housekeeping modification. Consistent with
this idea, knockdown phenotypes of the main studied N-terminal
acetyltransferase (NAT) complexes are generally associated with cell
cycle arrest or apoptosis (Ametzazurra et al., 2008; Arnesen et al.,
2006b; Fisher et al., 2005; Lim et al., 2006; Starheim et al., 2008;
Starheim et al., 2009). In contrast to the NatA, NatB and NatC
complexes, knockdown of the NatE complex leads to more specific
phenotypes.
The NatE complex is composed by the NAT Naa50p
associated to Naa10p and Naa15p (Arnesen et al., 2006a; Gautschi et
al., 2003; Williams et al., 2003). dSan/dNaa50p was first identified in a
large-scale genetic screen for mitotic mutations in Drosophila (Williams
et al., 2003). dSan/dNaa50 mutant neuroblasts exhibited premature
sister chromatid separation. Moreover, in dSan/dNaa50-depleted
cultured cells, the cohesin subunit Drad21/Scc1 was delocalized from
the centromeres of the detached chromatids. This work, therefore,
associated dSan/dNaa50 function to centromeric sister chromatid
cohesion (Williams et al., 2003). However we further observed
dSan/dNaa50 was also required for chromosome resolution/
condensation implying a more general mitotic function of this
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acetyltransferase (Pimenta-Marques et al., 2008). Recent in vitro
studies showed hSan/hNaa50 preferentially acetylates N-termini with
the consensus MLGP- and MLDP- (Evjenth et al., 2009), however
there are no known in vivo substrates of San/Naa50p. Identifying the in
vivo substrates of dSan/dNaa50 would shed light on the molecular
pathway in which this NAT is involved and how protein N-acetylation
regulates mitosis.
With the goal of identifying in vivo substrates of dSan/dNaa50,
we took advantage of the N-terminal COmbined FRActional Diagonal
Chromatography (COFRADIC) methodology to identify proteins whose
N-acetylation levels were reduced in san mutant embryos. In this
chapter we describe the identification of 18 proteins whose N-
acetylation levels are indeed reduced in san mutants. From these 18
proteins we looked for candidate proteins as being associated to the
mitotic phenotypes observed in dSan/dNaa50 depleted cells. From
these, we identified the gamma subunit of the cytosolic chaperonin
containing T-complex polypeptide 1 (CTT) (Cct) which displayed
chromosome segregation defects very similar to dSan/dNaa50
depleted cells. Interestingly Cct is required for the metaphase to
anaphase transition by activating the APC/C complex, making this
protein an excellent candidate for a mitotic substrate of dSan/dNaa50.
Additionally, we describe the identification of candidate mitotic targets
of dSan/dNaa50 by analysis of protein N-terminus. Since both
Drosophila and human San/Naa50p depleted cells share similar mitotic
phenotypes (Hou et al., 2007; Williams et al., 2003) we expect mitotic
substrates of this NAT to also share a conserved N-terminus.
Interestingly, we found the cohesin Drad21/Scc1 protein contains a
conserved N-terminus within higher eukaryotes. Additionally, this N-
terminus falls into the category of an N-terminus acetylated by
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hSan/hNaa50, making Drad21/Scc1 a candidate to further explore as a
mitotic substrate of dSan/dNaa50.
2. Materials and methods
2.1. Embryonic protein extracts
Germ line clones of san4 were made using standard techniques
(Chou and Perrimon, 1992) as described in chapter II. Females with
mutant germ-line (Cy+ females) were crossed with wild-type (Oregon
R) males. Maternal mutant embryos for san4 and wild-type (control)
embryos were independently collected every two hours in apple juice
plates, dechorionated in 50% bleach for 5 min, rinsed 3x in ddH20, 2x
rinsed in PBT and 1x PBS. Embryos were frozen in liquid nitrogen and
kept at -80ºC. Embryos were homogenized in lysis buffer containing 50
mM Tris, 12 mM EDTA, 250 mM NaCl, 140 mM Na2HPO4 (pH 7,6),
and protease inhibitor (Roche). Samples were centrifuged 3x at
14000g for 5 min at 4ºC, between each centrifugation the middle layer
was collected avoiding the upper-lipid layer as much as possible. A
Bio-Rad™ Bradford protein microassay was preformed to quantify the
total amount of protein in san mutant and wild-type (control) protein
extracts. Extracts were kept at -80ºC.
2.2. Identification of dSan/dNaa50 NAT substrates by COFRADIC
Work developed by Petra Van Damme in Kris Gavert’s laboratory (VIB
Department of Medical Protein Research, Ghent University) and in
collaboration with Thomas Arnesen (University of Bergen).
To identify in vivo targets of dSan/dNaa50, we used
COFRADIC proteomics. Briefly, proteins were denaturated to their
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primary structure (fig. 1). All free primary amines (-amines of the N-
terminals and -amines from internal amino acids) were further blocked
by a forced in vitro AcD3C13-acetylation (5Da heavier form of NHS-
acetate which introduced a 13C2 and D3 labeled acetyl moiety on all
free amines). Extracts were further digested with trypsin. Digestion
resulted in a mixture of N-terminal peptides which were in vivo or in
vitro acetylated and internal peptides which now had a free -amine
group. By performing a strong cation exchange (SCX) step at pH 3.0,
acetylated peptides which carried one positive charge less than the
internal peptides were retained significantly less with SCX resins. This
step allowed discarding the majority of internal peptides. SCX
treatment was followed by a primary high performance liquid
chromatography (HPLC) fractionation of the different samples. After
the first HPLC run all fractions were treated with 2,4,6-
trinitrobenzenesulfonic acid (TNBS). This allowed blockage of internal
peptides that were not eliminated by the SCX treatment. Since TNBS
treatment conferred a high hydrophobicity to the remaining internal
peptides, they were efficiently discarded by a second HPLC run. This
step increases the purity of the final analysed samples to 95% of true
N-terminal peptides. The different fractions were analyzed by liquid
chromatography-tandem mass spectrometry (LC-MS/MS), which
allowed the identification and quantification of the in vivo N-terminal
acetylated peptides (fig. 1) (Gevaert et al., 2003; Van Damme et al.,
2009).
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Figure 1: General work-flow of the N-terminal COFRADIC Procedure. (Adapted from Van
Damme et al., 2009).
N-acetylation states of N-termini identified in both setups were
comparatively analyzed by inspection of their respective MS-spectra.
We distinguished between in vivo N-acetylation and free N-termini by
making use of in vitro AcD3C13-acetylation. Each N-terminus was
defined as a peptide that was N-acetylated in vivo or AcD3C13-
acetylated in vitro (in vivo free N-terminus) starting at position 1 or 2 of
the annotated protein sequence or at positions beyond position 2 of
the annotated protein sequence according to the SwissProt database.
The ratios of all Arg-C type N-terminal peptides were quantified
by MASCOT Distiller (http://www.matrixscience.com/distiller.html) and
the extent of N-acetylation was calculated after extracting the peak-
intensities. Therefore, the modified peptide sequences were used to
calculate the theoretical isotope peak distribution using the MS-isotope
pattern calculator (http://prospector.ucsf.edu). For all two possible
variants (in vivo N-acetylated (peak at m/Z) and in vitro 13C2D3-N-
acetylated (peak at m/z +5Da) the predicted intensity of the 5th
contributing isotope (isotopic pattern of contributing -5Da peak) was
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subtracted from the measured intensity of all corresponding
monoisotopic peaks of the other isotopic clusters in order to correct for
the overlapping isotopic envelopes.
For all unique N-termini identified, the average of all ratios were
calculated per peptide and the corresponding highest scoring MS-
spectra were visually inspected in order to evaluate the extent of the
N-acetylation calculated and to assure a high quality catalogue of the
global N-acetylation status in control and san mutant proteomes.
2.3. RNA interference and drug treatment of cultured Drosophila
Dmel2 cells
Cells were always cultured at 25ºC. Drosophila Dmel2 cells
were grown in SFM Medium (GIBCO) supplemented with 1x glutamine
and 1x PenStrep. Cells were counted and diluted to 2x106 cells/mL in
SFM medium, supplemented with glutamine but without Penstrep.
RNA interference (RNAi) was performed according to Clemens et al.
(Clemens et al., 2000) in Drosophila Dmel2 cells. Table 1 contains the
primers used for the construction of different amplicons and their
corresponding size. Each result was always confirmed using two
different dsRNAs against the same mRNA to minimize off-target
effects. GFP RNAi was used as control. Each primer incorporated a T7
RNA polymerase binding site. All PCR products were used as
templates to synthesize dsRNA by utilizing the T7 RiboMAX™ Express
kit (Promega). Cells were incubated during 1h with 40µg of dsRNA at a
concentration of 1µg/µL for each RNAi experiment performed. After 1h
incubation with dsRNA, 3mL of SFM media supplemented with
glutamine and PenStrep were added back.
To arrest cells in mitosis, colchicine (Sigma) was added to
culture medium to a final concentration of 25 µM and then incubated
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for 11 or 16 hours. 11h colchicine treatment corresponded to 88h
incubation with dsRNAs and 16h colchicine treatment corresponded to
93h dsRNA treatment. At each desired time point, cells were harvested
for immunofluorescence and/or immunoblotting.
Protein to
deplete Amplicon Primers
Amplicon
size (bp)
dSan
dSan Amp1 5’- AGCAGCATCGAACTGGGC -3’5’-CGCTTATAGTATTGCTCCTTGGT-3’ 413
dSan Amp2 5’-CAACACTGAGAACCAGCGGC-3’5’-CGTAGTAAAGCACGACAGTTCAC-3’ 354
PPP4R24
PPP4R2r
Amp1
5’-AAGACAGGCGGAGTTACAGC-3’
5’-AGGTCGTCGAGTCTGATAAACC-3’ 613
PPP4R2r
Amp2
5’-CACAATCGATCCTGGACGCAAGC-3’
5’-GCCTCGTCATCGGCAGATGATGGG-3’ 489
CG1785
CG1785 Amp1 5’-TATTGATCAGGTGGTGGAACG-3’5’-CCTCTTGAGCTCTGTTTGACG-3’ 450
CG1785 Amp2 5’-CGTTCGCGGATAAACAGGATG-3’5’-CAGACGCTGTTCCAGTTTTACG-3’ 299
CkII
CkII Amp 1 5’-TAATGCATCGTGATGTAAAGCC-3’5’-TGGCTTCTATCCCAAACTCG-3’ 615
CkII Amp 2 5’-CGGCTCGCGTGTACACAGATG-3’5’-GGCTTTACATCACGATGCATTATTCC-3’ 454
Cct
Cct Amp1 5’-AGGAGTCGTGTGTTCTTAAGGG-3’5’-GTATGATCTCTAGGGCGTGGG-3’ 696
Cct Amp2 5’-CCAAGGCCTGCACCATCCTGC-3’5’-GATGTTCTTCACGTTCATGTCCACG-3’ 454
RpL19
RpL19 Amp1 5’-GAAAGCGTAAGGGTACTGCG-3’5’-ATCATTTCGGCCAAACTAAAGG-3’ 464
RpL19 Amp 2 5’-CTTTCCTAGCCACGACGAGG-3’5’-CACGGTAACGGGAGTGGAC-3’ 215
GFP GFP Amp 5’-ACCATGCCGCTACTGTGAATC-3’5’-GTGCGCCAATGGAAGAATC-3’ 420
Table 1: Primers used to produce different dsRNAs for RNAi experiments.
2.4. Immunofluorescence of Dmel2 Cells
After 93 hours of dsRNA treatment with or without colchicine
induced mitotic arrest, 2x106 cells were added to coverslips by 1h
incubation at 25ºC. Cells were fixed with 4% formaldehyde, 0.03M
PIPES, 0.11M HEPES, 0.01M EGTA and 4mM MgSO4 for 10 min,
followed by two washes in 1x PBS. Permeabilization and blocking was
performed for 1h with PBSTB (PBS, 0.1% Triton X-100, 1% fetal
bovine serum). Primary antibody incubations were done in PBSTB for
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2h at room temperature or overnight at 4°C, followed by three 5 min
washes in PBSTB. Secondary antibody incubations were performed as
described for the primary antibodies, including the three 5 min washes.
Primary antibodies used were mouse anti--tubulin DM1A (1:500;
Sigma) and rabbit anti-pSer10-Histone H3 (1:500; Upstate
Biotechnology). Rabbit anti-pSer10-Histone H3 was used to mark and
count mitotic cells. DNA was stained with DAPI at 1:1000 (stock
concentration 1 mg/ml).
2.5. Microscopy
Visualization of fixed cells was performed using a Delta Vision
Core System (Applied Precision) using a 100× UplanSApo objective
and a cascade2 EMCCD camera (Photometrics). Images were
acquired as a series of z-sections separated by 0.2-µm intervals.
Deconvolution was performed using the conservative ratio method in
softWoRx software. Phenotypic quantification was performed using a
regular Epifluorescent microscope, DMRA2 (Leica).
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3. Results
3.1. dSan/dNaa50 N-terminal acetyltransferase acetylates
multiple different substrates in vivo
NATs can have a large number of in vivo substrates (Arnesen
et al., 2009). In order to define the in vivo consensus of dSan/dNaa50
substrates we took advantage of COFRADIC to analyze in vivo the N-
terminal acetylation profiles of wild-type (control) and san mutant
embryos proteomes. This work was done in collaboration with Thomas
Arnesen (University of Bergen, Norway) and Kris Gavert (Department
of Medical Protein Research, VIB, B-9000 Ghent, Belgium).
The COFRADIC method allowed the identification of 432
unique N-termini derived from 399 unique SwissProt Drosophila
protein accessions. Of the 432 unique N-termini identified, 364
acquired a start position at amino acid 1 or 2 (84%), while 68 had a
start position after the amino acid 2 (16%). 292 unique N-termini were
identified in control and san mutant protein extracts, while 100 and 40
were uniquely identified in the control or mutant protein extracts,
respectively. The N-acetylation profile of 265 out of 292 unique N-
termini were identified in both control and san mutant embryos (Van
Damme and Kris Gevaert; unpublished data).
The COFRADIC analysis allowed the identification of 18
proteins whose in vivo N-acetylation was reduced in san mutant
embryos (fig. 2). Significant variations in N-acetylation between
control and san mutant embryos were arbitrarily set at 10% difference.
Nevertheless some of the N-termini affected to a lesser extent
(between >5% and 10% difference in the extent of N-acetylation)
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were also considered as possible targets of dSan/dNaa50 due to
known mitotic functions. Such targets were included in the substrate
list (table 2).
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Figure 2: Plot representing proportion of N-acetylation in control and san mutant embryos. Green and blue bars represent control and san mutant embryos,
respectively. Numbers below the plot correspond to the number of counts done for each peptide.
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Identified N-termini Ac aa Coding gene Fly basesymbol %Ac wild-type %Ac san mutant % Ac
VTMENSDEIMQILER VT CG2890 PPP4R2r 82,8 31,8 51,0
TTTENVSTER TT CG3057 COLT 90,6 59,0 31,6
TAVEPATKKKR TA CG1785 - 73,4 45,1 28,3
TLPSAAR TL CG17520 CKIIα 52,7 31,0 21,7
TQAEIVKCLR TQ CG4510 Surf6 59,6 40,9 18,7
TEEADFSEQITDGKNKSNVR TE CG7787 - 91,0 76,4 14,60
TESVELMNKYGEPLR TE CG11880 - 38,0 24,4 13,6
MFGGQQPILVLSQNTKR MF CG8977 Cct 72,2 59,4 12,90
SSLKLQKR SS CG2746 RpL19 95,1 82,5 12,6
SAPTDQPPR SA CG9159 Kr-h2 80,6 68,4 12,2
TEIKSEAAPSTSAEAKPEDVR TE CG8759 Nac 100,0 87,2 12,8
MQIDPELEAIKAR MQ CG2163 Pabp2 87,3 75,0 12,4
TKVQKEVR TK CG2199 - 18,8 6,5 12,3
SGASTTYPMQCSALR SG CG3186 elF-5ª 25,2 14,6 10,5
ANLNFQQPPR AN CG2161 Rga 100,0 94,5 5,5
VDFYYLPGSSPCR VD CG10045 GstD1 56,5 49,1 7,5
AQKKAVTVKGKKATNGEEKPLAKR AQ CG2050 Mod 14,6 7,6 7,0
TLASPLSIAGTR TL CG5374 T-cp1 21,4 15,0 6,4
Table 2: Summary of N-acetylation in control and san mutant embryos. Reduction of in vivo protein N-acetylation in control and san mutant embryos. Yellow
cells show N-acetylated peptides at position 1 or 2 of the annotated protein sequence at SwissProt database, whereas pink cells show peptides N-acetylated at
positions beyond position two of the annotated protein sequence. (AC aa) Column displaying two residues of each peptide in which the first residue was detected as
being acetylated one.
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3.2. Tissue culture cells depleted for dSan/dNaa50 showed
chromosome segregation defects
We used RNAi in Dmel2 cells to analyze the consequence of
dSan/dNaa50-depletion in tissue culture. Cells treated during 93h with
dsRNA for dSan/dNaa50 demonstrated a clear decrease in
dSan/dNaa50 protein levels (fig. 3).
Figure 3: Decrease of dSan/dNaa50 protein levels after RNAi treatment. Dmel2
cells showed a decrease of dSan/dNaa50 protein. Tubulin was used as loading
control. C, control RNAi; S, dSan/dNaa50 RNAi.
While the control exhibited mostly normal metaphase and
anaphase cells (fig. 4 A,B,C), dSan/dNaa50-depleted cells showed a
moderate increase in chromosome congression defects during
metaphase (fig. 4 D,G). 28% of dSan/dNaa50-depleted cells in
metaphase displayed a visible metaphase plate, but still with DNA out
of the equator (vs. 5% in control cells) (fig. 5 A). 10,9% of
dSan/dNaa50-depleted cells in metaphase were highly abnormal with
DNA scattered along the mitotic spindle (vs. 1,7% in control cells) (fig.
5 A). Also, dSan/dNaa50-depleted cells, showed a mitotic index
increase (fig. 5 B). There was a 2-fold increase in dSan/dNaa50-RNAi
cells positive for histone H3 phosphorilated on serine 10 (PH3) (a
marker for mitosis) (fig. 5 B), suggesting a cell cycle arrest during
metaphase.
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During the metaphase to anaphase transition, sister chromatids
lose cohesion and segregate equally from the metaphase plate to both
poles of the mitotic spindle (fig. 4 B, C). dSan/dNaa50-depleted cells
did not segregate sister chromatids equally to the spindle poles,
showing segregation defects that included lagging chromosomes and
chromosome bridges (fig. 4 E, F, H and I). dSan/dNaa50-depleted
cells showed segregation defects in 67,8% of cells undergoing
anaphase A (early anaphase)(vs. 13,3% in control cells) and 49,7% of
cells undergoing anaphases B (late anaphase)(vs. 6% in control cells)
(fig. 5 A). Both control and dSan/dNaa50-depleted cells arrested
mitosis in response to incubation with the microtubule (MT)
depolymerization agent colchicine (fig. 5 C). This suggested
dSan/dNaa50 depleted cells had an active spindle assembly
checkpoint (SAC). Depleting dSan/dNaa50 in Drosophila cultured cells
caused chromosome segregation defects identical to the ones
observed in vivo in san mutant embryos (Pimenta-Marques et al.,
2008). Similar to what was observed in vivo, dSan/dNaa50-depleted
cells transiently arrested in mitosis, most likely in a SAC-dependent
manner.
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Figure 4: dSan/dNaa50 is required for proper metaphase chromosome alignment
and chromosome segregation during anaphase. dSan/dNaa50-depleted cells
displayed chromosome congression defects during metaphase. Metaphase
congression defects were either classified into mildly or highly abnormal. (A) Control
metaphase. (D) Cell representative of a mildly abnormal metaphase, with congression
of the majority of chromosomes but where some chromosomes are still not aligned at
the metaphase equator. (G) Cell representative of a highly abnormal metaphase
showing chromosomes scattered along the mitotic spindle instead of being aligned at
the spindle equator. dSan/dNaa50-depleted cells showed chromosome segregation
defects which included lagging chromosomes and chromosome bridges. (B, C) Control
cells undergoing anaphase B. (E, F) dSan/dNaa50-depleted cells undergoing
anaphase B with lagging chromosomes. (H, I) dSan/dNaa50-depleted cells undergoing
anaphase B displaying extensive chromosome bridges. Histone 3 phosphorylated on
Serine 10 (red), α-tubulin (green) and DNA (blue). Gray pictures illustrate Histone 3
phosphorylated on Serine 10.
Figure 5: dSan/dNaa50 is required for proper chromosome alignment in
metaphase and chromosome segregation during anaphase. (A) Quantification of
mitotic defects. Percentage of cells undergoing metaphase with mildly and highly
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abnormal chromosome congression defects (M Ab Met and H Ab Met) and anaphases
A and B with lagging chromosomes or chromosome bridges (Ab Ana A and Ab Ana B)
in control and dSan/dNaa50 dsRNA-treated cells. Quantification: Mildly abnormal
metaphases in 28% ± 7,2 in dSan/dNaa50-depleted cells versus 5% ± 5 in control
cells. 10,9% ± 2,4 of dSan/dNaa50-depleted cells exhibited highly abnormal
metaphases versus 1,7% ± 2,9 in control cells. dSan/dNaa50-depleted cells, n=64
metaphases; control cells, n=61 metaphases. dSan/dNaa50-depleted cells exhibited
67,8% ± 19,7 abnormal anaphases A (n=60) versus 13,3% ± 7,6 in control cells
(n=60). dSan/dNaa50 depleted cells exhibited 49,7% ± 9 abnormal anaphases B
(n=65) versus 6% ± 6,6 in control cells (n=63) (**p<0,01; ***p<0,001 Student’s test).
(B) Mitotic index in dSan/dNaa50-depleted cells and control cells. dSan/dNaa50-
depleted cells showed a mitotic index of 14,2% ± 2,6 (n=1326) against 6% ± 1,5 in
control cells (n=1086) (**p<0,01 Student’s test). (C) Control and dSan/dNaa50-
depleted cells were incubated with 25µM colchicine, and the mitotic index was
recorded after 11 and 16 h colchicine treatment. (Colchicine 11h: Control RNAi n=501,
dSan/dNaa50 RNAi n=523; Colchicine 16h: Control RNAi n=504, dSan/dNaa50 RNAi
n=582; Asynchronous cells: Control RNAi n=525, dSan/dNaa50 RNAi n=565).
3.3. Cct and dSan/dNaa50-depleted cells have similar
chromosome segregation defects
In vivo analysis of dSan/dNaa50 targets allowed the
identification of 18 putative substrates of dSan/dNaa50. From these, 5
proteins (table 3) were chosen to be tested as mitotic targets of
dSan/dNaa50. These proteins were selected from the initial 18 taking
into account two main criteria: a) proteins with an already described
mitotic function and/or positive hits in a previous published screen for
mitotic spindle morphology (Goshima et al., 2007); b) proteins for
which the COFRADIC analysis displayed a large reduction in N-
acetylation.
PPP4R2r showed the highest decrease in N-acetylation in
dSan/dNaa50 mutants. Importantly, PPP4R2r is required for
neuroblast asymmetric divisions by mediating the correct localization
of the Miranda protein complex (Sousa-Nunes et al., 2009). The
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protein encoded by the gene CG1785 also showed a large reduction in
N-acetylation in san mutants (fig. 2 and table 2). CG1785 shared a
high degree of similarity with the human protein Glioma tumor-
suppressor candidate region gene 2 (GLTSCR2) and several results
suggested it might be a tumor suppressor (Kim et al., 2008; Okahara
et al., 2006; Smith et al., 2000). Casein kinase II α subunit (CkII) is
the catalytic subunit of the casein kinase II (CKII) tetrameric complex
which was shown to in vitro modulate topoisomerase II (TopoII) activity
by phosphorilation (Ackerman et al., 1985). Cct is a subunit of the
conserved chaperonin containing TCP-1 (CCT) complex that
functioned as a molecular chaperone in the eukaryotic cytosol. The
chaperone activity of this complex has been shown to be associated
with tubulin, actin and activators of the APC/C, cdc20 and cdh1
(Camasses et al., 2003). Interestingly Cct was a positive hit in a
screen performed to identify regulators of the mitotic spindle assembly
(Goshima et al., 2007). RpL19 is a 60S ribosomal protein L19, involved
in translational elongation. This protein was recently suggested to be
involved in centrosome duplication (Muller et al., 2010), and was
previously associated with mitotic spindle morphology (Goshima et al.,
2007).
Candidate
proteins Dmel. N-terminus Human N-terminus
Known mitotic
function
PPP4R2r MVTMENSDEIMQILER MDVERLQEALKDFEK Yes
CG1785 MTAVEPATKKKR MAAGGSGVGGKRSSK Yes
CkII MTLPSAAR MSGPVPSRARVYTDV Yes
Cct MFGGQQPILVLSQNTKR MMGHRPVLVLSQNTK Yes
RpL19 MSSLKLQKR MSMLRLQKRLASSVL Yes
Table 3: Putative substrates of dSan/dNaa50 selected for further analysis.
Column 1 contains the corresponding proteins to the N-termini identified by the
COFRADIC procedure in column 2. In all targets with exception of Cct the initial
methionine was cleaved by aminopeptidases prior to N-acetylation.  Blue residues
highlight amino acids at the initial start position 1 and 2 in the N-termini identified by
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MS in COFRADIC analysis. Column 3 contains the N-termini of the corresponding
homologous proteins in humans.
Substrates of dSan/dNaa50 selected for further analysis were
initially tested in Drosophila cell cultures by RNAi. RpL19-depleted
cells revealed pleiotropic defects. After 72 h RNAi treatment there
were very few cells suggesting a strong cell cycle arrest and further
cell death (data not shown). Depletion of PPP4R2r and CG1785 had
no effect on mitosis and these cells presented a mitotic index
comparable with control cells (fig. 6B) without major defects on
chromosome alignment during metaphase and chromosome
segregation during anaphase (fig. 7A and table 4). 35% of CkIIα-
depleted cells showed chromosome segregation defects during
anaphase A (vs. 13,3% in control cells) and 16,3% during anaphase B
(vs. 6% in control cells) (fig. 7A and table 4). CkII depletion had
however no effect on the mitotic index (fig. 7B).
Cct-depleted cells showed striking chromosome segregation
defects with 36% of cells in anaphase A and 59% in anaphase B
displaying lagging chromosomes and/or chromosome bridges (table 4,
fig. 6A and fig 7B, C and E).  Moreover, Cct-depleted cells showed a
major increase in the mitotic index (fig. 6B). Interestingly, the
chromosome segregation defects observed in Cct and dSan/dNaa50-
depleted cells were very similar (fig. 6 E, F). These data suggest that
Cct is the best candidate as being a mitotic target of dSan/dNaa50,
and therefore being involved in the mitotic phenotypes observed in
dSan/dNaa50-depleted cells.
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Figure 6: Cct is required for chromosome segregation during anaphase and
Cct-depleted cells arrest transiently in mitosis. (A) Percentage of abnormal
anaphases B for mitotic targets of dSan/dNaa50. (B) Percentage of cells positive for
histone 3 phosphorylated on Serine 10 (PH3).
CHAPTER IV
112
RNAi Mildly abnormalMetaphases (%)
Highly abnormal
Metaphases (%)
Abnormal
Anaphases A (%)
Abnormal
Anaphases B (%)
GFP 4,92 ± 5 1,7 ± 2,9 13,3 ± 7,6 6 ± 6,6
dSan 28 ± 7,2 10,9 ± 2,4 67,8 ± 19,7 49,7 ± 9
PPP4R2r 8,3 ± 5,8 0 21,2 ± 9,9 5 ± 0,1
CG1785 0 0 7,7 ± 2,5 8,84 ± 1,6
CKII 15,7 ± 8,1 5,7 ± 6 35 ± 5 16,3 ± 5,5
Cct 11,4 ± 5,6 1,6 ± 2,7 36,7 ± 14,4 59 ± 17,7
Table 4: Percentage of mitotic defects in cells depleted for candidate substrates
of dSan/dNaa50. For each RNAi experiment, between 60-64 cells in metaphase, 60-
63 in anaphase A and 61-65 in anaphase B were counted.
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Figure 7: Cct and dSan/dNaa50 depleted cells show identical chromosome
segregation defects (A-C) Anaphase B. (D-F) Telophase. (A) Anaphase B in control
cells with equal distribution of DNA to both poles of the mitotic spindle. (B, C) Cct-
depleted cells undergoing anaphase B with lagging chromosomes and unequal
distribution of DNA content to mitotic spindle poles. (D) Control late anaphase/
telophase. (E) Cct-depleted cells showed late anaphases/telophases with stretched
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DNA at the spindle equator region, similarly to dSan/dNaa50-depleted cells (F). (PH3)
Histone 3 phosphorylated on Serine 10. (Tubulin) α-tubulin immunostaining. (DNA)
DAPI staining.
3.4. Looking for mitotic substrates of dSan/dNaa50 using a N-
terminal substrate consensus
Recent in vitro studies showed hSan/hNaa50 preferentially
acetylates N-termini with the consensus MLGP- and MLDP- (Evjenth
et al., 2009). Similar to Drosophila San/Naa50p, hSan/hNaa50
associated with hNaa10 (hARD1) and hNaa15 (hNATH).
hSan/hNaa50-depleted HeLa cells showed loss of the cohesin SMC1
at the centromere (Hou et al., 2007), similar to what was previously
observed in Drosophila neuroblasts (Williams et al., 2003). We
expected the mitotic substrates of San/Naa50p in Drosophila and
humans to be conserved, which implied a conserved N-terminus.
Taking this into account, hSan/hNaa50 N-terminus substrate
consensus was used to search in Drosophila for candidate substrates
of San/Naa50p. Such analysis was performed using the 4 amino acids
of the consensus MLGP- and MLDP-. Analysis of proteins with such
consensus was done using the available database from ExPasy:
ScanProsite (http://expasy.org/tools/ scanprosite/). This analysis failed
to retrieve any potentially interesting candidate mitotic proteins.
3.5. Cohesin Drad1/Scc1 shares a well conserved N-terminus
within higher eukaryotes
Drosophila cultured cells depleted for the cohesin Drad21/Scc1
showed loss of sister chromatid cohesion (Vass et al., 2003). Inhibition
of Drad21/Scc1 in Drosophila embryos caused chromosome
segregation defects, which included chromosome bridges similar to
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san mutant embryos (Oliveira et al.; Pimenta-Marques et al., 2008;
Vass et al., 2003). Drosophila mutants for subunits of the condensing
complex such as barren and gluon showed defects in chromosome
segregation, which also included extensive chromosome bridges (Bhat
et al., 1996; Steffensen et al., 2001). Moreover, inhibition of TopoII, an
interactor of the condensing complex, also lead to chromosome
bridges during Drosophila syncytial blastoderm (Buchenau et al.,
1993).
Both Drosophila san mutants and hSan/hNaa50-depleted cells
showed chromosome segregation defects and mislocalization of
cohesin subunits at the centromeric region (Hou et al., 2007; Pimenta-
Marques et al., 2008; Williams et al., 2003).
Since mutants or inhibition of the cohesin and condensing
complexes shared phenotypic similarities with san mutants, the N-
termini of these proteins were analyzed from yeast to humans and
compared to the in vitro substrate consensus of hSan/hNaa50 (fig. 8).
Drad21/Scc1 displayed conservation in the first 3 amino acids off all
organisms analyzed and the N-terminus shared hydrophobic
properties compatible with the in vitro substrate consensus reported for
hSan/hNaa50 (Evjenth et al., 2009). Nevertheless we failed to detect
any change in total protein levels of Drad21/Scc1 in san mutant
embryos by western blot analysis (fig. 9).
Cohesin
Complex SMC1 SMC3 Rad21/Scc1 Scc3/SA1 SA2
D.mel
H.sap
M.mus
D.rer
S.p
S.c
MTEEMGFLMGFLMGYLMGRLMGRL
MATAMHIKMYIKMYIKMYIKMYITMYIK
MFYEMFYAMFYAMFYAMFYSMVTE
MMARMITSMITSMITSMTAVMSES
MSDIMIAAMIAAMIAAMTAVMSES
* * *. * *
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Condensin
Complex I SMC2 SMC4 CAP-H CAP-G CAP-D2
D.mel
H.sap
M.mus
D.rer
S.p
S.c
MYVKMHIKMYVKMYIKMKIEMKVE
MQKAMPRKMRRKMPVKMSDKMSDS
MTLPMGPPMNSSMSAFMKRAMKRA
MAKPMGAEMAAQMPGDMSCIMQDP
MEESMAPQMSPHMSWDMSLDMSGF
* :: * * * *
Condensin
Complex II CAP-D3 CAP-H2
Candidate
proteins Topo II
D.mel
H.sap
M.mus
D.rer
S.p
S.c
MSDFMRQTMVALMALQ-
--
MSDDMERIMEDVMEDVMWRCMDSV--
D.mel
H.sap
M.mus
D.rer
S.p
S.c
MENGMAKSMAKSMSNGMSIDMSTE*
Figure 8: N-terminus alignments of subunits of the cohesin and condensing
complexes. Both condensin complex I and II were analyzed. Topoisomerase II is
known to interact with the condensin complex and promote chromosome condensation
(Bhat et al., 1996; Uemura et al., 1987). (*) residues or nucleotides in that column are
identical in all sequences in the alignment. (:) Conserved substitutions have been
observed, according to the color table above. (.) Semi-conserved substitutions were
observed. Red corresponds to small aa (small+ hydrophobic (incl.aromatic -Y)). Blue
correspond to acidic aa. Magenta corresponds to basic residues. Green corresponds
to   Hydroxyl + Amine + Basic – Q residues. Gray shaded N-termini correspond to
additional isoforms which contain different N-terminus.
Figure 9: Drad21/Scc1 protein levels were not affected in san mutant embryos.
Actin was used as loading control. Protein extracts from wild-type (wt) and (san) san4
mutant GLC embryos.
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4. Discussion
4.1. Is Cct a mitotic substrate of dSan/dNaa50?
dSan/dNaa50 N-terminal acetyltransferase is required for
chromosome segregation during anaphase (Hou et al., 2007; Pimenta-
Marques et al., 2008; Williams et al., 2003). In contrast to other NATs
whose mutants showed pleiotropic phenotypes (e.g., mutants of the
gene coding for dNaa10 (dArd1) (Wang et al., 2010) san mutant
phenotypes were comparatively more specific. Given this we
hypothesized that only a small subset of proteins should have their
function impaired in san mutants. In order to define the substrate
consensus of Drosophila San/Naa50p and identify mitotic substrates of
this NAT, we took advantage of COFRADIC and liquid
chromatography-tandem mass spectrometry LC-MS/MS for in vivo
identification of proteins whose N-acetylation was reduced in san
mutant embryos.
From the 399 unique Drosophila proteins identified in our
analysis, 292 were present in both control and san mutant embryo
samples. The annotated Drosophila proteome is over 13000 proteins
(Adams et al., 2000) and recently nearly 2000 new transcribed regions
were identified in the Drosophila transcriptome (Graveley et al., 2010).
The fact that more than 70% of the identified proteins were present in
both samples suggested a strong experimental bias, possibly to highly
abundant and soluble proteins. Although this bias was potentially
problematic, as highly abundant proteins were likely to be involved in
housekeeping functions, we rationalized our dataset would
nevertheless be useful to identify proteins whose N-acetylation was
impaired in san mutant embryos and define an in vivo N-terminal
substrate consensus for dSan/dNaa50.
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From this work we identified 18 proteins (table 2) whose N-
acetylation was significantly reduced in san mutant embryos.
Interestingly we failed to identify any protein that had completely lost
acetylation in san mutant embryos, which suggested dSan/dNaa50
was likely to be partially redundant with one or more NATs in vivo. The
majority of the identified 18 proteins showed initial methionine (iMet)
cleavage and acetylation of Thr-, Val-, Ser-, or Ala- residues. Since the
NatA complex was already known to acetylate these residues after
iMet cleavage (Arnesen et al., 2005; Arnesen et al., 2009; Mullen et
al., 1989; Polevoda et al., 1999) and Drosophila and human
San/Naa50p was known to be partially associated with this complex
(Hou et al., 2007; Williams et al., 2003), we concluded the NatA activity
was being partially impaired in san mutant embryos. Nevertheless, the
effect on NatA activity had to be only partial as the phenotypes
associated after depletion of NatA subunits were significantly more
pleotropic than the ones observed after dSan/dNaa50-depletion. For
example, Drosophila mutants for the NatA catalytic subunit dNaa10
showed severe oogenesis defects (Wang et al., 2010), whereas loss of
function alleles of san showed no detectable defects during oogenesis
and displayed normal egg-laying (Pimenta-Marques et al., 2008)
(Chapter III). Moreover, cohesion defects were observed in HeLa cells
depleted for hSan/hNaa50, but not in cells depleted for either hNaa10
or hNaa15, suggesting the NatA complex is not involved in sister
chromatid cohesion (Hou et al., 2007). Although it was possible san
mutant mitotic phenotypes were mediated by a partial reduction of
NatA activity, we did not favor this hypothesis, as the observed
phenotypes were significantly distinct.
hNaa10 was proposed to be involved in cell division through
facilitating reformation of the midbody in the late phase of cell mitosis,
and stabilization of MTs. Human cells showed specific localization of
hNaa10 at the midbody region, and hNaa10-depleted cells showed
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reduced levels of acetylated -tubulin at this region (Shen et al., 2009).
One possibility could be san mutants affecting the proposed mitotic
function of dNaa10. However, in contrast to hNaa10-depleted cells, we
were not able to detect any significant difference in acetylated -
tubulin at midbody region between WT and dSan/dNaa10-depleted
cells (data not shown).
hSan/hNaa50 was shown to preferentially acetylate in vitro and
in vivo N-termini without iMet cleavage (Evjenth et al., 2009) (Van
Damme and Kris Gevaert; unpublished data). Of the identified proteins
whose N-acetylation was reduced in san mutant embryos, Cct and
Pabp2 were the only ones to be acetylated at the iMet (table 2).
Analysis of the best candidates by RNAi in Dmel2 cells
revealed that cells depleted for Cct showed chromosome segregation
defects identical to the ones observed in dSan/dNaa50-depleted cells,
including lagging chromosomes and chromosome bridges. This
suggested Cct was a good candidate as a mitotic substrate of
dSan/dNaa50. Interestingly, Cct N-terminus was, among all 18
candidates, the one that fulfilled the requirements of a previously
published in vitro substrate consensus for hSan/hNaa50 (Evjenth et
al., 2009). This work showed that small and hydrophobic N-termini
such as MLGP- or negatively charged MLDP-, are good in vitro
substrates of hSan/hNaa50. Cct N-terminal sequence (MFGG-)
included the highly hydrophobic phenylanine amino acid at position 2
and two small glycin residues.
Cct is a subunit of the conserved CCT complex that acts as a
molecular chaperone within the eukaryotic cytosol (Brackley and
Grantham, 2009). Work done in budding yeast showed that Cct
promotes the activation of the APC/C complex through the generation
of active Cdc20 and Cdh1 (Camasses et al., 2003). Activation of the
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APC/C by Ccd20 at the metaphase to anaphase transition is essential
for sister chromatid separation and to initiate inactivation of cyclin-
dependent kinases (Cdks), namely cyclin-dependent kinase 1 (Cdk1)
(Sullivan and Morgan, 2007). During late anaphase, Cdc20 is replaced
by Cdh1, which sustains APC/C activity during mitotic exit (Fang et al.,
1998; Jaspersen et al., 1999; Kramer et al., 2000; Visintin et al., 1998;
Zachariae et al., 1998). We expected reduced levels of Cct activity
would be associated with a reduced activation of the APC/C complex.
As a result, Cdk1 would not be properly inhibited for effective mitotic
exit.
Recent data has associated high levels of Cdk1 in Drosophila
embryos with abnormal syncytial nuclear divisions (Li et al., 2010;
Oliveira et al., 2010). Xeroderma pigmentosum group D (Xpd) is
known to negatively regulate the cell cycle function of Cyclin-
dependent kinase 7 (Cdk7). Cdk7 regulates cell cycle progression as
the major Cdk-activating kinase (CAK) activity. Drosophila xpd mutant
embryos showed an abnormal anaphase inactivation of Cdk1 (Li et al.,
2010). Interestingly, xpd and san mutant embryos showed similar
chromosome segregation defects (Li et al.; Pimenta-Marques et al.,
2008). Furthermore, recent data showed that the correct segregation
of chromosomes required not only degradation of cohesin, but also
effective degradation of Cdk1 (Oliveira et al., 2010). If we further
observe Cct activity is dSan/dNaa50-acetylation dependent, we
hypothesize that cells depleted for dSan/dNaa50 function did not have
the required amount of functional Cct to correctly induce the APC/C
activation through Cdc20 and Cdh1. Since san mutant neuroblasts
showed mislocalisation of Drad21/Scc1 at the centromeric region
(Williams et al., 2003), we speculated there was sufficient activation of
the APC/C to induce cohesin degradation, but not enough to induce
complete degradation of Cdk1.
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To test if Cct dSan/dNaa50-dependent acetylation is required
for proper metaphase to anaphase transition, future work will focus on
addressing the following questions:
1) Can high levels of Cct suppress dSan/dNaa50-depleted cells?
N-acetylation has been associated to protein stability (Jornvall,
1975; Rubenstein and Deuchler, 1979). One possibility is the mitotic
phenotypes observed in dSan/dNaa50-depleted cells being mediated
by destabilization of total levels of Cct due to reduced levels of N-
acetylation. If that is the case, we would expect to suppress the mitotic
defects observed in dSan/dNaa50-depleted cells by expressing high
levels of Cct. If indeed we observe a suppression of the phenotype we
will proceed with the following set of experiments described below.
2) Is Cct function dependent on N-terminus acetylation?
We will first investigate if indeed Cct N-acetylation is required
for its role in mitosis. To do that we will take advantage of the (X)PX
role which states that a protein with the sequence X1-Pro-X3 or Pro-X2
at its very amino-terminus remains unacetylated under all
circumstances (X being Met or any small amino acid that allows iMet
removal by aminopeptidases) (Goetze et al., 2009). Previous studies in
Drosophila indeed demonstrated that proteins with a proline residue at
the N-terminus position 1 or 2 had an in vitro and in vivo acetylation
inhibitory effect (Goetze et al., 2009). We will therefore modify the
MFGG- wild-type Cct N-terminus to a mutated MPGG- form and test
its relevance for the proteins function. If our hypothesis is correct we
expect to rescue Cct-depleted cells and homozygous mutants with a
wild-type N-terminus Cct form, but not with a MPGG- mutated form.
These experiments will be performed in vitro and in vivo as described
in the study mentioned above.
3) Is Cct N-acetylation dependant on dSan/dNaa50?
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If N-acetylation of Cct turns out to be required for its mitotic
function, we will further investigate if this acetylation event is
dSan/dNaa50-dependent. If that is the case we expect to rescue
dSan/dNaa50-depleted cells and homozygous san mutants with a
MAGG-, MEGG- or MIGG- N-terminus Cct form amenable of being
acetylated by the Drosophila NatA, NatB and NatC complexes,
respectively.
If our hypothesis is correct, we expect Cdk1 to not be
effectively inhibited in dSan/dNaa50-depleted cells during the
metaphase to anaphase transition. Cdk1 is inhibited through
degredation of cyclin B by the APC/C. We will therefore perform
immunostainings for these mitotic players to further check if they are
still active during anaphase.
4) Live imaging analysis of dSan/dNaa50-depleted cells
Additional studies will involve a detailed live-cell imaging
analysis of the mitotic phenotypes observed after dSan/dNaa50
depletion. These experiments will allow us to have better insights into
the mitotic phenotypes of dSan/dNaa50 and narrow the molecular
pathways in which dSan/dNaa50 might be involved.
4.2. Is Drad21/Scc1 a mitotic substrate of dSan/dNaa50?
In vitro human San/Naa50p preferentially acetylated the Met
residue from N-terminus that contained hydrophobic amino acids
(Evjenth et al., 2009). Drosophila mutants or embryos inhibited for
cohesin and condensing subunits showed chromosome segregation
defects similar to san mutant embryos (Bhat et al., 1996; Dej et al.,
2004; Oliveira et al., 2010; Vass et al., 2003). Therefore, these
proteins were good candidates to be acetylated by dSan/dNaa50.
Since the mitotic function of San/Naa50p was apparently conserved
from Drosophila to humans, we expected the mitotic targets of
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dSan/dNaa50 to show some degree of conservation within their N-
terminal sequence. Consistent with this possibility, Drad21/dScc1
presented a high degree of conservation and the N-terminus shared
hydrophobic properties compatible with the in vitro consensus of
hSan/hNaa50. Nevertheless, since we failed to detect any change of
total Drad21/Scc1 levels in san mutant embryos, it is possible
dSan/dNaa50-dependent acetylation of the cohesin subunit is
important for its correct localization at the centromeric region.
Most of metazoan cells oscillate their chromosomes at the
metaphase plate for many minutes until anaphase initiates. As a result
of bipolar spindle-pulling forces, these movements are accompanied
by changes in the distance between sister kinetochores (Mellone and
Allshire, 2003), commonly referred to as “centromere breathing”.
Studies done in yeast suggested there are two pools of cohesin,
cohesin loaded before DNA replication and cohesin loaded after DNA
replication (Lengronne et al., 2006). The first pool which establishes
sister chromatid cohesion disappears during “breathing”, while the
second pool is partially retained (Ocampo-Hafalla et al., 2007).
Interestingly as sisters re-associate after transient separation, cohesin
is reloaded at the centromere in a manner independent of the
canonical cohesin loader Scc2/Scc4. Additionally, this work suggested
sister chromatid cohesion is likely to be re-established in a manner
dependent, to some extent, on Eco1 (Ocampo-Hafalla et al., 2007).
Interestingly, Deco acetyltransferase, the Drosophila homologue of
yeast Eco1, was identified in the same genetic screen as
dSan/dNaa50. Both san and deco mutant neuroblasts exhibited
mislocalization of the cohesin subunit Drad21/Scc1 at the centromeric
region (Williams et al., 2003). We hypothesize N-terminal acetylation
dRad21/Scc1 by dSan/dNaa50 is potentially required for either
reloading of cohesin or reestablishment of cohesion at the centromere
after breathing movements.
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To test this hypothesis, we will create a stable cell line
expressing Drad21/Scc1 C-terminal hemagglutinin (HA) tagged. In
order to only deplete the endogenous Drad21/Scc1, these cells will be
subjected to RNAi by targeting the 5’UTR region of the drad21/scc1
mRNA. We will further purify and analyze Drad21/Scc1-HA by using
LC-MS/MS. Since these cells will be simultaneously induced to
transiently arrest in mitosis we expect to have an enrichment of
centromeric Drad21/Scc1-HA. If our hypothesis is correct we expect a
substantial pool of the centromeric cohesin subunit Drad21/Scc1-HA to
be N-acetylated. If we observe Drad21/Scc1 is indeed N-acetylated
we will further address if the acetylation is relevant for its function and
if it is dSan/dNaa50-dependent. These experiments will be performed
as described above for Cct.
4.3. Are dSan/dNaa50 knockout phenotypes mediated by internal
acetylation of -tubulin?
Recently, hSan/Naa50 was proposed to negatively regulate MT
polymerization by acetylation of -tubulin at K252 (Chu et al., 2010).
hSan/hNaa50-depleted showed a normal MT cytoskeleton in
interphase cells. However, cold-induced MT depolymerization and
regrowth assays showed that MT regrowth from the centrosome was
much faster in hSan/hNaa50-depleted cells. Interestingly,
hSan/hNaa50 acetylated Lys252 of -tubulin in vitro, which was shown
to be acetylated in vivo at the same residue. To establish a relationship
between MT polymerization and acetylation of -tubulin at K252, the
authors investigated tubulin polymerization rates of K252A/Q and
K252R mutants, which they considered to mimic acetylated and
unacetylated forms of -tubulin, respectively. Although the K252
mutants formed less stable heterodymers in vitro, they were
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incorporated into MTs in vivo. Yet, Cold-induced MT depolymerization
and regrowth assays showed that the acetylation-mimicking forms of
-tubulin (K252A/Q) were incorporated into MTs at much slower rates
than the wild-type protein. Based on this work it was proposed that
hSan/hNaa50 catalyzes -tubulin K252 internal acetylation, which
inhibits tubulin incorporation into MTs (Chu et al., 2010).
In our opinion there are significant problems with the above
results and conclusions:
1) The authors did not show that hSan/hNaa50-depleted cells
displayed reduced levels of acetylation of -tubulin at Lys252.
Therefore it is still unclear if hSan/hNaa50 acetylates K252 in vivo.
2) The authors considered that K252A and K252Q are acetylation
mimicking forms of -tubulin at Lys252. This assumption came from
previous functional studies performed with acetylation mimicking
forms of Hsp90 at K294 (K194A/Q) (Scroggins et al., 2007).
Nevertheless, we cannot exclude the possibility that in the case of
-tubulin these two point mutations are simply inducing
conformational changes that affect the function of -tubulin
independently of its “acetylation mimicking properties”. Consistent
with this possibility, both acetylation (K252A and K252Q) and
unacetylation (K252R) mimicking mutations affected protein
stability.
3) The authors observed that the acetylation mimicking mutant forms
(K252A/Q) were incorporated at slower rates than the wild-type
protein, which is consistent with the faster MT regrowth observed in
hSan/hNaa50-depleted cells. However, the authors also observe a
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decrease in MT incorporation in the unacetylated mimicking
mutation (K252R), which is consistent with the hypothesis that
these mutations are behaving as simple point mutations,
independently of any “acetylation mimicking effect”. Furthermore,
the mutant forms are also expressed at lower levels, which is likely
to introduce a bias in the MT incorporation assays.
If indeed hSan/hNaa50 regulates MT polymerization by -
tubulin acetylation, one obvious question to this project, is if the mitotic
chromosome segregation defects observed in San/Naa50p-depleted
cells and loss of function mutants are mediated by -tubulin
acetylation? If that was the case, we would expect that expression of
an unacetylated form of -tubulin at K252 in -tubulin-depleted cells,
would lead to mitotic phenotypes similar to the ones observed in
San/Naa50p depleted cells. Expression of a supposedly unacetylated
mimicking form (K252R) of -tubulin lead to a disorganized and/or
disintegrated MT cytoskeleton in both interphase and mitotic cells,
which is a phenotype dramatically different from the one observed in
San/Naa50p depleted-cells. This is consistent with the hypothesis that
these -tubulin mutations are simply affecting the normal folding and
stability of this protein.
Furthermore, if the mitotic defects observed in San/Naa50p-
depleted cells were mediated by lack of acetylation of -tubulin K252,
we predict that expression of the acetylation-mimicking forms of -
tubulin (K252A/Q) in San/Naa50p-depleted cells, would lead to a
suppression of the chromosome segregation defects. The authors did
not address these questions, failing to integrate the suggested function
of San/Naa50p in modulating MT polymerization with the mitotic
phenotypes observed in San/Naa50p-depleted cells.
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1. Introduction
N-terminal acetyltransferases (NATs) are conserved from
yeast to humans both in subunit composition and substrate specificity
(Starheim et al., 2009b). There is a higher number of NAT paralogues
in higher eukaryotes (Arnesen et al., 2006; Arnesen et al., 2009a),
which suggests these new paralogues have evolved to accommodate
new tissue-specific functions. Consistent with this hypothesis, our
previous data suggests there are tissue-specific requirements for N-
acetylation. dSan/dNaa50 NAT, is required for chromosome
segregation in somatic tissues but not in the female germ-line
(Pimenta-Marques et al., 2008). Understanding why dSan/dNaa50 is
not rate-limiting in the female germ-line might shed light on how N-
acetylation is possibly regulating tissue-specific functions during the
development of a multicellular organism.
Each NAT complex preferentially acetylates distinct N-termini
(Arnesen et al., 2009b; Evjenth et al., 2009; Kimura et al., 2000;
Polevoda et al., 1999; Polevoda and Sherman, 2003; Tercero et al.,
1993). However, recent data suggests that NATs are partially
redundant (Arnesen et al., 2009b; Van Damme et al., 2011). We
therefore hypothesized that dSan/dNaa50 is not required within the
female germ-line due to another redundant NAT specifically in this
tissue.
In this chapter, we describe the identification of the putative
Drosophila paralogues of dSan/Naa50. Phylogenetic analysis revealed
dNaa60 is the closest paralogue to dSan/dNaa50. Interestingly,
dNaa60-depleted cultured cells showed chromosome segregation
defects remarkably similar to dSan/dNaa50, suggesting this NAT is
also required for chromosome segregation in mitosis. Our data
suggests that dNaa60 is likely to be redundant to dSan/dNaa50
specifically in the female germ-line.
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2. Materials and methods
2.1. Bioinformatic analysis of Drosophila paralogues of
dSan/dNaa50
In order to identify the closest NATs related to dSan/dNaa50
within the Drosophila proteome, we performed a BLAST (Basic Local
Alignment Search Tool) followed by a PSI-BLAST
(http://blast.ncbi.nlm. nih.gov/Blast.cgi) analysis with a cut-off E-value
of 1.0e-10. PSI-BLAST allowed us to build a PSSM (position-specific
scoring matrix) using the results of the first BlastP run and search new
sequences (Altschul et al., 1997). This analysis retrieved eight
dSan/dNaa50-related NATs (table 2). Homologues of the
dSan/dNaa50-related NATs from Homo sapiens, Mus musculus, Danio
rerio, Saccharomyces cerevisiae and Schizosaccharomyces pombe
were obtained by BlastP analysis of species-specific protein
databases. All NATs were confirmed to contain a GNAT5 domain by a
PROSITE database search (Sigrist et al., 2009).
All sequences were aligned using CLUSTALW. A phylogenetic
tree was constructed using distance neighbor-joining (NJ). The tree
was based on pair-wise distances between amino acids using MEGA4
program (Tamura et al., 2007).
2.2. RNA interference on cultured Drosophila Dmel2 cells
Cells were cultured at 25ºC. RNAi was performed according to
Clemens and colleagues (Clemens et al., 2000) in Drosophila Dmel2
cells. Table 1 contains the primers used for the construction of the
different amplicons, and the corresponding size of each amplicon used
for RNAi. GFP RNAi was used as a control. Each primer incorporated
a T7 RNA polymerase binding site. All PCR products were used as
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templates to synthesize dsRNA by utilizing the T7 RiboMAX™ Express
kit (Promega). Drosophila Dmel2 cells were grown in SFM Medium
(GIBCO) supplemented with 1x glutamine and 1x PenStrep. Cells were
counted, diluted to 2x106 cells/mL, and incubated for 1h with 40µg of
each dsRNA at a concentration of 1µg/µL. After 1h incubation with
dsRNA, 3mL of SFM media supplemented with glutamine and
PenStrep was added back. After 93h of dsRNA treatment, cells were
harvested and prepared for immunofluorescence.
Protein to
deplete Amplicon Primers
Amplicon
size (bp)
dSan San Amp1 5’-AGCAGCATCGAACTGGGC-3’5’-CGCTTATAGTATTGCTCCTTGGT-3’ 413
CG18177
CG18177 Amp1 5’-CAACAAACACAGTGCGCC-3’5’-CACATTTCGATAGGGTTTGATTTC-3’ 274
CG18177 Amp2 5’-GACTCGATGGGTCGTTCCGC-3’5’-GTGGATGGCCGCCGTTAAT-3’ 300
CG11412 CG11412 Amp1 5’-GATCGGATTCGAACTCCCTC-3’5’-CATTTGGTGTTCAGCCTCG-3’ 305
Ard1 Ard1 Amp 1 5’-ACACCACCACGGCAGAGC-3’5’-AGGGCGTTGGTGTAGAGGTTC-3’ 447
CG10414 CG10414 Amp1 5’-ACCATGCCGCTACTGTGAATC-3’5’-GTGCGCCAATGGAAGAATC-3’ 321
CG14222 CG14222 Amp1 5’-TCACCTGCGACGACCTCTT-3’5’-GTATGACCGACTTTTTGTTGACG-3’ 465
CG31730 CG31730 Amp1 5’-ATGCGTTTCGATGATTTGTTC-3’5’-TTCTCAATTCGTAGGCACTTTCTG-3’ 439
CG32319 CG32319 Amp1 5’-GCCGTTCTTATTCAAAAGGAAC-3’5’-GTAGAGCGCCAATGCAGGT-3’ 495
CG31851 CG31851 Amp1 5’-GTGATGGATCCCTTGGCG-3’5’-TCGTATCCATGGTCGTCGG-3’ 404
GFP GFP Amp 5’-ACCATGCCGCTACTGTGAATC-3’5’-GTGCGCCAATGGAAGAATC-3’ 420
Table 1: Primers used to produce different dsRNA’s for RNAi experiments
2.3. Transfection of constructs with tagged proteins
cDNA clones of CG18177 isoform A and B (LD46538 and
LD27619, DGRC) were cloned into a plasmid with a C-terminal Myc
tag, using the Gateway system (Invitrogen).
Drosophila Dmel2 cells were maintained in SFM Medium
(GIBCO) supplemented with 1x glutamine and 1x PenStrep, according
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to standard tissue culture techniques. To transiently transfect cells, we
used the following protocol: 4x106 cells were plated per well (6-well
plate); the following day, 3 µg of the plasmid construct were mixed in
ddH20 (sterile and free of nucleases) to a final volume of 100 µL. To
this mixture, 15 µL of FuGENE transfection agent (Roche) were added.
This solution was incubated at room temperature (RT) for 30 min and
added to the cells. Cells were left to express the tagged proteins for 48
hours. Both proteins were tagged with a Myc protein. Control cells
were transfected with a construct expressing Myc tag alone.
2.4. Immunofluorescence of Dmel2 Cells
After 93 hours of dsRNA treatment or transient transfection
experiments, 2x106 cells were added to coverslips by 1h incubation at
25ºC. Cells were fixed with 4% formaldehyde, 0.03M PIPES, 0.11M
HEPES, 0.01M EGTA and 4mM MgSO4 for 10 min, followed by two
washes in 1x PBS. Permeabilization and blocking was performed for
1h with PBSTB (PBS, 0.1% Triton X-100, 1% fetal bovine serum).
Primary antibody incubations were done in blocking solution for 2h at
room temperature or overnight at 4°C, followed by three 5 min washes
in PBSTB. Secondary antibody incubations were performed as
described for the primary antibodies, including the three 5 min washes.
Primary antibodies included mouse anti--tubulin DM1A (1:500;
Sigma), rabbit anti-pSer10-Histone H3 (1:500; Upstate Biotechnology),
chicken anti-Cid (1:500; kindly provided by David Glover), rat anti-Cnn
(1:500; kindly provided by Jordan Raff), rabbit cis-Golgi marker anti-
Gm130 (1:500; Abcam, ab30637) and mouse anti-Myc (1:250;
Hybridoma bank, clone 9E 10). F-actin was stained with rhodamine-
conjugated phalloidin (Sigma) and DNA was stained with DAPI at
1:1000 (stock concentration 1 mg/ml).
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2.5. Microscopy
Visualization of fixed cells was performed using a Delta Vision
Core System (Applied Precision) using a 100× UplanSApo objective
and a cascade2 EMCCD camera (Photometrics). Images were
acquired as a series of z-sections separated by 0.2-µm intervals.
Deconvolution was performed using the conservative ratio method in
softWoRx software. Phenotypic quantification was performed using a
regular Epifluorescent microscope Leica DMRA2.
2.6. Creation of CG18177/dnaa60 mutants
The fly stock, w;;PCG18177EP3301/TM3,Sb, with a P-element
insertion (EP3301) near the beginning of the 5’UTR of the CG18177
gene, was obtained from the Bloomington Drosophila Stock Center.
Excision of PCG18177EP3301 was generated by crossing the P-element
line to a transposase-expressing line (w;;(2:3)99B,Sb/TM6B). Male
progeny with the genotype w;; PCG18177EP3301/ (2:3)99B,Sb and
patchy colored eyes, were then crossed with virgin females of
w;;MKRS/TM6B. From each cross, potential excision events were
identified by the loss of the w+ marker, and white-eyed males with the
genotype w; CG18177*/TM6B were collected to establish a balanced
P-element stock. Twenty excision lines were crossed with the
deficiency Df(3L)AC1 which deletes the CG18177 gene. The progeny
obtained from each different cross with the genotype
CG18177*/Df(3L)AC1, was tested by genomic PCR reaction with
primers that covered the CG18177 gene locus. We identified a line
where approximately 1305bp were deleted. This deletion mutant line
was called dNaa6020. This deletion abrogates the 5’UTR and first and
second exons of the predicted isoforms, B and C. For predicted
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isoform A, the deletion abrogates the 5’UTR as well as the first exon
and half of the second exon (fig. 1).
Figure 1: Deletion mutant line of CG18177 abrogates the first 3 exons of this
gene. Gray boxes represent the 5’ and 3’ UTR of the genes represented in the figure.
Pink boxes represent the exons of the represented genes. Blue triangle represents the
P-element used to create the mutant deletion lines. The blue shaded box represents
the genome region deleted in the dNaa6020 line. The created deletion line does not
affect any of the neighboring genes of CG18177, deflated (def1) and ATP synthase,
subunit b (ATPsun-b).
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3. Results
3.1. Identification of Drosophila paralogues of dSan/dNaa50
dSan/dNaa50 was shown to be essential for chromosome
congression and segregation during mitosis in different somatic
tissues, but was dispensable within germ-line stem cells (Pimenta-
Marques et al., 2008). COFRADIC analysis on san mutant embryonic
protein extracts suggested a partial redundancy between
dSan/dNaa50 and other NATs (Chapter IV). We hypothesized there
was another NAT redundant with dSan/dNaa50 within the germ-line. If
that was to be the case we expected the NATs most closely related to
dSan/dNaa50 to be the best candidates for this redundancy.
BLAST analysis retrieved eight dSan/dNaa50-related NATs
(table 2). Phylogenetic analysis of the NATs most similar to
dSan/dNaa50 allowed the identification of the putative homologues of
the NatA, NatB and NatC complexes (fig. 2). The gene coding for the
NatA catalytic subunit, Naa10p, suffered a duplication event giving rise
to a new NAT, Naa11p, which is present in both humans and mouse
(Arnesen et al., 2006). We did not identify a gene coding for Naa11p
within Drosophila and Zebrafish (fig. 2). The Drosophila CG14222
gene encodes a putative NAT which is likely to be the closest
homologue of hNaa20. Additionally, within the NatB complex group we
identified two putative paralogs of Drosophila Naa20p. These proteins
were not found in the genomes of other analyzed organisms (fig. 2).
Within the NatC complex, Drosophila has two putative paralogues of
hNaa30. Both CG11412 and CG32319 encode proteins which are
closely related to hNaa30 (fig.2). The CG10414 gene encodes a new
putative NAT which is only present in higher eukaryotes (fig. 2).
According to our phylogenetic analysis, the protein encoded by
CG18177 is the closest NAT related to dSan/dNaa50. dSan/dNaa50
CHAPTER V
135
and CG18177 seem to have originated from a common ancestor (fig.
2).
The NAT encoded by CG18177 is the putative homologue of
the human Naa60 protein, which was recently shown to display in vivo
NAT activity (Van Damme et al., 2011).
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Figure 2: Phylogenetic tree of dSan/dNaa50 NAT paralogues. dSan/dNaa50
paralogues include Drosophila homologues of the NatA, NatB and NatC catalytic
subunits. CG18177 is the closest NAT related to dSan/dNaa50. Both dSan/dNaa50
and CG18177 originated from a common ancestor protein. Tree was drawn to scale,
with branch lengths in the same units as those of the evolutionary distances used to
infer the phylogenetic tree. Scale bar corresponds to 0.1 millions of years ago. Hs,
Homo sapiens (Hs Naa10, NP_003482; Hs Naa10, NP_116082; Hs Naa20,
NP_057184; Hs Naa30, NP_001011713; Hs San/Naa50, NP_079422; Hs Naa60,
NP_079121; Hs Csrp2bp, NP_065397; Nat8L, NP_848652); Mm, Mus musculus (Mm
Naa10, NP_001171436; Mm Naa11, NP_001028363; Mm Csrp2bp, NP_852082; Mm
Nat8l, NP_001001985); Dr, Danio rerio; Dm, Drosophila melanogaster (Dm Naa10,
NP_648378; Dm CG31730, NP_723799; CG31851, NP_723798; CG14222,
NP_608331; CG32319, NP_728606; CG11412, NP_569903; Dm San/Naa50,
NP_524779; Dm CG18177, NP_996032; Dm CG10414,  NP_609889); Sc,
Saccharomyces cerevisiae (Sc Naa10/Ard1, NP_011877; Sc Naa20/Nat3,
NP_015456; Sc Naa30/Mak3, NP_015376; Sc Naa50/Nat5, NP_014896); Sp,
Schizosaccharomyces pombe (Sp cwf24, NP_596257).
Gene ontology
number
Gene
Symbol
Closest human
Homologue
NAT
Complex
CG18177 - Naa60 NatF
CG11412 - Naa30 NatC
CG11989 Ard1 Naa10 NatA
CG10414 - Csrp2bp -
CG14222 - Naa20 NatB
CG31730 - Naa20 NatB
CG32319 - Naa30 NatC
CG31851 - Naa20 NatB
Table 2: Drosophila NATs most closely related to dSan/dNaa50.
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3.2. Identification of a new NAT required for chromosome
segregation
Both dSan/dNaa50 and dNaa60 seemed to have originated
from a common ancestor (fig. 2). To test if dNaa60 also had mitotic
functions, we depleted this NAT in Dmel2 cells and analyzed mitotic
cells. Chromosome congression at the metaphase plate was
indistinguishable between control and dNaa60-depleted cells (fig. 3 A
compare with B). dNaa60-depleted cells displayed a mitotic index
comparable to control cells (5,7% in dNaa60-depleted cells and 6,0%
in control cells), suggesting they did not arrest in mitosis. However,
dNaa60-depleted cells displayed a moderate but consistent increase in
the percentage of cells undergoing anaphase with chromosome
segregation defects (22,9% ± 3,9 of dNaa60-depleted cells had
abnormal anaphases versus 7,0% ± 3,1 in control cells). Interestingly
the observed lagging chromosomes and chromosome bridges in
dNaa60-depleted cells were identical to the ones observed in
dSan/dNaa50 depleted cells (fig. 3 D, F and G).
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Figure 3: dNaa60 is required for chromosome segregation during anaphase. (A
and B) dNaa60-depleted Dmel2 cells did not exhibit detectable chromosome
congression defects during metaphase. (C-F) dNaa60-depleted cells displayed lagging
chromosomes and chromosome bridges during anaphase. Histone 3 phosphorylated
at Serine 10 (PH3) (red), α-tubulin (green) and DNA (blue). (A’, B’, C’ D’ E’ and F’)
Black and white images display cells with PH3 staining alone. (G) Quantification of
chromosome segregation defects in dNaa60-depleted cells (n=278) and control cells
(n=179) (***P<0,001 Student’s test).
Chromosome lagging and bridging in dNaa60-depleted cells
may be explained by kinetochore abnormalities, but we failed to detect
any obvious defects in the localization of the Centromere identifier
(Cid) protein during metaphase or anaphase (fig. 4 A-D). We also
failed to detect any obvious cohesion defects since the distance
between kinetochores during metaphase was apparently normal
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according to Cid localization (fig. 4 A, B). Chromosome lagging could
also be explained by centrosome/mitotic spindle defects. Yet, we did
not detect any obvious defects in the localization of Centrosomin
(Cnn), and the mitotic spindle was bipolar and correctly attached to
chromosomes and centrosomes (fig. 8 A-D). dNaa60-depleted cells
showed no obvious defects in the actin and microtubule cytoskeleton
in both mitotic and interphase cells (fig. 8 E-J). Additionally, dNaa60-
depleted cells undergoing chromosome segregation defects also
showed an apparently normal actin cytoskeleton (Figure 8 H).
These data suggested dNaa60 was required for normal
chromosome segregation during mitosis.
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Figure 4: dNaa60-depleted cells show apparently normal mitotic spindles and
normal actin cytoskeleton. Control dsRNA treated cells (A,C,E,G, and I). dNaa60
dsRNA treated cells (B,D,F,H and J). dNaa60-depleted cells showed no significant
defects in the localization of both Cnn and Cid proteins (A-D). Both control and
dNaa60-depleted cells exhibited bypolar spindles with correct alignment of
chromosomes at the metaphase plate (A,B). Anaphase cells with chromosome
segregation defects in dNaa60-depleted cells showed no obvious defects in Cnn and
CID localization (C,D). α-tubulin (red), CID (green) and Cnn (blue). dNaa60-depleted
cells undergoing anaphase with chromosome segregation defects also showed a
normal actin and microtubule cytoskeleton (G,H; detail with Histone 3 phosphorylated
on Serine 10 staining). Control and dNaa60-deplted cells exhibit proper chromosome
alignment during metaphase with no detectable defects in the actin and microtubule
cytoskeleton (E,F). dNaa60-depleted cells in interphase show no detectable defects
regarding the actin and microtuble cytoskeleton (I-J). Actin (red), α-tubulin (green) and
Histone 3 phosphorylated on Serine 10 (blue).
3.3. dnaa60 is not an essential gene
Since dNaa60 is required for mitosis in Drosophila cultured
cells, it is therefore a good candidate for the putative NAT redundant
with dSan/dNaa50 in the germ-line. In order to test this hypothesis we
created a deletion mutant of dNaa60 (see Materials and methods) that
deleted the 5’UTR along with the first and second exons of the
predicted isoforms of this NAT. The generated deletion was likely to be
a loss of function allele of dNaa60 as it generated a severely truncated
protein. The deletion mutant was zygotic lethal with occasional
escaper homozygous adult flies. To investigate if dNaa60 was an
essential gene, the created dNaa60 deletion mutants were crossed
with a deficiency that completely abrogated the CG18177 gene locus.
Virgin females of w;;dNaa6020/TM6B were crossed with males of the
deficiency Df(3L)AC1/TM3,Sb. This cross gave rise to viable dNaa60
mutant progeny with the genotype w;;dNaa60 20/Df(3L)AC1 (table 3),
which suggested dNaa6020 deletion contained a second lethal
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mutation not associated with dNaa60. To test the maternal
requirement of dNaa60, virgin females of the genotype w;;dNaa60
20/Df(3L)AC1 were crossed with males of the same genotype. These
flies laid normal eggs that gave rise to normal progeny. We concluded
that in contrast to dSan/dNaa50, dNaa60 is not an essential gene.
F0 w;; dNaa6020/TM6B x Df(3L)AC1/TM3, SB
F1 TM6B and/or TM3,Sb TM6B+ or TM3,Sb+
Counted flies 63 22
Table 3: dnaa60 is not an essential gene. Crossing dnaa60 deletion mutant with a
deficiency for the CG18177 gene resulted in F1 progeny containing transheterozygous
flies for the dnaa60 deletion at the expected Mendelian proportion.
3.4. dNaa60 is not required for female oogenesis
Oogenesis in maternal mutant dnaa60 flies was
indistinguishable from control flies. According to DNA staining, nuclei
within the germarium had a normal morphology comparable to control
germariums (fig. 5 A, B compared with E, F). dnaa60 mutant egg
chambers contained 15 nurse cells and a posteriorly-localized oocyte,
and they were surrounded by a layer of somatically derived follicular
cells (fig.5 D, H). This suggested the germ-line stem cells were dividing
normally, giving rise to cytoblasts that would undergo 4 rounds of
mitosis resulting in a normal egg chamber. The germ-line-specific
Vasa protein immunostaining confirmed that the female germ-line was
correctly determined in dnaa60 mutants.
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Figure 5: dNaa60 is not required for female oogenesis. Control (A-C) and mutant
(E-G) dnaa60 ovariole showing a germarium and a stage 1 egg chamber. (D) Control
stage 10 egg chamber. (H) dnaa60 mutant stage 10 egg chamber. Ovaries were
stained for the germ-line specific RNA binding protein Vasa, actin and DNA.
3.5. dNaa60 localizes to cellular membranous compartments
Expression of a tagged version of hNaa60, showed
colocalization between this NAT and membranous compartments,
such as Golgi, lysosomes and late endosomes (Arnesen T.,
unpublished data). This data suggested hNaa60 was potentially the
first identified NAT that could be involved in post-translational N-
acetylation (Arnesen T., unpublished data). To have better insights into
a possible functional conservation between human and Drosophila
Naa60p, both isoforms A and B of dNaa60 were expressed in
Drosophila cultured cells. Both isoforms displayed localization patterns
suggestive of the membranous compartments (fig 6). Myc–tagged
dNaa60 isoforms showed a strong localization around the nucleus and
partial colocalization with a cis-Golgi marker (Gm130). This suggests
that hNaa60 and dNaa60 are likely to be functionally conserved from
Drosophila to humans.
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Figure 6: dNaa60 potentially localized to the membranous compartments of
Dmel2 cells. dNaa60 expression partially colocalized with a cis-Golgi marker. These
results were confirmed using a GFP tagged version of dNaa60 Isoform A and B (data
not shown). (Green) dNaa60-Myc, (red) Cis-Golgi marker - Gm130, (blue) DNA.
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4. Discussion
4.1. Higher complexity in the regulation of protein N-terminal
acetylation in Drosophila melanogaster
N-terminal acetylation is a highly conserved and widespread
protein modification. This modification is performed by NATs, which
are highly conserved from yeast to humans. Higher eukaryotes seem
not only to have a higher number of NATs, but alternative splicing of
some of the coding genes is associated to the expression of additional
NAT isoforms. We performed a phylogenetic analysis of most
Drosophila NATs and consistent with other higher eukaryotes,
Drosophila has a higher number of NATs when compared to yeast.
Yet, surprisingly, Drosophila contained additional paralogues not found
in humans. Drosophila-putative homologues of the genes coding
Naa20p and Naa30p suffered duplication events. dNaa20 (encoded by
CG14222) suffered two rounds of gene duplication into two new
putative NATs encoded by the genes CG31730 and CG31851. These
new paralogues are adjacent to each other within the 2L chromosome.
We also detected two Drosophila paralogues within the Naa30p NAT
group.
These duplication events seem to correlate with the localization
of one of the paralogues on the X chromosome. Drosophila-putative
Naa20p (encoded by CG14222) is located on the X chromosome and
its putative paralogues encoded by the genes CG31730 and CG31851
are located on the 2L chromosome. Among the two Drosophila
paralogues of Naa30p, CG11412 is located on the X chromosome,
while CG32319 is located on the 3L chromosome. In mouse and
humans the genes encoding Naa20p and Naa30p are located on
autosomal chromosomes and they are not associated with gene
duplication events. In contrast, both human and mouse Naa10p are
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located on the X chromosome and both contain paralogues (Naa11p)
on autosomal chromosomes. Both Drosophila and Zebrafish Naa10p
are located on autosomal chromosomes and we failed to detect any
gene duplication event of Naa10p in these two organisms.
Since mouse Naa11p was shown to be highly expressed in
testis during male meiosis (Pang et al., 2009), it was proposed Naa11p
expression would compensate for the loss of the X-chromosome linked
gene mNAA10 during male meiosis (Pang et al., 2009). Likewise, a
requirement for dNaa20p and dNaa30p in male meiosis would explain
why these NATs are duplicated in Drosophila but not in other
organisms. Indeed, according to Affymetrix data available at FlyAtlas,
both CG31730 and CG31851 mRNAs were only detected in male
testis. Affymetrix data also detected an upregulation of CG32319
mRNA in testis and none or low levels of transcript in other tissues. As
for the other eukaryotic organisms, dSan/dNaa50, dNaa60 and the
putative NAT encoded by CG10414, which are located on autosomal
chromosomes, did not duplicate into new genes.
4.2. Potential redundancy between dSan/dNaa50 and dNaa60
within the female germ-line
dSan/dNaa50 is required for normal mitosis in the soma but not
in the germ-line. We hypothesize that this is likely due to a redundancy
of another mitotic NAT within the female germ-line. According to
phylogenetic analysis, dNaa60 and dSan/dNaa50 originated from a
common ancestral gene, making dNaa60 the closest dSan/dNaa50
paralogue. Consistent with the phylogenetic proximity between both
these NATs, we found that dNaa60-depleted Dmel2 cells show
chromosome segregation defects identical to dSan/dNaa50-depleted
cells. These defects included lagging chromatids and chromosome
bridges during anaphase. COFRADIC analysis of yeast cells
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expressing human San/Naa50p and human Naa60p suggested these
NATs have similar substrate specificity in vivo (Van Damme et al.,
2011; Van Damme and Kris Gevaert; unpublished data). Moreover, in
vitro peptide library screening assays confirmed these NATs share an
identical substrate-repertoire with rather subtle differences (Van
Damme et al., 2011; Van Damme and Kris Gevaert; unpublished data).
We hypothesize that dNaa60 is a good candidate NAT to be redundant
with dSan/dNaa50 within the female germ-line. However, in contrast to
dSan/dNaa50, dnaa60 deletion mutants are viable, showing dnaa60 is
not an essential gene. Embryos mutant for dnaa60 show normal
syncytial nuclei divisions (data not shown) and we failed to detect any
defects within female oogenesis. If our hypothesis is correct this
suggests that although these two NATs are partially redundancy,
dSan/dNaa50 is most likely the main mitotic NAT. Since dnaa60 is
highly expressed in the ovaries (Chintapalli et al., 2007), this raises the
hypothesis that dSan/dNaa50 activity is not rate-limiting in the female
germ-line due to high levels of dNaa60 activity. To test this hypothesis
we will generate a san/dnaa60 double mutant and check if we can
detect mitotic defects in the female germ-line.
If complementation of dSan/dNaa50 mitotic functions in the
female germ-line was due to high levels of dNaa60 this would imply
that zygotic mutants of san would only show mitotic phenotypes on
somatic tissues with low levels of dnaa60 expression. However, we
detected chromosome segregation defects in san mutant larvae
neuroblasts (zygotic mutants) where dNaa60 mRNA was apparently
detected at high levels (Chintapalli et al., 2007).  This suggests that if
dSan/dNaa50 and dNaa60 are redundant in the female germ-line, then
dNaa60 activity in the female germ-line must be significantly higher or
distinct (maybe due to different cofactors) from its activity in the soma.
Another issue associated with the dSan/dNaa50 and dNaa60
redundancy hypothesis relates with the fact that most genes highly
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expressed in the female germ-line show a strong maternal contribution
in the embryo. Since dnaa60 is highly expressed in the ovaries, it is
likely to be present at high levels in the syncytial embryo. Yet, maternal
mutant embryos of san show chromosome segregation defects during
syncytial blastoderm (early embryonic development). We hypothesize
dNaa60 complements dSan/dNaa50 function in the female germ-line
but not during early embryogenesis, due to the extremely fast
blastoderm syncytial nuclear divisions. If this hypothesis is correct,
then we would predict that up-regulation of dNaa60 will suppress the
chromosome segregation defects observed in embryos mutant for
dSan/dNaa50.
If we failed to detect any mitotic defect in the san/dnaa60
double mutant female germ-line, it is still possible that another NAT is
partially redundant with dSan/dNaa50 and maybe dNaa60. The NatC
complex N-acetylates Met-Leu- N-termini (Polevoda et al., 1999;
Starheim et al., 2009a), which were also shown to be N-acetylated by
hNaa50 in vitro (Evjenth et al., 2009), hNaa60 in vivo and both human
and Drosophila Naa60p in vitro (Van Damme et al., 2011). Although
unlikely, these three NATs could all together be redundant in N-
acetylating a substrate containing a Met-Leu- N-terminus. An
alternative explanation is that our hypothesis is wrong and these two
NATs are not redundant in the female germ-line. If this is the case, the
absence of mitotic defects in female germ-line mutant for san could be
associated with the fact that the dSan/dNaa50-dependent N-
acetylation and/ or the mitotic substrates of dSan/dNaa50 are not rate-
limiting for female germ-line development. If this is the case, it is
crucial to identify the mitotic substrates of dSan/dNaa50 and test their
functional requirements in the soma and in the germ-line.
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4.3. dNaa60 is possibly involved in posttranslational N-
acetylation
Phylogenetic analysis of dSan/dNaa50, allowed the
identification of a closely related NAT named dNaa60. Naa60p is a
highly conserved NAT within higher eukaryotes. In vitro peptide library
assays revealed hNaa60 and dNaa60 share almost indistinguishable
substrate specificity (Van Damme et al., 2011). Human Naa60p was
recently identified in human cells and was shown to have N-
acetylation activity (Van Damme et al., 2011). hNaa60 was shown to
be enriched at membranous fractions, and expression-tagged studies
found that this NAT colocalized with Golgi, lyzosomes and late
endosomes (Arnesen T., unpublished data). Consistently, we also
observed that myc-tagged dNaa60 was localized to cellular
membranous compartments of Dmel2 cells, which suggested both
NATs were functionally conserved.
Association of NAT complexes with ribosomes suggests a
model where these enzymes perform co-translational acetylation of
nascent polypeptides during protein synthesis (Arnesen et al., 2005).
The localization of hNaa60 to the Golgi, lysosomes and possibly late
endosomes suggests Naa60p might be the first known NAT to be
involved in posttranslational N-acetylation. Interestingly, COFRADIC
analysis on human cells revealed the majority of the identified hNaa60
protein substrates contain membrane-spanning /transmembrane
regions (Van Damme and Kris Gevaert; unpublished data). We
hypothesize Naa60p function is important to the posttranslation N-
acetylation of integral membrane proteins. Future studies will elucidate
the impact of Naa60p-mediated N-acetylation on these proteins.
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1. Tissue specific functions of N-terminal acetylation?
Protein N-terminal acetylation is a highly conserved and
widespread modification that occurs on approximately 80% of all
soluble, cytoplasmic human proteins (Arnesen et al., 2009b). However,
with some few examples, little is known about the biological function of
this modification. N-acetylation acetylation was shown to be important
for the localization and function of specific proteins (Behnia et al.,
2004; Caesar and Blomberg, 2004; Coulton et al., 2009). Some reports
suggested N-acetylation could act as a stabilizer, for instance by
blocking N-terminal ubiquitination mediated degradation (Ciechanover
and Ben-Saadon, 2004), while recent work in yeast suggested it could
act as a general destabilization signal (Hwang et al., 2010). In higher
eukaryotes knockdowns of NatA, NatB and NatC subunits by RNAi
produce pleiotropic phenotypes generally associated with cell cycle
arrest or apoptosis (Ametzazurra et al., 2008; Arnesen et al., 2006b;
Fisher et al., 2005; Lim et al., 2006; Starheim et al., 2008; Starheim et
al., 2009).
Higher eukaryotes contain an increased number of N-terminal
acetyltransferases (NATs) when compared to lower eukaryotes due to
gene duplication events. Maintenance of these duplicated genes
suggest either neo-functionalization, where one gene copy acquired a
new beneficial function while the other retained the original function
(Nowak et al., 1997; Ohta, 1988; Walsh, 1995) or subfunctionalization,
where the two gene copies specialize to perform complementary
functions (Force et al., 1999; Lynch and Force, 2000). For example,
during retinoic acid-induced differentiation in NB4 cells, human NAA10
expression levels show a significant decrease, while the paralog
(hNAA11) expression remained unchanged (Arnesen et al., 2006a).
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We hypothesize that the higher number of NATs observed in
Drosophila and humans increased the complexity of N-acetylation
regulation and allowed a higher prevalence of tissue-specific
regulatory functions. For example, dSan/dNaa50 is required for normal
chromosome segregation during mitosis in somatic but not in the
female germ-line stem cells (Pimenta-Marques et al., 2008).
Furthermore, female oogenesis develops normally in the absence of
dSan/dNaa50. This suggests that dSan/dNaa50 is either redundant
with another NAT specifically in the female germ-line or that
San/dNaa50-dependent N-terminal acetylation is not rate limiting
during Drosophila oogenesis. Since tissue culture cells depleted for
dNaa60 (Chapter V), the closest paralogue of dSan/dNaa50, show
chromosome segregation defects identical to cells depleted for
dSan/dNaa50, and since these two NATs show similar substrate
specificities in vitro and in vivo (Van Damme et al., 2011; Van Damme
and Kris Gevaert; unpublished data), we favor the hypothesis that
dNaa60 complements the mitotic functions of dSan/dNaa50 in the
female germ-line but not in the soma.
The germ line is a highly specialized and differentiated cell-
lineage whose function is to give rise to the male and female gametes.
The ability of giving rise to totipotent cells is associated to unique
regulatory processes that avoid somatic differentiation and maintain
totipotent potential (Gilboa and Lehmann, 2004). To what extend the
redundancy between dSan/dNaa50 and dNaa60 is important for germ
line development is still unclear. We propose that dSan/dNaa50 is not
rate-limiting in the female germ-line due to either a selective pressure
for redundancy with dNaa60 to ensure N-acetylation robustness or
that dSan/dNaa50 function is differentially required in the soma and in
the germ-line. We speculate that similar to dSan/dNaa50, other NATs
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and/ or other NAT isoforms are likely to have such tissue-specific
functions in higher eukaryotes.
2. Regulatory functions of N-terminal acetylation?
If higher eukaryotes show tissue-specific regulation of N-
terminal acetylation (as shown for dSan/dNaa50), and if depletion of
some NATs produces tissue-specific phenotypes, it is unlikely these
enzymes are just performing strictly cellular housekeeping functions
important for cell viability. We hypothesize that a subset of NATs has
regulatory functions important for proliferation and development of
different cell-lineages.
If a subset of NATs has tissue-specific functions, we expect
these NATs to have a small number of substrates and reduced
redundancy with other NATs, as this would facilitate tissue-specific
modulation of N-acetylation. Nevertheless, the available experimental
data suggests otherwise. Recent in vivo and in vitro data showed
NATs can have a high number of substrates and many show
significant substrate redundancy (Arnesen et al., 2009b; Van Damme
et al., 2011). Consistently, although cells deleted for dSan/dNaa50
show tissue-specific mitotic phenotypes, COFRADIC analysis of
protein extracts from Drosophila mutant embryos for san identified at
least two different putative substrates of dSan/dNaa50 out of 292
proteins analyzed (which is less than 2% of the Drosophila proteome;
Chapter IV). Assuming this proportion is representative of the entire
proteome, this suggests dSan/dNaa50 is likely to have at least 100
substrates. Furthermore, since these two substrates of dSan/dNaa50
(Cct and Pabp2) are not completely unacetylated in loss of function
alleles of san (Chapter IV), this suggests that another partially
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redundant NAT (most likely dNaa60) is capable of acetylating these
two proteins in vivo.
In order to resolve the apparent paradox between the increased
regulatory complexity of NAT activity in higher eukaryotes and the
tissue-specific phenotypes on the one hand, and the partial
redundancy and high number of NAT substrates on the other hand, we
propose a regulatory “Net-model” for N-acetylation.
2.1. “Net model” for N-terminal acetylation
We propose that in the cases where N-acetylation has tissue-
specific regulatory functions, the associated substrates will be mostly
acetylated by one or two NATs (fig. 1). In contrast, in the cases where
N-acetylation has housekeeping functions, the associated substrates
will be acetylated by multiple NATs (fig. 1). If correct, this hypothesis
would allow the modulation of N-acetylation for tissue specific
functions even if most NATs were partially redundant and were likely to
have a large number of substrates. Furthermore, this model suggests
that although most NATs have a high number of substrates, the
described knockdown phenotypes are mostly due to the loss/reduction
of N-acetylation in a small subset of substrates. Consistently, whereas
san mutant embryos show highly specific mitotic phenotypes (Pimenta-
Marques et al., 2008), our COFRADIC analysis suggests this enzyme
has a large number of substrates.
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Figure 1: “Net model” hypothesis for N-terminal acetylation. Hypothetical Nat1,
Nat2 and Nat3, N-acetylate different proteins from “A” to “S”. Substrates whose
acetylation has housekeeping functions are mostly acetylated by several NATs.
Substrates whose acetylation has tissue-specific regulatory functions are mostly
acetylated by one or two NATs.
2.2. Can different substrates require different levels of N-terminal
acetylation?
Analysis of protein N-acetylation levels in humans, estimated
that from the approximately 76% of N-acetylated proteins, 8% were
only partially N-acetylated (Arnesen et al., 2009b). Our COFRADIC
analysis suggested that wild-type Drosophila embryos contain a
significant fraction of partially N-acetylated proteins (Chapter IV). This
suggests the total levels of N-acetylation are differentially important
for the function of different substrates. If this hypothesis is correct then
the down-regulation of a given NAT activity will differentially affect the
activity of its substrates as they have distinct N-acetylation cutoffs.
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Likewise, tissue-specific expression of different NATs (even if partially
redundant) can differentially modulate the activity of their substrates,
as they will be associated to different kinetics of N-acetylation (fig.2).
Figure 2: Different substrates require different levels of N-terminal acetylation.
Tissue X expresses Nat1, tissue Y expresses Nat2 and tissue Z expresses both NATs.
Red bar represents the % of N-acetylation that a given substrate requires to
effectively perform its function. In tissue X, only substrate A is functional as Nat1 is not
able to efficiently N-acetylate the other two substrates above the functional cutoff. In
tissue Y, substrates A and B are functional as Nat2 is capable of N-acetylating these
two proteins (but not substrate C) above their functional cutoff. Tissue Z expresses
both NATs and all substrates are efficiently N-acetylated above their functional cutoff.
2.3. Is NATs activity modulated by cofactor proteins?
Distinct NAT activities can potentially arise from the
combination of different catalytic subunits with different auxiliary
subunits. For example, the paralogue catalytic subunits hNaa10 and
hNaa11 and the paralogue auxiliary subunits hNaa15 and hNaa16
differentially participate in functional hNatA complexes (Arnesen et al.,
2006a; Arnesen et al., 2009a). Moreover, these paralogues seem to be
differentially expressed in different tissues and cell lines (Arnesen et
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al., 2006a; Arnesen et al., 2009a; Pang et al., 2009; Sugiura et al.,
2003). One might think that expression of different NAT complex
subunits or alternative splicing of these subunits could modulate the
activity of different NAT complexes. In Drosophila, dnaa60 gene locus
encodes two different protein isoforms due to alternative splicing
(Chapter V). One possibility is that these isoforms display different
NAT activities and are therefore expressed in different tissues which
show differential requirements for protein N-acetylation.
3. Conclusion
Our work confirms that during Drosophila melanogaster
development, the regulation of protein N-acetylation is unexpectedly
complex and some of its functions are tissue-specific. We propose that
similar to other post-translational modifications, N-acetylation has
tissue-specific regulatory functions important for development and
maintenance of tissue homeostasis.
4. Future work
Our goal is to better understand the function of protein N-
acetylation during multicellular organism development. From our work
we hypothesize that similarly to dSan/dNAA50, other NATs are likely
have tissue-specific functions in higher eukaryotes (Chapter VI 1.1.).
1) To test if NATs tissue-specific functions can be obtained at
transcriptional level by differential expression of these enzymes we
propose to perform a systematic expression screen of the main NAT
complexes subunits during Drosophila development. We will perform in
situ hybridization and immunostaining experiments to detect the mRNA
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and protein levels of the different NAT subunits during development,
such as ovaries, testis, embryos and larval wing discs and brain
neuroblasts. We expect NATs that have predominantly housekeeping
functions to be ubiquitously expressed, whereas NATs with
predominantly regulatory functions to have more narrowed expression
profiles. If we manage to identify a NAT whose expression is highly
enriched in a given tissue (or developmental stage) we will investigate
the function of this enzyme during Drosophila development.
2) Alternatively the tissue specific functions of N-acetylation can be
simply due to different combinations of partially redundant NATs that
are broadly (but not ubiquitously) expressed in different tissues. Based
on this hypothesis we propose a “net model”, where most tissue-
specific N-acetylation events are mostly (but not exclusively)
performed by one or two NATs. Since this model hypothesizes most
housekeeping N-acetylation events are usually performed by multiple
partially redundant NATs, than we predict most phenotypes observed
in cells depleted for different NATs subunits would be only due to the
loss/reduction of N-acetylation of a small subset of substrates
(Chapter V 1.2.1.).
To test this we propose to analyze the N-acetylation profiles of wild-
type and mutants for different subunits of the NAT complexes during
Drosophila development. If the "net model" is correct and there is a
tissue-specific combinatory code of NATs expression, than we expect
some proteins will be differentially acetylated during Drosophila
development even if most NATs show broadly expression profiles. By
performing a similar analysis with different NAT mutants we should be
able to identify some of the functionally relevant NATs.
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3) It is also possible that the distinct NAT activities can potentially
arise from the differential combination of catalytic and regulatory NAT
subunits (section 2.3). To test this hypothesis we will immunopurify,
using fusion-tagged proteins expressed at endogenous levels, all
known NAT complexes from different tissues and identify interacting
proteins by LC-MS/MS. If our hypothesis is correct we expect to
identify different NAT complexes in different tissues.
If our expectations are fulfilled, the experiments previously
described will provide strong evidence suggesting N-acetylation has
tissue-specific functions and has evolved to accommodate regulatory
functions in a developing multicellular organism.
161
References
References
162
(2004). Finishing the euchromatic sequence of the human genome.
Nature 431, 931-45.
Ackerman, P., Glover, C. V. and Osheroff, N. (1985).
Phosphorylation of DNA topoisomerase II by casein kinase II:
modulation of eukaryotic topoisomerase II activity in vitro. Proc Natl
Acad Sci U S A 82, 3164-8.
Adams, M. D. Celniker, S. E. Holt, R. A. Evans, C. A. Gocayne, J.
D. Amanatides, P. G. Scherer, S. E. Li, P. W. Hoskins, R. A. Galle,
R. F. et al. (2000). The genome sequence of Drosophila
melanogaster. Science 287, 2185-95.
Afshar, K., Stuart, B. and Wasserman, S. A. (2000). Functional
analysis of the Drosophila diaphanous FH protein in early embryonic
development. Development 127, 1887-97.
Alexandru, G., Uhlmann, F., Mechtler, K., Poupart, M. A. and
Nasmyth, K. (2001). Phosphorylation of the cohesin subunit Scc1 by
Polo/Cdc5 kinase regulates sister chromatid separation in yeast. Cell
105, 459-72.
Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z.,
Miller, W. and Lipman, D. J. (1997). Gapped BLAST and PSI-BLAST:
a new generation of protein database search programs. Nucleic Acids
Res 25, 3389-402.
Ametzazurra, A., Larrea, E., Civeira, M. P., Prieto, J. and Aldabe,
R. (2008). Implication of human N-alpha-acetyltransferase 5 in cellular
proliferation and carcinogenesis. Oncogene 27, 7296-306.
Arnesen, T., Anderson, D., Baldersheim, C., Lanotte, M., Varhaug,
J. E. and Lillehaug, J. R. (2005a). Identification and characterization
of the human ARD1-NATH protein acetyltransferase complex.
Biochem J 386, 433-43.
Arnesen, T., Anderson, D., Torsvik, J., Halseth, H. B., Varhaug, J.
E. and Lillehaug, J. R. (2006a). Cloning and characterization of
hNAT5/hSAN: an evolutionarily conserved component of the NatA
protein N-alpha-acetyltransferase complex. Gene 371, 291-5.
Arnesen, T., Betts, M. J., Pendino, F., Liberles, D. A., Anderson,
D., Caro, J., Kong, X., Varhaug, J. E. and Lillehaug, J. R. (2006b).
Characterization of hARD2, a processed hARD1 gene duplicate,
encoding a human protein N-alpha-acetyltransferase. BMC Biochem 7,
13.
Arnesen, T., Gromyko, D., Horvli, O., Fluge, O., Lillehaug, J. and
Varhaug, J. E. (2005b). Expression of N-acetyl transferase human
and human Arrest defective 1 proteins in thyroid neoplasms. Thyroid
15, 1131-6.
Arnesen, T., Gromyko, D., Kagabo, D., Betts, M. J., Starheim, K.
K., Varhaug, J. E., Anderson, D. and Lillehaug, J. R. (2009a). A
novel human NatA Nalpha-terminal acetyltransferase complex:
hNaa16p-hNaa10p (hNat2-hArd1). BMC Biochem 10, 15.
References
163
Arnesen, T., Gromyko, D., Pendino, F., Ryningen, A., Varhaug, J.
E. and Lillehaug, J. R. (2006c). Induction of apoptosis in human cells
by RNAi-mediated knockdown of hARD1 and NATH, components of
the protein N-alpha-acetyltransferase complex. Oncogene 25, 4350-
60.
Arnesen, T., Starheim, K. K., Van Damme, P., Evjenth, R., Dinh, H.,
Betts, M. J., Ryningen, A., Vandekerckhove, J., Gevaert, K. and
Anderson, D. The chaperone-like protein HYPK acts together with
NatA in cotranslational N-terminal acetylation and prevention of
Huntingtin aggregation. Mol Cell Biol 30, 1898-909.
Arnesen, T., Van Damme, P., Polevoda, B., Helsens, K., Evjenth,
R., Colaert, N., Varhaug, J. E., Vandekerckhove, J., Lillehaug, J.
R., Sherman, F. et al. (2009b). Proteomics analyses reveal the
evolutionary conservation and divergence of N-terminal
acetyltransferases from yeast and humans. Proc Natl Acad Sci U S A
106, 8157-62.
Asaumi, M., Iijima, K., Sumioka, A., Iijima-Ando, K., Kirino, Y.,
Nakaya, T. and Suzuki, T. (2005). Interaction of N-terminal
acetyltransferase with the cytoplasmic domain of beta-amyloid
precursor protein and its effect on A beta secretion. J Biochem 137,
147-55.
Askree, S. H., Yehuda, T., Smolikov, S., Gurevich, R., Hawk, J.,
Coker, C., Krauskopf, A., Kupiec, M. and McEachern, M. J. (2004).
A genome-wide screen for Saccharomyces cerevisiae deletion
mutants that affect telomere length. Proc Natl Acad Sci U S A 101,
8658-63.
Bannister, A. J. and Kouzarides, T. (2005). Reversing histone
methylation. Nature 436, 1103-6.
Bannister, A. J., Miska, E. A., Gorlich, D. and Kouzarides, T.
(2000). Acetylation of importin-alpha nuclear import factors by
CBP/p300. Curr Biol 10, 467-70.
Barbosa, V., Kimm, N. and Lehmann, R. (2007). A maternal screen
for genes regulating Drosophila oocyte polarity uncovers new steps in
meiotic progression. Genetics 176, 1967-77.
Beausoleil, S. A., Villen, J., Gerber, S. A., Rush, J. and Gygi, S. P.
(2006). A probability-based approach for high-throughput protein
phosphorylation analysis and site localization. Nat Biotechnol 24,
1285-92.
Behnia, R., Panic, B., Whyte, J. R. and Munro, S. (2004). Targeting
of the Arf-like GTPase Arl3p to the Golgi requires N-terminal
acetylation and the membrane protein Sys1p. Nat Cell Biol 6, 405-13.
Bement, W. M., Benink, H. A. and von Dassow, G. (2005). A
microtubule-dependent zone of active RhoA during cleavage plane
specification. J Cell Biol 170, 91-101.
Bettencourt-Dias, M., Giet, R., Sinka, R., Mazumdar, A., Lock, W.
G., Balloux, F., Zafiropoulos, P. J., Yamaguchi, S., Winter, S.,
References
164
Carthew, R. W. et al. (2004). Genome-wide survey of protein kinases
required for cell cycle progression. Nature 432, 980-7.
Bhat, M. A., Philp, A. V., Glover, D. M. and Bellen, H. J. (1996).
Chromatid segregation at anaphase requires the barren product, a
novel chromosome-associated protein that interacts with
Topoisomerase II. Cell 87, 1103-14.
Bilton, R., Mazure, N., Trottier, E., Hattab, M., Dery, M. A., Richard,
D. E., Pouyssegur, J. and Brahimi-Horn, M. C. (2005). Arrest-
defective-1 protein, an acetyltransferase, does not alter stability of
hypoxia-inducible factor (HIF)-1alpha and is not induced by hypoxia or
HIF. J Biol Chem 280, 31132-40.
Bilton, R., Trottier, E., Pouyssegur, J. and Brahimi-Horn, M. C.
(2006). ARDent about acetylation and deacetylation in hypoxia
signalling. Trends Cell Biol 16, 616-21.
Boissel, J. P., Kasper, T. J. and Bunn, H. F. (1988). Cotranslational
amino-terminal processing of cytosolic proteins. Cell-free expression of
site-directed mutants of human hemoglobin. J Biol Chem 263, 8443-9.
Bollen, M., Gerlich, D. W. and Lesage, B. (2009). Mitotic
phosphatases: from entry guards to exit guides. Trends Cell Biol 19,
531-41.
Brackley, K. I. and Grantham, J. (2009). Activities of the chaperonin
containing TCP-1 (CCT): implications for cell cycle progression and
cytoskeletal organisation. Cell Stress Chaperones 14, 23-31.
Bradshaw, R. A., Brickey, W. W. and Walker, K. W. (1998). N-
terminal processing: the methionine aminopeptidase and N alpha-
acetyl transferase families. Trends Biochem Sci 23, 263-7.
Brand, A. H. and Perrimon, N. (1993). Targeted gene expression as
a means of altering cell fates and generating dominant phenotypes.
Development 118, 401-15.
Brodsky, M. H., Weinert, B. T., Tsang, G., Rong, Y. S., McGinnis,
N. M., Golic, K. G., Rio, D. C. and Rubin, G. M. (2004). Drosophila
melanogaster MNK/Chk2 and p53 regulate multiple DNA repair and
apoptotic pathways following DNA damage. Mol Cell Biol 24, 1219-31.
Brown, L., Ongusaha, P. P., Kim, H. G., Nuti, S., Mandinova, A.,
Lee, J. W., Khosravi-Far, R., Aaronson, S. A. and Lee, S. W. (2007).
CDIP, a novel pro-apoptotic gene, regulates TNFalpha-mediated
apoptosis in a p53-dependent manner. EMBO J 26, 3410-22.
Buchenau, P., Saumweber, H. and Arndt-Jovin, D. J. (1993).
Consequences of topoisomerase II inhibition in early embryogenesis of
Drosophila revealed by in vivo confocal laser scanning microscopy. J
Cell Sci 104 ( Pt 4), 1175-85.
Burnett, G. and Kennedy, E. P. (1954). The enzymatic
phosphorylation of proteins. J Biol Chem 211, 969-80.
Caesar, R. and Blomberg, A. (2004). The stress-induced Tfs1p
requires NatB-mediated acetylation to inhibit carboxypeptidase Y and
to regulate the protein kinase A pathway. J Biol Chem 279, 38532-43.
References
165
Caesar, R., Warringer, J. and Blomberg, A. (2006). Physiological
importance and identification of novel targets for the N-terminal
acetyltransferase NatB. Eukaryot Cell 5, 368-78.
Camasses, A., Bogdanova, A., Shevchenko, A. and Zachariae, W.
(2003). The CCT chaperonin promotes activation of the anaphase-
promoting complex through the generation of functional Cdc20. Mol
Cell 12, 87-100.
Chintapalli, V. R., Wang, J. and Dow, J. A. (2007). Using FlyAtlas to
identify better Drosophila melanogaster models of human disease. Nat
Genet 39, 715-20.
Chou, T. B. and Perrimon, N. (1992). Use of a yeast site-specific
recombinase to produce female germline chimeras in Drosophila.
Genetics 131, 643-53.
Chu, C. W., Hou, F., Zhang, J., Phu, L., Loktev, A. V., Kirkpatrick,
D. S., Jackson, P. K., Zhao, Y. and Zou, H. A novel acetylation of
{beta}-tubulin by San modulates microtubule polymerization via down-
regulating tubulin incorporation. Mol Biol Cell.
Chun, K. H., Cho, S. J., Choi, J. S., Kim, S. H., Kim, K. W. and Lee,
S. K. (2007). Differential regulation of splicing, localization and stability
of mammalian ARD1235 and ARD1225 isoforms. Biochem Biophys
Res Commun 353, 18-25.
Ciechanover, A. and Ben-Saadon, R. (2004). N-terminal
ubiquitination: more protein substrates join in. Trends Cell Biol 14, 103-
6.
Ciosk, R., Shirayama, M., Shevchenko, A., Tanaka, T., Toth, A. and
Nasmyth, K. (2000). Cohesin's binding to chromosomes depends on a
separate complex consisting of Scc2 and Scc4 proteins. Mol Cell 5,
243-54.
Clemens, J. C., Worby, C. A., Simonson-Leff, N., Muda, M.,
Maehama, T., Hemmings, B. A. and Dixon, J. E. (2000). Use of
double-stranded RNA interference in Drosophila cell lines to dissect
signal transduction pathways. Proc Natl Acad Sci U S A 97, 6499-503.
Coelho, P. A., Queiroz-Machado, J. and Sunkel, C. E. (2003).
Condensin-dependent localisation of topoisomerase II to an axial
chromosomal structure is required for sister chromatid resolution
during mitosis. J Cell Sci 116, 4763-76.
Corradetti, M. N. and Guan, K. L. (2006). Upstream of the
mammalian target of rapamycin: do all roads pass through mTOR?
Oncogene 25, 6347-60.
Coulton, A. T., East, D. A., Galinska-Rakoczy, A., Lehman, W. and
Mulvihill, D. P. The recruitment of acetylated and unacetylated
tropomyosin to distinct actin polymers permits the discrete regulation
of specific myosins in fission yeast. J Cell Sci 123, 3235-43.
Craiu, A., Gaczynska, M., Akopian, T., Gramm, C. F., Fenteany, G.,
Goldberg, A. L. and Rock, K. L. (1997). Lactacystin and clasto-
lactacystin beta-lactone modify multiple proteasome beta-subunits and
References
166
inhibit intracellular protein degradation and major histocompatibility
complex class I antigen presentation. J Biol Chem 272, 13437-45.
Crawford, J. M., Harden, N., Leung, T., Lim, L. and Kiehart, D. P.
(1998). Cellularization in Drosophila melanogaster is disrupted by the
inhibition of rho activity and the activation of Cdc42 function. Dev Biol
204, 151-64.
Cuthbert, G. L., Daujat, S., Snowden, A. W., Erdjument-Bromage,
H., Hagiwara, T., Yamada, M., Schneider, R., Gregory, P. D.,
Tempst, P., Bannister, A. J. et al. (2004). Histone deimination
antagonizes arginine methylation. Cell 118, 545-53.
D'Ambrosio, C., Schmidt, C. K., Katou, Y., Kelly, G., Itoh, T.,
Shirahige, K. and Uhlmann, F. (2008). Identification of cis-acting
sites for condensin loading onto budding yeast chromosomes. Genes
Dev 22, 2215-27.
D'Avino, P. P., Savoian, M. S. and Glover, D. M. (2005). Cleavage
furrow formation and ingression during animal cytokinesis: a
microtubule legacy. J Cell Sci 118, 1549-58.
Darwiche, N., Freeman, L. A. and Strunnikov, A. (1999).
Characterization of the components of the putative mammalian sister
chromatid cohesion complex. Gene 233, 39-47.
Dej, K. J., Ahn, C. and Orr-Weaver, T. L. (2004). Mutations in the
Drosophila condensin subunit dCAP-G: defining the role of condensin
for chromosome condensation in mitosis and gene expression in
interphase. Genetics 168, 895-906.
Dixon, S. J., Fedyshyn, Y., Koh, J. L., Prasad, T. S., Chahwan, C.,
Chua, G., Toufighi, K., Baryshnikova, A., Hayles, J., Hoe, K. L. et
al. (2008). Significant conservation of synthetic lethal genetic
interaction networks between distantly related eukaryotes. Proc Natl
Acad Sci U S A 105, 16653-8.
Dorsett, D., Eissenberg, J. C., Misulovin, Z., Martens, A., Redding,
B. and McKim, K. (2005). Effects of sister chromatid cohesion
proteins on cut gene expression during wing development in
Drosophila. Development 132, 4743-53.
Drapeau, M. D. (2001). The Family of Yellow-Related Drosophila
melanogaster Proteins. Biochem Biophys Res Commun 281, 611-3.
Driessen, H. P., de Jong, W. W., Tesser, G. I. and Bloemendal, H.
(1985). The mechanism of N-terminal acetylation of proteins. CRC Crit
Rev Biochem 18, 281-325.
Evjenth, R., Hole, K., Karlsen, O. A., Ziegler, M., Arnesen, T. and
Lillehaug, J. R. (2009). Human Naa50p (Nat5/San) displays both
protein N alpha- and N epsilon-acetyltransferase activity. J Biol Chem
284, 31122-9.
Fang, G., Yu, H. and Kirschner, M. W. (1998). Direct binding of
CDC20 protein family members activates the anaphase-promoting
complex in mitosis and G1. Mol Cell 2, 163-71.
References
167
Field, C. M., Coughlin, M., Doberstein, S., Marty, T. and Sullivan,
W. (2005). Characterization of anillin mutants reveals essential roles in
septin localization and plasma membrane integrity. Development 132,
2849-60.
Fisher, T. S., Etages, S. D., Hayes, L., Crimin, K. and Li, B. (2005).
Analysis of ARD1 function in hypoxia response using retroviral RNA
interference. J Biol Chem 280, 17749-57.
Fluge, O., Bruland, O., Akslen, L. A., Varhaug, J. E. and Lillehaug,
J. R. (2002). NATH, a novel gene overexpressed in papillary thyroid
carcinomas. Oncogene 21, 5056-68.
Foe, V. E. and Alberts, B. M. (1983). Studies of nuclear and
cytoplasmic behaviour during the five mitotic cycles that precede
gastrulation in Drosophila embryogenesis. J Cell Sci 61, 31-70.
Foe, V. E., Field, C. M. and Odell, G. M. (2000). Microtubules and
mitotic cycle phase modulate spatiotemporal distributions of F-actin
and myosin II in Drosophila syncytial blastoderm embryos.
Development 127, 1767-87.
Force, A., Lynch, M., Pickett, F. B., Amores, A., Yan, Y. L. and
Postlethwait, J. (1999). Preservation of duplicate genes by
complementary, degenerative mutations. Genetics 151, 1531-45.
Foster, K. G. and Fingar, D. C. Mammalian target of rapamycin
(mTOR): conducting the cellular signaling symphony. J Biol Chem 285,
14071-7.
Gandhi, R., Gillespie, P. J. and Hirano, T. (2006). Human Wapl is a
cohesin-binding protein that promotes sister-chromatid resolution in
mitotic prophase. Curr Biol 16, 2406-17.
Gareau, J. R. and Lima, C. D. The SUMO pathway: emerging
mechanisms that shape specificity, conjugation and recognition. Nat
Rev Mol Cell Biol 11, 861-71.
Gautschi, M., Just, S., Mun, A., Ross, S., Rucknagel, P., Dubaquie,
Y., Ehrenhofer-Murray, A. and Rospert, S. (2003). The yeast
N(alpha)-acetyltransferase NatA is quantitatively anchored to the
ribosome and interacts with nascent polypeptides. Mol Cell Biol 23,
7403-14.
Gendron, R. L., Adams, L. C. and Paradis, H. (2000). Tubedown-1, a
novel acetyltransferase associated with blood vessel development.
Dev Dyn 218, 300-15.
Gendron, R. L., Good, W. V., Adams, L. C. and Paradis, H. (2001).
Suppressed expression of tubedown-1 in retinal neovascularization of
proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 42, 3000-7.
Gendron, R. L., Good, W. V., Miskiewicz, E., Tucker, S., Phelps, D.
L. and Paradis, H. (2006). Tubedown-1 (Tbdn-1) suppression in
oxygen-induced retinopathy and in retinopathy of prematurity. Mol Vis
12, 108-16.
References
168
Gerlich, D., Hirota, T., Koch, B., Peters, J. M. and Ellenberg, J.
(2006). Condensin I stabilizes chromosomes mechanically through a
dynamic interaction in live cells. Curr Biol 16, 333-44.
Gevaert, K., Goethals, M., Martens, L., Van Damme, J., Staes, A.,
Thomas, G. R. and Vandekerckhove, J. (2003). Exploring proteomes
and analyzing protein processing by mass spectrometric identification
of sorted N-terminal peptides. Nat Biotechnol 21, 566-9.
Gilboa, L. and Lehmann, R. (2004). How different is Venus from
Mars? The genetics of germ-line stem cells in Drosophila females and
males. Development 131, 4895-905.
Gillespie, P. J. and Hirano, T. (2004). Scc2 couples replication
licensing to sister chromatid cohesion in Xenopus egg extracts. Curr
Biol 14, 1598-603.
Glozak, M. A., Sengupta, N., Zhang, X. and Seto, E. (2005).
Acetylation and deacetylation of non-histone proteins. Gene 363, 15-
23.
Goetze, S., Qeli, E., Mosimann, C., Staes, A., Gerrits, B.,
Roschitzki, B., Mohanty, S., Niederer, E. M., Laczko, E.,
Timmerman, E. et al. (2009). Identification and functional
characterization of N-terminally acetylated proteins in Drosophila
melanogaster. PLoS Biol 7, e1000236.
Goshima, G., Wollman, R., Goodwin, S. S., Zhang, N., Scholey, J.
M., Vale, R. D. and Stuurman, N. (2007). Genes required for mitotic
spindle assembly in Drosophila S2 cells. Science 316, 417-21.
Graveley, B. R., Brooks, A. N., Carlson, J. W., Duff, M. O.,
Landolin, J. M., Yang, L., Artieri, C. G., van Baren, M. J., Boley, N.,
Booth, B. W. et al. The developmental transcriptome of Drosophila
melanogaster. Nature 471, 473-9.
Grewal, S. I. and Rice, J. C. (2004). Regulation of heterochromatin by
histone methylation and small RNAs. Curr Opin Cell Biol 16, 230-8.
Grosshans, J., Wenzl, C., Herz, H. M., Bartoszewski, S., Schnorrer,
F., Vogt, N., Schwarz, H. and Muller, H. A. (2005). RhoGEF2 and the
formin Dia control the formation of the furrow canal by directed actin
assembly during Drosophila cellularisation. Development 132, 1009-
20.
Gruber, S., Haering, C. H. and Nasmyth, K. (2003). Chromosomal
cohesin forms a ring. Cell 112, 765-77.
Haering, C. H., Lowe, J., Hochwagen, A. and Nasmyth, K. (2002).
Molecular architecture of SMC proteins and the yeast cohesin
complex. Mol Cell 9, 773-88.
Hagstrom, K. A., Holmes, V. F., Cozzarelli, N. R. and Meyer, B. J.
(2002). C. elegans condensin promotes mitotic chromosome
architecture, centromere organization, and sister chromatid
segregation during mitosis and meiosis. Genes Dev 16, 729-42.
Hartman, T., Stead, K., Koshland, D. and Guacci, V. (2000). Pds5p
is an essential chromosomal protein required for both sister chromatid
References
169
cohesion and condensation in Saccharomyces cerevisiae. J Cell Biol
151, 613-26.
Hauf, S., Roitinger, E., Koch, B., Dittrich, C. M., Mechtler, K. and
Peters, J. M. (2005). Dissociation of cohesin from chromosome arms
and loss of arm cohesion during early mitosis depends on
phosphorylation of SA2. PLoS Biol 3, e69.
Heidmann, D., Horn, S., Heidmann, S., Schleiffer, A., Nasmyth, K.
and Lehner, C. F. (2004). The Drosophila meiotic kleisin C(2)M
functions before the meiotic divisions. Chromosoma 113, 177-87.
Hermann, G. J., King, E. J. and Shaw, J. M. (1997). The yeast gene,
MDM20, is necessary for mitochondrial inheritance and organization of
the actin cytoskeleton. J Cell Biol 137, 141-53.
Hirano, T. (2005). Condensins: organizing and segregating the
genome. Curr Biol 15, R265-75.
Hirota, T., Gerlich, D., Koch, B., Ellenberg, J. and Peters, J. M.
(2004). Distinct functions of condensin I and II in mitotic chromosome
assembly. J Cell Sci 117, 6435-45.
Hofmann, I. and Munro, S. (2006). An N-terminally acetylated Arf-like
GTPase is localised to lysosomes and affects their motility. J Cell Sci
119, 1494-503.
Hornig, N. C. and Uhlmann, F. (2004). Preferential cleavage of
chromatin-bound cohesin after targeted phosphorylation by Polo-like
kinase. EMBO J 23, 3144-53.
Hou, F., Chu, C. W., Kong, X., Yokomori, K. and Zou, H. (2007).
The acetyltransferase activity of San stabilizes the mitotic cohesin at
the centromeres in a shugoshin-independent manner. J Cell Biol 177,
587-97.
Hudson, D. F., Ohta, S., Freisinger, T., Macisaac, F., Sennels, L.,
Alves, F., Lai, F., Kerr, A., Rappsilber, J. and Earnshaw, W. C.
(2008). Molecular and genetic analysis of condensin function in
vertebrate cells. Mol Biol Cell 19, 3070-9.
Hudson, D. F., Vagnarelli, P., Gassmann, R. and Earnshaw, W. C.
(2003). Condensin is required for nonhistone protein assembly and
structural integrity of vertebrate mitotic chromosomes. Dev Cell 5, 323-
36.
Hwang, C. S., Shemorry, A. and Varshavsky, A. (2010). N-terminal
acetylation of cellular proteins creates specific degradation signals.
Science 327, 973-7.
Igaki, T., Kanda, H., Yamamoto-Goto, Y., Kanuka, H., Kuranaga, E.,
Aigaki, T. and Miura, M. (2002). Eiger, a TNF superfamily ligand that
triggers the Drosophila JNK pathway. EMBO J 21, 3009-18.
Imhof, A., Yang, X. J., Ogryzko, V. V., Nakatani, Y., Wolffe, A. P.
and Ge, H. (1997). Acetylation of general transcription factors by
histone acetyltransferases. Curr Biol 7, 689-92.
Ingram, A. K., Cross, G. A. and Horn, D. (2000). Genetic
manipulation indicates that ARD1 is an essential N(infinity)-
References
170
acetyltransferase in Trypanosoma brucei. Mol Biochem Parasitol 111,
309-17.
Ivanov, D. and Nasmyth, K. (2007). A physical assay for sister
chromatid cohesion in vitro. Mol Cell 27, 300-10.
Jaffe, A. B. and Hall, A. (2005). Rho GTPases: biochemistry and
biology. Annu Rev Cell Dev Biol 21, 247-69.
Jaspersen, S. L., Charles, J. F. and Morgan, D. O. (1999). Inhibitory
phosphorylation of the APC regulator Hct1 is controlled by the kinase
Cdc28 and the phosphatase Cdc14. Curr Biol 9, 227-36.
Jeong, J. W., Bae, M. K., Ahn, M. Y., Kim, S. H., Sohn, T. K., Bae,
M. H., Yoo, M. A., Song, E. J., Lee, K. J. and Kim, K. W. (2002).
Regulation and destabilization of HIF-1alpha by ARD1-mediated
acetylation. Cell 111, 709-20.
Johnson, L. N. and Lewis, R. J. (2001). Structural basis for control by
phosphorylation. Chem Rev 101, 2209-42.
Jornvall, H. (1975). Acetylation of Protein N-terminal amino groups
structural observations on alpha-amino acetylated proteins. J Theor
Biol 55, 1-12.
Kaitna, S., Pasierbek, P., Jantsch, M., Loidl, J. and Glotzer, M.
(2002). The aurora B kinase AIR-2 regulates kinetochores during
mitosis and is required for separation of homologous Chromosomes
during meiosis. Curr Biol 12, 798-812.
Kamijo, K., Ohara, N., Abe, M., Uchimura, T., Hosoya, H., Lee, J. S.
and Miki, T. (2006). Dissecting the role of Rho-mediated signaling in
contractile ring formation. Mol Biol Cell 17, 43-55.
Karr, T. L. and Alberts, B. M. (1986). Organization of the cytoskeleton
in early Drosophila embryos. J Cell Biol 102, 1494-509.
Kenna, M. A. and Skibbens, R. V. (2003). Mechanical link between
cohesion establishment and DNA replication: Ctf7p/Eco1p, a cohesion
establishment factor, associates with three different replication factor C
complexes. Mol Cell Biol 23, 2999-3007.
Khan, S. N. and Khan, A. U. Role of histone acetylation in cell
physiology and diseases: An update. Clin Chim Acta 411, 1401-11.
Kim, S. H., Park, J. A., Kim, J. H., Lee, J. W., Seo, J. H., Jung, B.
K., Chun, K. H., Jeong, J. W., Bae, M. K. and Kim, K. W. (2006).
Characterization of ARD1 variants in mammalian cells. Biochem
Biophys Res Commun 340, 422-7.
Kim, Y. J., Cho, Y. E., Kim, Y. W., Kim, J. Y., Lee, S. and Park, J. H.
(2008). Suppression of putative tumour suppressor gene GLTSCR2
expression in human glioblastomas. J Pathol 216, 218-24.
Kimura, Y., Takaoka, M., Tanaka, S., Sassa, H., Tanaka, K.,
Polevoda, B., Sherman, F. and Hirano, H. (2000). N(alpha)-
acetylation and proteolytic activity of the yeast 20 S proteasome. J Biol
Chem 275, 4635-9.
Kitajima, T. S., Hauf, S., Ohsugi, M., Yamamoto, T. and Watanabe,
Y. (2005). Human Bub1 defines the persistent cohesion site along the
References
171
mitotic chromosome by affecting Shugoshin localization. Curr Biol 15,
353-9.
Kitajima, T. S., Sakuno, T., Ishiguro, K., Iemura, S., Natsume, T.,
Kawashima, S. A. and Watanabe, Y. (2006). Shugoshin collaborates
with protein phosphatase 2A to protect cohesin. Nature 441, 46-52.
Kops, G. J., Weaver, B. A. and Cleveland, D. W. (2005). On the road
to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5,
773-85.
Kouzarides, T. (1999). Histone acetylases and deacetylases in cell
proliferation. Curr Opin Genet Dev 9, 40-8.
Kouzarides, T. (2000). Acetylation: a regulatory modification to rival
phosphorylation? EMBO J 19, 1176-9.
Kramer, E. R., Scheuringer, N., Podtelejnikov, A. V., Mann, M. and
Peters, J. M. (2000). Mitotic regulation of the APC activator proteins
CDC20 and CDH1. Mol Biol Cell 11, 1555-69.
Kreher, S. A., Kwon, J. Y. and Carlson, J. R. (2005). The molecular
basis of odor coding in the Drosophila larva. Neuron 46, 445-56.
Kueng, S., Hegemann, B., Peters, B. H., Lipp, J. J., Schleiffer, A.,
Mechtler, K. and Peters, J. M. (2006). Wapl controls the dynamic
association of cohesin with chromatin. Cell 127, 955-67.
Kuo, H. P., Lee, D. F., Xia, W., Lai, C. C., Li, L. Y. and Hung, M. C.
(2009). Phosphorylation of ARD1 by IKKbeta contributes to its
destabilization and degradation. Biochem Biophys Res Commun 389,
156-61.
Lee, F. J., Lin, L. W. and Smith, J. A. (1988). Purification and
characterization of an N alpha-acetyltransferase from Saccharomyces
cerevisiae. J Biol Chem 263, 14948-55.
Lee, F. J., Lin, L. W. and Smith, J. A. (1989). N alpha-
acetyltransferase deficiency alters protein synthesis in Saccharomyces
cerevisiae. FEBS Lett 256, 139-42.
Lee, J. S., Kamijo, K., Ohara, N., Kitamura, T. and Miki, T. (2004).
MgcRacGAP regulates cortical activity through RhoA during
cytokinesis. Exp Cell Res 293, 275-82.
Lengronne, A., McIntyre, J., Katou, Y., Kanoh, Y., Hopfner, K. P.,
Shirahige, K. and Uhlmann, F. (2006). Establishment of sister
chromatid cohesion at the S. cerevisiae replication fork. Mol Cell 23,
787-99.
Li, M. and Zhang, P. (2009). The function of APC/CCdh1 in cell cycle
and beyond. Cell Div 4, 2.
Li, X., Urwyler, O. and Suter, B. Drosophila Xpd regulates Cdk7
localization, mitotic kinase activity, spindle dynamics, and chromosome
segregation. PLoS Genet 6, e1000876.
Lim, J. H., Park, J. W. and Chun, Y. S. (2006). Human arrest
defective 1 acetylates and activates beta-catenin, promoting lung
cancer cell proliferation. Cancer Res 66, 10677-82.
References
172
Line, A., Stengrevics, A., Slucka, Z., Li, G., Jankevics, E. and
Rees, R. C. (2002). Serological identification and expression analysis
of gastric cancer-associated genes. Br J Cancer 86, 1824-30.
Lodish, H. F. (2003). Molecular Cell Biology,  (ed.: New York, W.H.
Freeman and Company.
Longtine, M. S., Enomoto, S., Finstad, S. L. and Berman, J. (1993).
Telomere-mediated plasmid segregation in Saccharomyces cerevisiae
involves gene products required for transcriptional repression at
silencers and telomeres. Genetics 133, 171-82.
Losada, A., Hirano, M. and Hirano, T. (1998). Identification of
Xenopus SMC protein complexes required for sister chromatid
cohesion. Genes Dev 12, 1986-97.
Losada, A., Hirano, M. and Hirano, T. (2002). Cohesin release is
required for sister chromatid resolution, but not for condensin-mediated
compaction, at the onset of mitosis. Genes Dev 16, 3004-16.
Losada, A. and Hirano, T. (2005). Dynamic molecular linkers of the
genome: the first decade of SMC proteins. Genes Dev 19, 1269-87.
Losada, A., Yokochi, T. and Hirano, T. (2005). Functional
contribution of Pds5 to cohesin-mediated cohesion in human cells and
Xenopus egg extracts. J Cell Sci 118, 2133-41.
Lowther, W. T. and Matthews, B. W. (2000). Structure and function of
the methionine aminopeptidases. Biochim Biophys Acta 1477, 157-67.
Lynch, M. and Force, A. (2000). The probability of duplicate gene
preservation by subfunctionalization. Genetics 154, 459-73.
MacRae, T. H. (1997). Tubulin post-translational modifications--
enzymes and their mechanisms of action. Eur J Biochem 244, 265-78.
Malen, H., Lillehaug, J. R. and Arnesen, T. (2009). The protein
Nalpha-terminal acetyltransferase hNaa10p (hArd1) is phosphorylated
in HEK293 cells. BMC Res Notes 2, 32.
Manning, G., Whyte, D. B., Martinez, R., Hunter, T. and
Sudarsanam, S. (2002). The protein kinase complement of the human
genome. Science 298, 1912-34.
Martin, C. and Zhang, Y. (2005). The diverse functions of histone
lysine methylation. Nat Rev Mol Cell Biol 6, 838-49.
Martin, D. T., Gendron, R. L., Jarzembowski, J. A., Perry, A.,
Collins, M. H., Pushpanathan, C., Miskiewicz, E., Castle, V. P. and
Paradis, H. (2007). Tubedown expression correlates with the
differentiation status and aggressiveness of neuroblastic tumors. Clin
Cancer Res 13, 1480-7.
Mattaj, I. W., Tollervey, D. and Seraphin, B. (1993). Small nuclear
RNAs in messenger RNA and ribosomal RNA processing. FASEB J 7,
47-53.
Mavrakis, M., Rikhy, R. and Lippincott-Schwartz, J. (2009). Plasma
membrane polarity and compartmentalization are established before
cellularization in the fly embryo. Dev Cell 16, 93-104.
References
173
Mazumdar, A. and Mazumdar, M. (2002). How one becomes many:
blastoderm cellularization in Drosophila melanogaster. Bioessays 24,
1012-22.
McGuinness, B. E., Hirota, T., Kudo, N. R., Peters, J. M. and
Nasmyth, K. (2005). Shugoshin prevents dissociation of cohesin from
centromeres during mitosis in vertebrate cells. PLoS Biol 3, e86.
Mellone, B. G. and Allshire, R. C. (2003). Stretching it: putting the
CEN(P-A) in centromere. Curr Opin Genet Dev 13, 191-8.
Midorikawa, Y., Tsutsumi, S., Taniguchi, H., Ishii, M., Kobune, Y.,
Kodama, T., Makuuchi, M. and Aburatani, H. (2002). Identification of
genes associated with dedifferentiation of hepatocellular carcinoma
with expression profiling analysis. Jpn J Cancer Res 93, 636-43.
Moldovan, G. L., Pfander, B. and Jentsch, S. (2006). PCNA controls
establishment of sister chromatid cohesion during S phase. Mol Cell
23, 723-32.
Moorhead, G. B., Trinkle-Mulcahy, L. and Ulke-Lemee, A. (2007).
Emerging roles of nuclear protein phosphatases. Nat Rev Mol Cell Biol
8, 234-44.
Moreno, E., Yan, M. and Basler, K. (2002). Evolution of TNF
signaling mechanisms: JNK-dependent apoptosis triggered by Eiger,
the Drosophila homolog of the TNF superfamily. Curr Biol 12, 1263-8.
Morgan, D. O. (2007). The Cell Cycle: Principles of Control.
Mullen, J. R., Kayne, P. S., Moerschell, R. P., Tsunasawa, S.,
Gribskov, M., Colavito-Shepanski, M., Grunstein, M., Sherman, F.
and Sternglanz, R. (1989). Identification and characterization of
genes and mutants for an N-terminal acetyltransferase from yeast.
EMBO J 8, 2067-75.
Muller, H., Schmidt, D., Steinbrink, S., Mirgorodskaya, E.,
Lehmann, V., Habermann, K., Dreher, F., Gustavsson, N., Kessler,
T., Lehrach, H. et al. Proteomic and functional analysis of the mitotic
Drosophila centrosome. EMBO J 29, 3344-57.
Murray, A. W. (2004). Recycling the cell cycle: cyclins revisited. Cell
116, 221-34.
Nakayama, K. I. and Nakayama, K. (2006). Ubiquitin ligases: cell-
cycle control and cancer. Nat Rev Cancer 6, 369-81.
Noble, D., Kenna, M. A., Dix, M., Skibbens, R. V., Unal, E. and
Guacci, V. (2006). Intersection between the regulators of sister
chromatid cohesion establishment and maintenance in budding yeast
indicates a multi-step mechanism. Cell Cycle 5, 2528-36.
Nowak, M. A., Boerlijst, M. C., Cooke, J. and Smith, J. M. (1997).
Evolution of genetic redundancy. Nature 388, 167-71.
Ocampo-Hafalla, M. T., Katou, Y., Shirahige, K. and Uhlmann, F.
(2007). Displacement and re-accumulation of centromeric cohesin
during transient pre-anaphase centromere splitting. Chromosoma 116,
531-44.
References
174
Ohta, T. (1988). Time for acquiring a new gene by duplication. Proc
Natl Acad Sci U S A 85, 3509-12.
Okahara, F., Itoh, K., Nakagawara, A., Murakami, M., Kanaho, Y.
and Maehama, T. (2006). Critical role of PICT-1, a tumor suppressor
candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and
tumorigenic transformation. Mol Biol Cell 17, 4888-95.
Oliveira, R. A., Hamilton, R. S., Pauli, A., Davis, I. and Nasmyth, K.
Cohesin cleavage and Cdk inhibition trigger formation of daughter
nuclei. Nat Cell Biol 12, 185-92.
Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C.,
Mortensen, P. and Mann, M. (2006). Global, in vivo, and site-specific
phosphorylation dynamics in signaling networks. Cell 127, 635-48.
Ono, T., Fang, Y., Spector, D. L. and Hirano, T. (2004). Spatial and
temporal regulation of Condensins I and II in mitotic chromosome
assembly in human cells. Mol Biol Cell 15, 3296-308.
Ono, T., Losada, A., Hirano, M., Myers, M. P., Neuwald, A. F. and
Hirano, T. (2003). Differential contributions of condensin I and
condensin II to mitotic chromosome architecture in vertebrate cells.
Cell 115, 109-21.
Ouspenski, II, Elledge, S. J. and Brinkley, B. R. (1999). New yeast
genes important for chromosome integrity and segregation identified
by dosage effects on genome stability. Nucleic Acids Res 27, 3001-8.
Padash Barmchi, M., Rogers, S. and Hacker, U. (2005). DRhoGEF2
regulates actin organization and contractility in the Drosophila
blastoderm embryo. J Cell Biol 168, 575-85.
Pang, A. L., Peacock, S., Johnson, W., Bear, D. H., Rennert, O. M.
and Chan, W. Y. (2009). Cloning, characterization, and expression
analysis of the novel acetyltransferase retrogene Ard1b in the mouse.
Biol Reprod 81, 302-9.
Panizza, S., Tanaka, T., Hochwagen, A., Eisenhaber, F. and
Nasmyth, K. (2000). Pds5 cooperates with cohesin in maintaining
sister chromatid cohesion. Curr Biol 10, 1557-64.
Paradis, H., Islam, T., Tucker, S., Tao, L., Koubi, S. and Gendron,
R. L. (2008). Tubedown associates with cortactin and controls
permeability of retinal endothelial cells to albumin. J Cell Sci 121,
1965-72.
Paradis, H., Liu, C. Y., Saika, S., Azhar, M., Doetschman, T., Good,
W. V., Nayak, R., Laver, N., Kao, C. W., Kao, W. W. et al. (2002).
Tubedown-1 in remodeling of the developing vitreal vasculature in vivo
and regulation of capillary outgrowth in vitro. Dev Biol 249, 140-55.
Park, E. C. and Szostak, J. W. (1992). ARD1 and NAT1 proteins form
a complex that has N-terminal acetyltransferase activity. EMBO J 11,
2087-93.
Persson, B., Flinta, C., von Heijne, G. and Jornvall, H. (1985).
Structures of N-terminally acetylated proteins. Eur J Biochem 152,
523-7.
References
175
Peters, J. M. (2006). The anaphase promoting complex/cyclosome: a
machine designed to destroy. Nat Rev Mol Cell Biol 7, 644-56.
Pickart, C. M. and Eddins, M. J. (2004). Ubiquitin: structures,
functions, mechanisms. Biochim Biophys Acta 1695, 55-72.
Pimenta-Marques, A., Tostoes, R., Marty, T., Barbosa, V.,
Lehmann, R. and Martinho, R. G. (2008). Differential requirements of
a mitotic acetyltransferase in somatic and germ line cells. Dev Biol
323, 197-206.
Polevoda, B., Brown, S., Cardillo, T. S., Rigby, S. and Sherman, F.
(2008). Yeast N(alpha)-terminal acetyltransferases are associated with
ribosomes. J Cell Biochem 103, 492-508.
Polevoda, B., Cardillo, T. S., Doyle, T. C., Bedi, G. S. and Sherman,
F. (2003). Nat3p and Mdm20p are required for function of yeast NatB
Nalpha-terminal acetyltransferase and of actin and tropomyosin. J Biol
Chem 278, 30686-97.
Polevoda, B., Norbeck, J., Takakura, H., Blomberg, A. and
Sherman, F. (1999). Identification and specificities of N-terminal
acetyltransferases from Saccharomyces cerevisiae. EMBO J 18, 6155-
68.
Polevoda, B. and Sherman, F. (2000). Nalpha -terminal acetylation of
eukaryotic proteins. J Biol Chem 275, 36479-82.
Polevoda, B. and Sherman, F. (2001). NatC Nalpha-terminal
acetyltransferase of yeast contains three subunits, Mak3p, Mak10p,
and Mak31p. J Biol Chem 276, 20154-9.
Polevoda, B. and Sherman, F. (2002). The diversity of acetylated
proteins. Genome Biol 3, reviews0006.
Polevoda, B. and Sherman, F. (2003a). Composition and function of
the eukaryotic N-terminal acetyltransferase subunits. Biochem Biophys
Res Commun 308, 1-11.
Polevoda, B. and Sherman, F. (2003b). N-terminal acetyltransferases
and sequence requirements for N-terminal acetylation of eukaryotic
proteins. J Mol Biol 325, 595-622.
Rankin, S., Ayad, N. G. and Kirschner, M. W. (2005). Sororin, a
substrate of the anaphase-promoting complex, is required for sister
chromatid cohesion in vertebrates. Mol Cell 18, 185-200.
Ren, T., Jiang, B., Jin, G., Li, J., Dong, B., Zhang, J., Meng, L., Wu,
J. and Shou, C. (2008). Generation of novel monoclonal antibodies
and their application for detecting ARD1 expression in colorectal
cancer. Cancer Lett 264, 83-92.
Riedel, C. G., Katis, V. L., Katou, Y., Mori, S., Itoh, T., Helmhart, W.,
Galova, M., Petronczki, M., Gregan, J., Cetin, B. et al. (2006).
Protein phosphatase 2A protects centromeric sister chromatid
cohesion during meiosis I. Nature 441, 53-61.
Rieder, C. L., Cole, R. W., Khodjakov, A. and Sluder, G. (1995). The
checkpoint delaying anaphase in response to chromosome
References
176
monoorientation is mediated by an inhibitory signal produced by
unattached kinetochores. J Cell Biol 130, 941-8.
Rieder, C. L. and Maiato, H. (2004). Stuck in division or passing
through: what happens when cells cannot satisfy the spindle assembly
checkpoint. Dev Cell 7, 637-51.
Rieder, C. L., Schultz, A., Cole, R. and Sluder, G. (1994). Anaphase
onset in vertebrate somatic cells is controlled by a checkpoint that
monitors sister kinetochore attachment to the spindle. J Cell Biol 127,
1301-10.
Roberts, D. B. (1998). Drosophila: A Practical Approach,  (ed. O. U.
Press).
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L.,
Hwang, D. and Goldberg, A. L. (1994). Inhibitors of the proteasome
block the degradation of most cell proteins and the generation of
peptides presented on MHC class I molecules. Cell 78, 761-71.
Rolef Ben-Shahar, T., Heeger, S., Lehane, C., East, P., Flynn, H.,
Skehel, M. and Uhlmann, F. (2008). Eco1-dependent cohesin
acetylation during establishment of sister chromatid cohesion. Science
321, 563-6.
Rollins, R. A., Morcillo, P. and Dorsett, D. (1999). Nipped-B, a
Drosophila homologue of chromosomal adherins, participates in
activation by remote enhancers in the cut and Ultrabithorax genes.
Genetics 152, 577-93.
Roth, S. Y., Denu, J. M. and Allis, C. D. (2001). Histone
acetyltransferases. Annu Rev Biochem 70, 81-120.
Rowland, B. D., Roig, M. B., Nishino, T., Kurze, A., Uluocak, P.,
Mishra, A., Beckouet, F., Underwood, P., Metson, J., Imre, R. et al.
(2009). Building sister chromatid cohesion: smc3 acetylation
counteracts an antiestablishment activity. Mol Cell 33, 763-74.
Rubenstein, P. and Deuchler, J. (1979). Acetylated and
nonacetylated actins in Dictyostelium discoideum. J Biol Chem 254,
11142-7.
Saka, Y., Sutani, T., Yamashita, Y., Saitoh, S., Takeuchi, M.,
Nakaseko, Y. and Yanagida, M. (1994). Fission yeast cut3 and cut14,
members of a ubiquitous protein family, are required for chromosome
condensation and segregation in mitosis. EMBO J 13, 4938-52.
Salic, A., Waters, J. C. and Mitchison, T. J. (2004). Vertebrate
shugoshin links sister centromere cohesion and kinetochore
microtubule stability in mitosis. Cell 118, 567-78.
Sanchez-Puig, N. and Fersht, A. R. (2006). Characterization of the
native and fibrillar conformation of the human Nalpha-acetyltransferase
ARD1. Protein Sci 15, 1968-76.
Savvidou, E., Cobbe, N., Steffensen, S., Cotterill, S. and Heck, M.
M. (2005). Drosophila CAP-D2 is required for condensin complex
stability and resolution of sister chromatids. J Cell Sci 118, 2529-43.
References
177
Schmitz, J., Watrin, E., Lenart, P., Mechtler, K. and Peters, J. M.
(2007). Sororin is required for stable binding of cohesin to chromatin
and for sister chromatid cohesion in interphase. Curr Biol 17, 630-6.
Scroggins, B. T., Robzyk, K., Wang, D., Marcu, M. G., Tsutsumi, S.,
Beebe, K., Cotter, R. J., Felts, S., Toft, D., Karnitz, L. et al. (2007).
An acetylation site in the middle domain of Hsp90 regulates chaperone
function. Mol Cell 25, 151-9.
Seo, J. and Lee, K. J. (2004). Post-translational modifications and
their biological functions: proteomic analysis and systematic
approaches. J Biochem Mol Biol 37, 35-44.
Seo, J. H., Cha, J. H., Park, J. H., Jeong, C. H., Park, Z. Y., Lee, H.
S., Oh, S. H., Kang, J. H., Suh, S. W., Kim, K. H. et al. Arrest
defective 1 autoacetylation is a critical step in its ability to stimulate
cancer cell proliferation. Cancer Res 70, 4422-32.
Setty, S. R., Strochlic, T. I., Tong, A. H., Boone, C. and Burd, C. G.
(2004). Golgi targeting of ARF-like GTPase Arl3p requires its Nalpha-
acetylation and the integral membrane protein Sys1p. Nat Cell Biol 6,
414-9.
Shen, Q., Zheng, X., McNutt, M. A., Guang, L., Sun, Y., Wang, J.,
Gong, Y., Hou, L. and Zhang, B. (2009). NAT10, a nucleolar protein,
localizes to the midbody and regulates cytokinesis and acetylation of
microtubules. Exp Cell Res 315, 1653-67.
Sherman, F., Stewart, J. W. and Tsunasawa, S. (1985). Methionine
or not methionine at the beginning of a protein. Bioessays 3, 27-31.
Sigrist, C. J., Cerutti, L., de Castro, E., Langendijk-Genevaux, P.
S., Bulliard, V., Bairoch, A. and Hulo, N. PROSITE, a protein domain
database for functional characterization and annotation. Nucleic Acids
Res 38, D161-6.
Singer, J. M. and Shaw, J. M. (2003). Mdm20 protein functions with
Nat3 protein to acetylate Tpm1 protein and regulate tropomyosin-actin
interactions in budding yeast. Proc Natl Acad Sci U S A 100, 7644-9.
Smith, J. S., Tachibana, I., Pohl, U., Lee, H. K., Thanarajasingam,
U., Portier, B. P., Ueki, K., Ramaswamy, S., Billings, S. J.,
Mohrenweiser, H. W. et al. (2000). A transcript map of the
chromosome 19q-arm glioma tumor suppressor region. Genomics 64,
44-50.
Somers, W. G. and Saint, R. (2003). A RhoGEF and Rho family
GTPase-activating protein complex links the contractile ring to cortical
microtubules at the onset of cytokinesis. Dev Cell 4, 29-39.
Somma, M. P., Fasulo, B., Cenci, G., Cundari, E. and Gatti, M.
(2002). Molecular dissection of cytokinesis by RNA interference in
Drosophila cultured cells. Mol Biol Cell 13, 2448-60.
Song, O. K., Wang, X., Waterborg, J. H. and Sternglanz, R. (2003).
An Nalpha-acetyltransferase responsible for acetylation of the N-
terminal residues of histones H4 and H2A. J Biol Chem 278, 38109-12.
References
178
Song, Y. H. (2005). Drosophila melanogaster: a model for the study of
DNA damage checkpoint response. Mol Cells 19, 167-79.
Sonnichsen, B., Koski, L. B., Walsh, A., Marschall, P., Neumann,
B., Brehm, M., Alleaume, A. M., Artelt, J., Bettencourt, P., Cassin,
E. et al. (2005). Full-genome RNAi profiling of early embryogenesis in
Caenorhabditis elegans. Nature 434, 462-9.
Sousa-Nunes, R., Chia, W. and Somers, W. G. (2009). Protein
phosphatase 4 mediates localization of the Miranda complex during
Drosophila neuroblast asymmetric divisions. Genes Dev 23, 359-72.
Spiro, R. G. (2002). Protein glycosylation: nature, distribution,
enzymatic formation, and disease implications of glycopeptide bonds.
Glycobiology 12, 43R-56R.
Starheim, K. K., Arnesen, T., Gromyko, D., Ryningen, A., Varhaug,
J. E. and Lillehaug, J. R. (2008). Identification of the human N(alpha)-
acetyltransferase complex B (hNatB): a complex important for cell-
cycle progression. Biochem J 415, 325-31.
Starheim, K. K., Gromyko, D., Evjenth, R., Ryningen, A., Varhaug,
J. E., Lillehaug, J. R. and Arnesen, T. (2009a). Knockdown of human
N alpha-terminal acetyltransferase complex C leads to p53-dependent
apoptosis and aberrant human Arl8b localization. Mol Cell Biol 29,
3569-81.
Starheim, K. K., Gromyko, D., Velde, R., Varhaug, J. E. and
Arnesen, T. (2009b). Composition and biological significance of the
human Nalpha-terminal acetyltransferases. BMC Proc 3 Suppl 6, S3.
Steffensen, S., Coelho, P. A., Cobbe, N., Vass, S., Costa, M.,
Hassan, B., Prokopenko, S. N., Bellen, H., Heck, M. M. and Sunkel,
C. E. (2001). A role for Drosophila SMC4 in the resolution of sister
chromatids in mitosis. Curr Biol 11, 295-307.
Stone, E. M., Swanson, M. J., Romeo, A. M., Hicks, J. B. and
Sternglanz, R. (1991). The SIR1 gene of Saccharomyces cerevisiae
and its role as an extragenic suppressor of several mating-defective
mutants. Mol Cell Biol 11, 2253-62.
Strunnikov, A. V., Hogan, E. and Koshland, D. (1995). SMC2, a
Saccharomyces cerevisiae gene essential for chromosome
segregation and condensation, defines a subgroup within the SMC
family. Genes Dev 9, 587-99.
Sugiura, N., Adams, S. M. and Corriveau, R. A. (2003). An
evolutionarily conserved N-terminal acetyltransferase complex
associated with neuronal development. J Biol Chem 278, 40113-20.
Sugiura, N., Patel, R. G. and Corriveau, R. A. (2001). N-methyl-D-
aspartate receptors regulate a group of transiently expressed genes in
the developing brain. J Biol Chem 276, 14257-63.
Sullivan, M. and Morgan, D. O. (2007). Finishing mitosis, one step at
a time. Nat Rev Mol Cell Biol 8, 894-903.
References
179
Sullivan, W. and Theurkauf, W. E. (1995). The cytoskeleton and
morphogenesis of the early Drosophila embryo. Curr Opin Cell Biol 7,
18-22.
Sumara, I., Vorlaufer, E., Gieffers, C., Peters, B. H. and Peters, J.
M. (2000). Characterization of vertebrate cohesin complexes and their
regulation in prophase. J Cell Biol 151, 749-62.
Sumara, I., Vorlaufer, E., Stukenberg, P. T., Kelm, O., Redemann,
N., Nigg, E. A. and Peters, J. M. (2002). The dissociation of cohesin
from chromosomes in prophase is regulated by Polo-like kinase. Mol
Cell 9, 515-25.
Takahashi, T. S., Yiu, P., Chou, M. F., Gygi, S. and Walter, J. C.
(2004). Recruitment of Xenopus Scc2 and cohesin to chromatin
requires the pre-replication complex. Nat Cell Biol 6, 991-6.
Tamura, K., Dudley, J., Nei, M. and Kumar, S. (2007). MEGA4:
Molecular Evolutionary Genetics Analysis (MEGA) software version
4.0. Mol Biol Evol 24, 1596-9.
Tanaka, K., Hao, Z., Kai, M. and Okayama, H. (2001). Establishment
and maintenance of sister chromatid cohesion in fission yeast by a
unique mechanism. EMBO J 20, 5779-90.
Tang, Z., Shu, H., Qi, W., Mahmood, N. A., Mumby, M. C. and Yu,
H. (2006). PP2A is required for centromeric localization of Sgo1 and
proper chromosome segregation. Dev Cell 10, 575-85.
Tang, Z., Sun, Y., Harley, S. E., Zou, H. and Yu, H. (2004). Human
Bub1 protects centromeric sister-chromatid cohesion through
Shugoshin during mitosis. Proc Natl Acad Sci U S A 101, 18012-7.
Tatsumoto, T., Xie, X., Blumenthal, R., Okamoto, I. and Miki, T.
(1999). Human ECT2 is an exchange factor for Rho GTPases,
phosphorylated in G2/M phases, and involved in cytokinesis. J Cell
Biol 147, 921-8.
Tercero, J. C., Dinman, J. D. and Wickner, R. B. (1993). Yeast
MAK3 N-acetyltransferase recognizes the N-terminal four amino acids
of the major coat protein (gag) of the L-A double-stranded RNA virus. J
Bacteriol 175, 3192-4.
Tomonaga, T., Nagao, K., Kawasaki, Y., Furuya, K., Murakami, A.,
Morishita, J., Yuasa, T., Sutani, T., Kearsey, S. E., Uhlmann, F. et
al. (2000). Characterization of fission yeast cohesin: essential
anaphase proteolysis of Rad21 phosphorylated in the S phase. Genes
Dev 14, 2757-70.
Uemura, T., Ohkura, H., Adachi, Y., Morino, K., Shiozaki, K. and
Yanagida, M. (1987). DNA topoisomerase II is required for
condensation and separation of mitotic chromosomes in S. pombe.
Cell 50, 917-25.
Uhlmann, F. (2001). Secured cutting: controlling separase at the
metaphase to anaphase transition. EMBO Rep 2, 487-92.
References
180
Uhlmann, F., Lottspeich, F. and Nasmyth, K. (1999). Sister-
chromatid separation at anaphase onset is promoted by cleavage of
the cohesin subunit Scc1. Nature 400, 37-42.
Unal, E., Heidinger-Pauli, J. M., Kim, W., Guacci, V., Onn, I., Gygi,
S. P. and Koshland, D. E. (2008). A molecular determinant for the
establishment of sister chromatid cohesion. Science 321, 566-9.
Unal, E., Heidinger-Pauli, J. M. and Koshland, D. (2007). DNA
double-strand breaks trigger genome-wide sister-chromatid cohesion
through Eco1 (Ctf7). Science 317, 245-8.
Vagnarelli, P., Hudson, D. F., Ribeiro, S. A., Trinkle-Mulcahy, L.,
Spence, J. M., Lai, F., Farr, C. J., Lamond, A. I. and Earnshaw, W.
C. (2006). Condensin and Repo-Man-PP1 co-operate in the regulation
of chromosome architecture during mitosis. Nat Cell Biol 8, 1133-42.
Van Damme, P., K. Hole, A. Pimenta-Marques, K. Helsens,  J.
Vandekerckhove, R.G. Martinho, K. Gevaert, T. Arnesen. (2011).
NatF contributes to an evolutionary shift in protein N-terminal
acetylation and is important for normal chromosome segregation
PLoS Genet.
Van Damme, P., Van Damme, J., Demol, H., Staes, A.,
Vandekerckhove, J. and Gevaert, K. (2009). A review of COFRADIC
techniques targeting protein N-terminal acetylation. BMC Proc 3 Suppl
6, S6.
Vass, S., Cotterill, S., Valdeolmillos, A. M., Barbero, J. L., Lin, E.,
Warren, W. D. and Heck, M. M. (2003). Depletion of Drad21/Scc1 in
Drosophila cells leads to instability of the cohesin complex and
disruption of mitotic progression. Curr Biol 13, 208-18.
Verni, F., Gandhi, R., Goldberg, M. L. and Gatti, M. (2000). Genetic
and molecular analysis of wings apart-like (wapl), a gene controlling
heterochromatin organization in Drosophila melanogaster. Genetics
154, 1693-710.
Vetting, M. W., LP, S. d. C., Yu, M., Hegde, S. S., Magnet, S.,
Roderick, S. L. and Blanchard, J. S. (2005). Structure and functions
of the GNAT superfamily of acetyltransferases. Arch Biochem Biophys
433, 212-26.
Virshup, D. M. and Shenolikar, S. (2009). From promiscuity to
precision: protein phosphatases get a makeover. Mol Cell 33, 537-45.
Visintin, R., Craig, K., Hwang, E. S., Prinz, S., Tyers, M. and Amon,
A. (1998). The phosphatase Cdc14 triggers mitotic exit by reversal of
Cdk-dependent phosphorylation. Mol Cell 2, 709-18.
Wall, D. S., Gendron, R. L., Good, W. V., Miskiewicz, E., Woodland,
M., Leblanc, K. and Paradis, H. (2004). Conditional knockdown of
tubedown-1 in endothelial cells leads to neovascular retinopathy.
Invest Ophthalmol Vis Sci 45, 3704-12.
Walsh, C. T., Garneau-Tsodikova, S. and Gatto, G. J., Jr. (2005).
Protein posttranslational modifications: the chemistry of proteome
diversifications. Angew Chem Int Ed Engl 44, 7342-72.
References
181
Walsh, J. B. (1995). How often do duplicated genes evolve new
functions? Genetics 139, 421-8.
Wang, J. C. (2002). Cellular roles of DNA topoisomerases: a
molecular perspective. Nat Rev Mol Cell Biol 3, 430-40.
Wang, Y., Mijares, M., Gall, M. D., Turan, T., Javier, A.,
Bornemann, D. J., Manage, K. and Warrior, R. Drosophila variable
nurse cells encodes arrest defective 1 (ARD1), the catalytic subunit of
the major N-terminal acetyltransferase complex. Dev Dyn.
Watanabe, Y. and Kitajima, T. S. (2005). Shugoshin protects cohesin
complexes at centromeres. Philos Trans R Soc Lond B Biol Sci 360,
515-21, discussion 521.
Watrin, E., Schleiffer, A., Tanaka, K., Eisenhaber, F., Nasmyth, K.
and Peters, J. M. (2006). Human Scc4 is required for cohesin binding
to chromatin, sister-chromatid cohesion, and mitotic progression. Curr
Biol 16, 863-74.
Weissman, A. M. (2001). Themes and variations on ubiquitylation. Nat
Rev Mol Cell Biol 2, 169-78.
Wenzlau, J. M., Garl, P. J., Simpson, P., Stenmark, K. R., West, J.,
Artinger, K. B., Nemenoff, R. A. and Weiser-Evans, M. C. (2006).
Embryonic growth-associated protein is one subunit of a novel N-
terminal acetyltransferase complex essential for embryonic vascular
development. Circ Res 98, 846-55.
Wickner, R. B. and Toh-e, A. (1982). [HOK], a new yeast non-
Mendelian trait, enables a replication-defective killer plasmid to be
maintained. Genetics 100, 159-74.
Wignall, S. M., Deehan, R., Maresca, T. J. and Heald, R. (2003). The
condensin complex is required for proper spindle assembly and
chromosome segregation in Xenopus egg extracts. J Cell Biol 161,
1041-51.
Williams, B. C., Garrett-Engele, C. M., Li, Z., Williams, E. V.,
Rosenman, E. D. and Goldberg, M. L. (2003). Two putative
acetyltransferases, san and deco, are required for establishing sister
chromatid cohesion in Drosophila. Curr Biol 13, 2025-36.
Willis, D. M., Loewy, A. P., Charlton-Kachigian, N., Shao, J. S.,
Ornitz, D. M. and Towler, D. A. (2002). Regulation of osteocalcin
gene expression by a novel Ku antigen transcription factor complex. J
Biol Chem 277, 37280-91.
Wullschleger, S., Loewith, R. and Hall, M. N. (2006). TOR signaling
in growth and metabolism. Cell 124, 471-84.
Xiong, B. and Gerton, J. L. Regulators of the cohesin network. Annu
Rev Biochem 79, 131-53.
Yanagida, M. (2009). Clearing the way for mitosis: is cohesin a target?
Nat Rev Mol Cell Biol 10, 489-96.
Yang, X. J. (2004). Lysine acetylation and the bromodomain: a new
partnership for signaling. Bioessays 26, 1076-87.
References
182
Yu, H. (2002). Regulation of APC-Cdc20 by the spindle checkpoint.
Curr Opin Cell Biol 14, 706-14.
Yu, M., Gong, J., Ma, M., Yang, H., Lai, J., Wu, H., Li, L. and Tan, D.
(2009). Immunohistochemical analysis of human arrest-defective-1
expressed in cancers in vivo. Oncol Rep 21, 909-15.
Zachariae, W., Schwab, M., Nasmyth, K. and Seufert, W. (1998).
Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the
anaphase promoting complex. Science 282, 1721-4.
Zhang, J., Shi, X., Li, Y., Kim, B. J., Jia, J., Huang, Z., Yang, T., Fu,
X., Jung, S. Y., Wang, Y. et al. (2008). Acetylation of Smc3 by Eco1 is
required for S phase sister chromatid cohesion in both human and
yeast. Mol Cell 31, 143-51.
References
183
APPENDIX
NatF Contributes to an Evolutionary Shift in Protein
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Abstract
N-terminal acetylation (N-Ac) is a highly abundant eukaryotic protein modification. Proteomics revealed a significant
increase in the occurrence of N-Ac from lower to higher eukaryotes, but evidence explaining the underlying molecular
mechanism(s) is currently lacking. We first analysed protein N-termini and their acetylation degrees, suggesting that
evolution of substrates is not a major cause for the evolutionary shift in N-Ac. Further, we investigated the presence of
putative N-terminal acetyltransferases (NATs) in higher eukaryotes. The purified recombinant human and Drosophila
homologues of a novel NAT candidate was subjected to in vitro peptide library acetylation assays. This provided evidence
for its NAT activity targeting Met-Lys- and other Met-starting protein N-termini, and the enzyme was termed Naa60p and its
activity NatF. Its in vivo activity was investigated by ectopically expressing human Naa60p in yeast followed by N-terminal
COFRADIC analyses. hNaa60p acetylated distinct Met-starting yeast protein N-termini and increased general acetylation
levels, thereby altering yeast in vivo acetylation patterns towards those of higher eukaryotes. Further, its activity in human
cells was verified by overexpression and knockdown of hNAA60 followed by N-terminal COFRADIC. NatF’s cellular impact
was demonstrated in Drosophila cells where NAA60 knockdown induced chromosomal segregation defects. In summary,
our study revealed a novel major protein modifier contributing to the evolution of N-Ac, redundancy among NATs, and an
essential regulator of normal chromosome segregation. With the characterization of NatF, the co-translational N-Ac
machinery appears complete since all the major substrate groups in eukaryotes are accounted for.
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Introduction
N-terminal acetylation (N-Ac) is a common modification of
proteins, but its general role has remained rather enigmatic. For
specific proteins, N-Ac is recognized as an important regulator
of function and localization [1–4]. Recently, it was suggested
that it may act as a general destabilization signal for some yeast
proteins, [5] while other reports imply that it might serve as a
stabilizer, for instance by blocking N-terminal ubiquitination
mediated degradation [6]. N-Ac in eukaryotes mainly occurs co-
translationally when 25–50 amino acids protrude from the
ribosome, by the action of ribosome associated N-terminal
acetyltransferases (NATs) [7–12]. N-Ac may occur on the
initiator Met (iMet) or on the first residue after iMet excision by
methionine aminopeptidases (MAPs) [13,14]. Three major NAT
complexes conserved from yeast to humans are thought to be
responsible for the majority of N-terminal acetylation events:
NatA, NatB and NatC [15]. Each complex is composed of
specific catalytic and auxiliary subunits. NatA, the first NAT
defined by Sternglanz and co-workers [16], potentially acety-
lates Ser-, Ala-, Thr-, Val-, Gly-, and Cys- N-termini after iMet-
cleavage [17–19]. NatB and NatC potentially acetylate Met- N-
termini when the second residue is either acidic or hydrophobic
respectively [19–21]. In yeast, NatD was described to acetylate
the Ser- N-termini of histones 2A and 4 in vitro and in vivo [22],
while no such activity has yet been presented for higher
eukaryotes. NatE is another NAT of which the in vitro activity
was described for the human hNaa50p towards some Met-Leu-
N-termini [23], but direct evidence of in vivo activity is still
lacking. Thus, each hitherto in vivo characterized NAT appears
to acetylate a distinct subset of substrates defined by the very
first N-terminal amino acids. Phenotypes induced by loss or
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reduction of NATs suggest that these enzymes, and thus
probably N-Ac, are implicated in a number of cellular processes.
In higher eukaryotes, depletion of NatA, NatB or NatC is
associated with cell cycle arrest or apoptosis [20,21,24–28] while
sister chromatid cohesion defects are observed upon NatE
depletion [29–31].
N-Ac occurs on more than 50% and 80% of cytosolic yeast and
human proteins, respectively [18]. The reason for the major
difference in occurrence of N-Ac between yeast and humans to
date is not known. Furthermore, the fact that specific subsets of
protein N-termini, like those initiated by Met-Lys-, are often
acetylated in humans and fruit fly while rarely being acetylated in
yeast, is also an unsolved issue [18,32]. Further, such substrates do
not match the predicted substrate specificity of any of the known
NATs. Potential explanations for this evolutionary shift from lower
to higher eukaryotes include: i) evolution towards more acetyla-
tion-prone N-termini in higher eukaryotes, ii) a shift in the
substrate specificity between species-specific NATs, iii) the
presence of novel, yet uncharacterized NATs in higher eukaryotes,
and iv) the presence of species-specific co-factors or chaperones
such as HYPK [33]. However, so far, no evidence for any of these
hypotheses was presented.
In the current investigation, we sought to elucidate the
mechanistic explanations for the evolutionary shift in N-terminal
acetylation from lower to higher eukaryotes. To this end we
investigated the potential evolution of acetylation prone N-termini,
but found this to be a trivial contributing factor. We further
explored the presence of novel NATs in higher eukaryotes as a
possible explanation. In silico analysis revealed the existence of an
uncharacterized human protein with a significant sequence
similarity to known catalytic NAT subunits. Indeed, multiple lines
of in vitro and in vivo evidence clearly demonstrate that this
candidate protein conserved among animals is a major NAT
displaying distinct substrate specificity, denoted Naa60p (NatF).
Our data collectively suggest that Naa60p contributes to the
increased occurrence of N-terminal acetylation in higher versus
lower eukaryotes, and additionally revealed a novel regulator of
chromosome segregation.
Results
Analyses of yeast and human N-termini reveal deviations
of the residue contact order but provide no evidence for
a significant evolution to more acetylation-prone
N-termini in higher eukaryotes
We first investigated whether an evolution towards more
acetylation-prone N-termini in higher eukaryotes could help
explain the higher acetylation levels observed. Upon comparing
the yeast, fruit fly and human proteomes, it is evident that the
general distribution of N-termini is largely unaltered between the
different classes, ‘NatA’, ‘NatB’, ‘NatC’ and ‘Other’ (Figure 1A).
However, when considering all different subgroups based on the
first two N-terminal amino acids, some significant alterations
(p,0.01) appeared. Besides the general difference of the amino
acid usage in yeast versus human N-termini in agreement with
recent observations [34], the occurrence of (Met-)Ala- N-termini
increased from 8% in yeast to 23% in humans, while Met-Glu- N-
termini increased from 5% to 10%. On the other hand, (Met-)Ser-
N-termini have decreased in occurrence from 23% in yeast to 11%
in humans (Figure 1B). Interestingly, for these major trends, the
occurrences in fruit-fly are intermediate between yeast and
humans, indicating that these might be characteristic of the
evolution to multicellular and more complex organisms. The next
question is thus whether these changes in N-terminal sequences
are causing a shift in N-Ac. In the current work, we performed
COFRADIC-based N-terminal acetylation analyses of yeast and
HeLa proteomes and present datasets covering 868 and 1,497
unique yeast and human N-termini, respectively (Tables S1 and
S2). An overview of the occurrence of N-Ac of the different classes
of assigned N-termini in the yeast (n = 648) and human (n= 1345)
control samples is presented in Table 1. When relating the
occurrence of N-Ac in yeast to the distribution of human N-
termini and vice versa (based on the first two amino acids of the
identified N-termini), we found no overall significant changes in N-
Ac levels (Table S3). Thus, alteration in usage of the first two N-
terminal amino acids, which are the major determinants for N-Ac,
is not a significant cause for the observed shift from lower to higher
eukaryotes.
Since it was shown that amino acid usage at protein N-termini
differs significantly from what is expected [34], and differences in
dipeptide composition have been used to predict protein
expression levels [35], thermostability [36] and subcellular
localization [37], we further characterized the residue contact
order at protein N-terminal parts by studying dipeptide frequen-
cies in the theoretical proteomes of Homo sapiens, Drosophila
melanogaster and Saccharomyces cerevisiae (UniProt/SwissProt entries
(version 2011-05)). Therefore, the occurrence of the 400 possible
dipeptides from the 20 amino acids in all proteins was estimated
for randomly selected human dipeptides and N-terminal (amino
acids 2–11) dipeptides by Monte-Carlo sampling. Further, a z-
score was applied to correct for differences in database size.
Contacting residues in a random, non-N-terminal set correlate
well with the expected theoretical contact order (data not shown).
In sharp contrast, the overall dipeptide composition deviates
significantly for database-annotated N-termini. A heatmap
visualization centered and scaled by species mean and standard
deviation for Homo sapiens, Drosophila melanogaster and Saccharomyces
cerevisiae is shown for the ten dipeptides with the highest and lowest
z-scores (union of n= 49) (Figure 1C). Overall, these data
strengthen the observation that N-terminal sequences not only
display altered patterns of amino acid frequencies but deviate
extensively in their residue contact order in a species-specific
Author Summary
Small chemical groups are commonly attached to proteins
in order to control their activity, localization, and stability.
An abundant protein modification is N-terminal acetyla-
tion, in which an N-terminal acetyltransferase (NAT)
catalyzes the transfer of an acetyl group to the very N-
terminal amino acid of the protein. When going from
lower to higher eukaryotes there is a significant increase in
the occurrence of N-terminal acetylation. We demonstrate
here that this is partly because higher eukaryotes uniquely
express NatF, an enzyme capable of acetylating a large
group of protein N-termini including those previously
found to display an increased N-acetylation potential in
higher eukaryotes. Thus, the current study has possibly
identified the last major component of the eukaryotic
machinery responsible for co-translational N-acetylation of
proteins. All eukaryotic proteins start with methionine,
which is co-translationally cleaved when the second amino
acid is small. Thereafter, NatA may acetylate these newly
exposed N-termini. Interestingly, NatF also has the
potential to act on these types of N-termini where the
methionine was not cleaved. At the cellular level, we
further found that NatF is essential for normal chromo-
some segregation during cell division.
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Figure 1. Overview of yeast, fruit fly, and human N-termini in NAT-classes and amino acid prevalence. A. Comparative analyses of the
distribution of all methionine-starting yeast (6561), fruit fly (3120) and human SwissProt entries (20238) (SwissProt version 2011-05) according to their
Nat-type. For simplicity, methionine processing was assumed to occur for (M)A-, (M)S-, (M)T-, (M)V-, (M)C-, (M)G- and (M)P- starting N-termini, while
the X-P- rule was used to assign unacetylated database entries [32]. B. Bar charts of the amino acid occurrence at position 2 of yeast, fruit fly and
human SwissProt protein entries. C. Heatmap of the ten highest and lowest ranking dipeptide z-scores across H. sapiens, D. melanogaster and S.
cerevisiae. Z-scores are scaled by species, with the highest and lowest ranking z-score colored with the same intensity in blue and red respectively.
The species (X-axis) and the dipeptides (Y-axis) were grouped by hierarchical clustering using the euclidian distance matrix of the z-scores.
doi:10.1371/journal.pgen.1002169.g001
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manner, which might additionally impose yet undetected con-
straints in determining N-Ac.
When considering each type of N-terminus, it is evident that
several of these are more acetylated in humans while some are
mainly unchanged, but none are less N-Ac. The major groups of
protein N-termini with an increase in N-Ac in humans as
compared to yeast include (Met-)Ala-, (Met-)Val-, and Met-Lys-
N-termini and thus represent major contributors to the overall
evolutionary shift (Table 1 and Table S3).
Another potential cause for the evolution towards the higher
level of N-Ac is a shift in the substrate specificity between species-
specific NATs. For NatA, which is responsible for N-Ac of two of
the important N-terminal types mentioned above, (Met-)Ala- and
(Met-)Val- this seemed not to be the case as both human NatA and
yeast NatA acetylated the very same subset of N-termini in yeast
[18]. For the final group, Met-Lys- N-termini, no information is
available since such N-termini have not been linked to any of the
NAT classes previously characterized.
Naa60p is a novel NAT displaying a unique substrate
specificity in vitro
In search of novel human NATs, we used the sequences of
known human NATs in NCBI BLAST queries (search set: Swiss-
Prot database restricted to human proteins). We identified one
Table 1. Overview of N-terminal acetylation of yeast and human proteins.*
hNat yNat
No. completely, %
completely and
partially, % No. completely, %
completely and
partially, %
NatA substrates
Ala- 495 91.6 95.3 52 25.0 48.1
Cys- 4 75.0 75.0 2 0.0 0.0
Gly- 10 0.0 0.0 12 0.0 8.3
Ser- 188 95.4 98.0 186 89.2 97.3
Thr- 39 75.9 89.7 36 19.4 55.6
Val- 39 3.2 19.3 31 0.0 9.7
NatB substrates
Met-Asp- 93 95.7 98.9 59 93.2 100.0
Met-Glu- 165 97.6 100.0 35 94.3 100.0
Met-Asn- 32 100.0 100.0 46 89.1 100.0
NatC substrates
Met-Ile 10 30.0 50.0 14 26.7 33.3
Met-Leu- 32 56.3 75.0 30 26.7 33.3
Met-Phe- 18 83.3 83.3 10 60.0 60.0
Other
Asp- 1 100.0 100.0
Ile- 1 0.0 0.0 1 0.0 0.0
Glu- 1 100.0 100.0
Pro- 68 0.0 0.0 25 0.0 0.0
Met-Ala 14 64.3 92.9 1 0.0 100.0
Met-Cys- 1 100.0 100.0
Met-Gly- 3 33.3 100.0 3 0.0 100.0
Met-Lys- 46 13.0 47.8 46 4.3 13.0
Met-Met- 12 83.3 100.0 6 16.7 83.3
Met-Pro- 6 0.0 0.0
Met-Gln- 16 81.3 93.8 13 30.8 84.6
Met-Ser- 9 88.9 88.9 14 7.1 64.3
Met-Thr- 18 83.3 94.4 7 0.0 28.6
Met-Val- 20 50.0 85.0 11 0.0 45.5
Met-Tyr- 4 75.0 100.0 8 25.0 62.5
Total 1345 79.1 85.2 648 52.5 67.9
Quantitative COFRADIC-based analysis of N-terminal acetylation in yeast (S. cerevisiae) and HeLa proteomes determined the acetylation status of 648 and 1345 unique
N-termini in the two species, respectively. Overall, 67.9% and 85.2% of the yeast and HeLa proteomes, respectively, are N-terminally acetylated (fully or partially). The
analysed proteins are categorized based on their N-terminal sequences (substrate classes).
*Only N-termini of which the degree of N-Ac could be univocally calculated/determined in the control yeast (648) and control human (1345) setups were used for the
overall calculation of N-Ac.
doi:10.1371/journal.pgen.1002169.t001
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protein with a significant similarity to several of the known NATs,
namely NAT15/Q9H7X0/Naa60p (Figure 2). NAT15/Naa60p is
highly conserved among animals (Figure 2B) and homologues are
also potentially present in plants (for instance At5g16800). In order
to assess whether NAT15 was an N-terminal acetyltransferase, the
NAT15 ORF was recombinantly expressed and purified from
Escherichia coli and applied to a newly developed in vitro proteome-
derived peptide library N-terminal acetylation assay [38]. In brief,
natural proteomes are used to generate Na-free peptide substrate
pools (libraries) by enrichment with strong cation exchange (SCX).
When such a peptide library is incubated with a NAT enzyme, the
newly Na-acetylated peptides are enriched by a second SCX
fractionation step, resulting in a positive selection of NAT-specific
peptide substrates. Subsequently, the NAT-oligopeptide substrates
are identified by LC-MS/MS, and the in vitro substrate specificity
profile of the NAT in question is analyzed using IceLogo [39], an
analytical tool that uses probability theory to visualize significant
conserved sequence patterns in multiple peptide sequence
alignments by comparing against a chosen background (reference)
sequence set. Using this proteome-derived peptide assay, NAT15
Na-acetylated numerous peptides in vitro and displayed a distinct
substrate specificity profile (Figure 3A). Thus, according to the
revised NAT-nomenclature system [15], we named this protein
Naa60p and its activity NatF. Remarkably, the preferred N-
termini included Met-Lys-, Met-Ala-, Met-Val-, and Met-Met-,
categories for which there are currently no known N-terminal
acetyltransferase(s). Of particular interest, recent data revealed
that several Met-Lys- N-termini were acetylated in humans and
fruit fly while no such N-Ac events of Met-Lys- N-termini were
found in yeast, pointing to the presence of (a) NAT(s) specific for
higher eukaryotes or an altered specificity profile of (a) higher
eukaryotic NAT(s) as compared to yeast NAT(s) [18,32]. To
expand these observations to higher eukaryotes in general, we
purified the predicted fruit fly homologue dNaa60p (CG18177)
and confirmed this protein to be a NAT with a nearly
indistinguishable specificity profile as compared to hNaa60p
(Figure 3B). As deduced from the in vitro specificity profile, besides
Met-; Leu- was also preferred at the first position, which, as we
described previously [38], is expected since both Met and Leu
share similar physiochemical characteristics [40,41]. However, for
co-translational Na-acetylation, Leu at the first position appears
physiologically irrelevant as it is not expected as the first amino
acid, since when it follows the initiator methionine, its size
precludes the removal of this initiator methionine by MAPs [14].
When only including Met residues at the first position, the
specificity profile remains largely unchanged (Figure 3C, 3D and
Figure S1). Given its in vitro specificity, we considered Naa60p a
qualified candidate for the Met-Lys- acetylation activities observed
in higher eukaryotes.
Naa60p is a NAT in vivo, and ectopic expression in yeast
shifts the global N-Ac patterns
In order to assess whether hNaa60p represents a NAT in vivo
and to address its potential role in the evolutionary N-Ac shift, we
generated a yeast strain expressing hNaa60p. We were not able to
observe any differences in growth rates or plating efficiencies
between yeast control strains and yeast strains expressing hNaa60p
(data not shown). Since yeast does not have an obvious homolog of
hNaa60p, ectopic expression was expected to reveal whether
hNaa60p endows yeast with a greater acetylating potential.
Indeed, when comparing N-terminal acetylation in the proteome
of control yeast (yeast control) to the yeast expressing hNaa60p
(yeast+NatF), significant alterations in the Na-acetylome were
observed (Figure 4). For example the Smr domain-containing
protein YPL199C and uncharacterized protein YGR130C, with
respectively Met-Lys- and Met-Leu- N-termini, were unacetylated
in control yeast while 82% and 48% acetylated in the strain
expressing hNaa60p/NatF (Figure 5). In total, for 464 of the 544
(or 85%) unique N-termini identified in both proteomes, the N-
acetylation status could univocally be determined. Of these, 72 N-
termini were more acetylated in the hNaa60p expressing strain,
while none were less acetylated, indicating that at least 16% of the
identified yeast proteome was acetylated by hNaa60p (Figure 4
and Table S4). 44 of the 72 hNaa60p acetylated N-termini were
completely unacetylated in control yeast, while 28 were partially
acetylated. For the latter group, hNaa60p increased the degree of
acetylation with at least 10%. It should be noted that this may
represent an underestimation of hNaa60p’s capacity since fully
acetylated N-termini (53%) in the control strain may also represent
targets, which would be masked by redundancy with the yeast
NAT-machinery. The hNaa60p yeast substrates identified in vivo
were in agreement with the in vitro determined substrate
specificities. The most common in vivo substrate classes were
Met-Lys- (n = 14), Met-Ser- (n = 9), Met-Val- (n = 8), Met-Leu-
(n = 8), Met-Gln- (n = 6), Met-Ile- (n = 5), Met-Tyr- (n = 5), and
Met-Thr- (n = 5) (Table 2).
Among those acetylated by hNaa60p were proteins with Met-
Lys- starting N-termini, which are of particular interest because
these are acetylated in humans by an unknown NAT, while only
rarely acetylated in yeast [18]. When considering the yeast control
dataset, only 13% of the Met-Lys- N-termini are fully or partially
acetylated, while the corresponding number for the yeast+NatF
strain increases to 48%. In striking resemblance, 40% to 70% of
Met-Lys- N-termini are N-terminally acetylated in human cell
lines as respectively demonstrated previously [18] and in the
current dataset (Table 1). Met-Leu-, Met-Ile-, and Met-Phe-
starting N-termini, a class of N-termini considered NatC
substrates, are other types of N-termini frequently found to be
acetylated by hNaa60p. Finally, many substrate N-termini without
a proper NAT-classification (including initiator Met-retaining N-
termini of which the iMet is only partially removed) were
acetylated: Met-Ser-, Met-Val-, Met-Thr- and Met-Met-, and
Met-Gln-. Thus, hNaa60p acetylates both N-free besides partially
acetylated protein N-termini in yeast, some without any known
corresponding yeast NAT, as well as N-termini for which there is a
putative NAT (NatC). This indicates that Naa60p may mediate a
significant part of the shift in N-terminal acetylation from lower to
higher eukaryotes. Furthermore, in contrast to the current
opinion, this also strongly suggests redundancy in the Na-
acetylation system, meaning that different NATs may have
(partially) overlapping substrates. The effect of hNaa60p on
overall N-terminal acetylation in yeast is shown in Figure 5C.
Overall, the expression of hNaa60p increased the fraction of Na-
acetylated yeast proteins from 68% to 78%, in particular affecting
the groups ‘yNatC’ and ‘Other’ (Figure 4 and Figure 5).
Overexpression or knockdown of hNAA60 affects
N-terminal acetylation in HeLa cells
Overexpression or knockdown of hNAA60 in HeLa cells was
found to increase or decrease, respectively, the N-terminal
acetylation of proteins matching the above defined in vitro and in
vivo substrate specificity of hNaa60p (Table S5). Examples include
the proteins STIP1 homology and U-box containing protein1
(1MKGKEEKEGGAR12) and mediator of RNA polymerase II
transcription subunit 25 (1MVPGSEGPAR10) where the Na-
acetylation status is shifted as a consequence of hNAA60
overexpression (from 18% to 32% acetylation) or knockdown
(from 26% to 17% acetylation), respectively (Figure 6). These data
An Evolutionary N-Acetylome Shift by NatF
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strongly point to the fact that hNaa60p in human cells can act on
the classes of N-termini deduced from the in vitro and in vivo yeast
analyses described above (Table 2). Obviously, overexpression
analysis will be limited by the redundancy among NATs and by
the fact that naturally hNaa60p-acetylated N-termini may be fully
acetylated and as such do not appear as substrates for the
overexpressed hNaa60p. Furthermore and in line with previous
knockdown analyses of NatA in HeLa cells, the semi-effective
nature of siRNA-mediated knockdown as well as the long time
period needed for a clear effect on N-terminal acetylations to
occur, make such analyses indicative rather that providing the full
picture of acetylation events mediated via a specific NAT and as
shown previously, primarily affects the least efficiently acetylated
N-termini [18]. Thus, the real number of Naa60p substrates in
human cells is likely to be significantly higher as compared to the
substrates identified in these particular analyses.
Finally, two of the acetylated N-termini of the predicted NatF
class picked up from the HeLa dataset (Table S2) were tested by a
direct in vitro approach. Synthetic peptides derived from the Met-
Lys- and Met-Ala- N-termini of Septin 9 and Protein phosphatase
6, respectively, were subjected to an in vitro acetylation assay with
purified hNaa60p followed by an HPLC-based analysis of
acetylated and unacetylated peptides. In agreement with the
human and yeast in vivo data and in vitro substrate profiles obtained
above, hNaa60p acetylated both these peptides, as well as
representatives of NatC and NatE class substrates (Figure 7).
Thus, we confirmed the N-terminal acetylation of human
substrates as well as the potential redundancy with NatC and
NatE enzyme classes (Table 2).
dNaa60p is required for chromosome segregation during
anaphase
In order to assess the cellular function of dNaa60p, its
expression was knocked down in Drosophila Dmel2 cells by RNAi.
Similarly to dNAA50-depleted cells [30,31] (data not shown),
dNAA60-depleted cells showed chromosomal segregation defects
Figure 3. Heatmap visualization reflecting the in vitro substrate specificity of hNaa60p and dNaa60p. A. Heatmap of the 248 unique
hNaa60p-specific oligopeptide substrates (353 substrate peptides in total). B. Heatmap of the 251 unique dNaa60p-specific oligopeptide substrates
(345 substrate peptides in total). C. Heatmap of the subset of 112 unique hNaa60p-specific methionine-starting oligopeptide substrates. D. Heatmap
of the subset of 126 unique dNaa60p-specific methionine-starting oligopeptide substrates. Data was normalized against the natural positional amino
acid composition of SwissProt (version 57.8) [iterative rounds (n = 100) of randomly selected sequences (n = 100) were taken as to correct for the
statistical variations (SD= standard deviation) intrinsically present at each position in the experimental datasets ranging from amino acid 1 to 6]. The
significance threshold was set at 0.01. Red color shades are negatively correlated with the occurrence in Naa60p peptide-substrates as compared to
random sequences in SwissProt, while green shades are positively correlated.
doi:10.1371/journal.pgen.1002169.g003
Figure 2. Amino acid sequence alignments of hNaa60p and other NATs. A. Amino acid sequence alignment of NAT15/hNaa60p and known
human NATs. Only amino acid 200–362 of hNaa30p was included in the alignment. The consensus Acetyl Coenzyme A (AcCoA) binding motif
RxxGxG/A, where x can be any amino acid, is indicated. T-Coffee (http://www.ebi.ac.uk/Tools/t-coffee/index.html) was used to make the alignment.
Purple background indicates acidic residues, red indicates basic residues, orange indicates glycine, yellow indicates proline, blue indicates
hydrophobic residues, green indicates polar residues, and turquoise indicates histidine and tyrosine. B. Amino acid sequence alignment of Naa60p
from Drosophila melanogaster (Dm), Danio rerio (Dr), Mus musculus (Mm), Rattus norvegicus (Rn) and Homo sapiens (Hs). The consensus Acetyl
Coenzyme A (AcCoA) binding motif RxxGxG/A, where x can be any amino acid, is indicated. Colour codes are used as in A.
doi:10.1371/journal.pgen.1002169.g002
An Evolutionary N-Acetylome Shift by NatF
PLoS Genetics | www.plosgenetics.org 7 July 2011 | Volume 7 | Issue 7 | e1002169
during anaphase (Figure 8A–C, 8F, 8G, 8J, 8K). However, while
dNAA50-depleted cells exhibit abnormal metaphases with an
obvious mitotic arrest, control and dNAA60-depleted cells
exhibited normal metaphases, with all chromosomes perfectly
aligned within the spindle equator and without any mitotic arrest
(Figure 8D, 8E, 8H, 8I and Figure S2). In contrast, during
anaphase we consistently observed chromosome segregation
defects in dNAA60-depleted cells, which included lagging chro-
mosomes (Figure 8K, highlighted by asterisk) and chromosomal
bridges (Figure 8B, 8G, highlighted by asterisk; quantification of
abnormal anaphases is shown in Figure 8C). Chromosome lagging
and bridging in dNAA60-depleted cells may be explained by
kinetochore abnormalities; however we failed to detect any
obvious defect in the localization of the Centromere identifier
protein (Cid) during metaphase or anaphase (Figure 8D–G). We
also failed to detect any obvious cohesion defect since the distance
between kinetochores during metaphase was normal according to
Cid localization (Figure 8D, 8E). Chromosome lagging could also
be explained by centrosome/mitotic spindle defects. Yet, we did
not detect any obvious defect in the localization of Centrosomin
(Cnn), and the mitotic spindle was bipolar and correctly attached
to chromosomes and centrosomes (Figure 8D–G). Furthermore,
dNAA60-depleted cells showed no obvious defects in the actin and
microtubule cytoskeleton in both mitotic and interphase cells
(Figure 8H–M). Since dNAA60-depleted cells were otherwise
normal, our data suggest that dNaa60p is required for chromo-
some segregation during anaphase. Naa60p-dependent N-terminal
acetylation of one or more substrates is therefore likely to be
required for chromosome segregation in vivo.
Discussion
The basic co-translational machinery performing N-Ac in
eukaryotes was believed to be fully identified and mostly
characterized, with five NATs, NatA-NatE, each of which
composed of specific subunits and acetylating its own subset of
substrates [15]. However, the significant shift in occurrence of N-
Ac from lower to higher eukaryotes, clearly points to the fact that
species-specific factors are major determinants for N-Ac. Indeed,
in the current study we revealed that higher eukaryotes express
NatF/Naa60p, a unique NAT responsible for N-Ac of a large
subset of eukaryotic proteins. These N-termini include Met-Lys-,
Met-Met-, Met-Val- and Met-Ser- to which so far no NAT has
been assigned. Also N-termini like Met-Leu- and Met-Ile-,
previously believed to be solely NatC substrates, may be acetylated
by NatF. Thus, the previous clear-cut classification between Nat
substrate classes based on the N-terminal sequences should be re-
evaluated when in vivo datasets are considered. The current
Figure 4. NatF N-terminally acetylates yeast substrates in vivo. Scatterplot displaying the correlation of the degrees of Na-acetylation when
comparing a control (X-axis) and a human NatF (hNaa60p)-expressing (Y-axis) yeast N-terminome dataset. The correlation was calculated with the R
statistical package to be R2 = 0.937. The N-termini displaying a significant variation in the degree of Na-acetylation (see Materials and Methods) are
highlighted in orange. The frequency histograms of the number of matching data points are also shown.
doi:10.1371/journal.pgen.1002169.g004
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knowledge on the NATs of higher eukaryotes and their
corresponding substrates is presented in Figure 9.
In contrast to the N-termini acetylated by NatF, for the
increased N-Ac of the processed (Met-)Ala- and (Met-)Val- N-
termini there is presently no explanation. The intrinsic enzymatic
properties of human and yeast NatA appeared to be very similar
when expressed in yeast [18]. Co-determining factors that should
be elaborated upon concerning the NatA substrates are interaction
partners specific for NatA of higher eukaryotes, like HYPK which
was demonstrated to modulate N-terminal acetylation [33].
Notwithstanding the generally lower expression levels, the
existence of higher eukaryotic paralogues of Naa15p and Naa10p,
being Naa16p and Naa11p respectively [42,43], might addition-
ally account for modulators of the observed Na-acetylome.
However, information regarding their potential proteome-wide
contribution to N-Ac is currently lacking.
We found that evolution of N-Ac prone N-termini most likely
contributes only to a very small degree to the overall evolutionary
shift in the occurrence of N-Ac. Furthermore, there might be a
shift in the substrate specificity between species-specific NATs, for
instance for the NatB, NatC and NatE activities, requiring further
experimental validation. However viewing their strict evolutionary
conservation, this may be rather unlikely.
The current data are more comprehensive as compared to
previous analyses [18], and overall the 648 unique yeast and 1345
unique human N-termini identified were analysed for their
acetylation status (Table 1, Tables S1 and S2). 68% of the yeast
N-termini and 85% of the human N-termini are partially or fully N-
terminally acetylated. Previously, we determined that 57% of yeast
proteins and 84% of human proteins were N-terminally acetylated,
thus implicating some shift in the N-Ac of the yeast N-termini
between experiments. We believe the current dataset likely holds a
more representative picture since more N-termini were sampled
and since yeast was grown under slightly different deprivating
(SILAC) conditions in the previous setup. Nevertheless, still a
significant difference between yeast (68%) and humans (85%) can be
observed and as demonstrated, this difference is significantly
diminished in yeast expressing NatF (78%) (Figure 4 and Figure 5).
The current study provides to the best of our knowledge, the
first evidence shedding light on the molecular basis of the
evolutionary shift in the Na-acetylome from lower to higher
eukaryotes. With the presence of NatF, higher eukaryotes are
Table 2. Types of N-termini acetylated by NatF using different methods.
In vitro peptide library assay
specificity of recombinant hNaa60p
(Figure 3 and Figure S1)
In vivo yeast substrates of
ectopically expressed hNaa60p#
(Figure 4, Figure 5, and Table S4)
HeLa substrates affected by
knockdown or overexpression of
hNaa60p#
(Figure 6 and Table S5)
In vitro assay using synthetic
peptides to verify selected
substrates of recombinant hNaa60p
(Figure 7)
Met-Lys- Met-Lys- Met-Lys- positive
Met-Ala- Met-Ala- Met-Ala- positive
Met-Val- Met-Val- Met-Val- n.d.
Met-Met- Met-Met- Met-Met- n.d.
Met-Ser- Met-Ser- n.d.
Met-Leu- Met-Leu- positive
Met-Gln- Met-Gln- n.d.
Met-Ile- n.d.
Met-Tyr- n.d.
Met-Thr- n.d.
Met-Phe- n.d.
Met-Gly- n.d.
Ser-(Glu-) negative
Ala-(Gly-) Ala-(Ala-) n.d.
Thr-(Asp-) n.d.
NatF/hNaa60p was shown to acetylate several types of N-terminal sequences by the different in vitro and in vivo methods applied in this study. This overview displays
which N-termini are acetylated by NatF using the different methods. Met-Lys-, Met-Ala-, Met-Val- and Met-Met- are among the N-terminal sequences that appear to
represent the preferred NatF substrates.
Underlined N-termini were most commonly represented (n.4).
#Underlined N-termini have at least two independent hits. N.d., not determined.
doi:10.1371/journal.pgen.1002169.t002
Figure 5. NatF expression shifts the overall status of the yeast N-terminal acetylome. A. A yeast strain expressing hNaa60p/NatF
‘Yeast+NatF’ was generated (see Materials and Methods), and processed by SDS-PAGE and Western blotting along with the control strain ‘Yeast ctr.’
containing an empty control plasmid. Anti-hNaa60p verified expression of hNaa60p in the Yeast+NatF strain (an unspecific band served as loading
control). B. MS-spectra from the MK- starting N-terminal peptide (doubly charged precursor) of the Smr domain-containing protein YPL199C
(1MKGTGGVVVGTQNPVR16) reveals two distinguishable isotopic envelopes in the hNaa60p expressing yeast strain [i.e. the acetylated (Ac) and 2C13
and trideutero-acetylated forms (2C13AcD3), right upper panel] indicative for the fact that this N-terminus is 82% in vivo N
a-acetylated while being Na-
free in the control sample (left upper panel). The lower panels show MS-spectra of the ML-starting N-terminal peptide (doubly charged precursor) of
the uncharacterized protein YGR130C (1MLFNINR7) in the control sample (0% Na-acetylated, left lower panel) or hNAA60 sample (48% acetylated,
right lower panel). C. Nat-category specific distribution of experimentally identified yeast N-termini in the yeast control or hNaa60p-expressing yeast
strain. Only those N-termini of which the N-Ac status could univocally be assigned (n = 464) were considered.
doi:10.1371/journal.pgen.1002169.g005
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enforced in their capacity to acetylate Met-Lys-, Met-Leu- and other
Met- starting N-termini, thus explaining in part the increased
occurrence of N-Ac. This additional NAT may have evolved to meet
the increased demands of more complex proteomes with a higher
level of regulation. In light of the recent suggestion that N-Ac
generates degrons and thus acts as a destabilizer [5], these issues will
be of particular importance. Our results suggested that dNaa60
activity is likely to be specifically required for chromosome segregation
during anaphase, as cells depleted for dNaa60 showed normal
alignment of chromosomes during metaphase plates and progressed
normally through mitosis, without any obvious cell cycle arrest
(Figure 8 and Figure S2). With an increasing support for N-Ac in
controlling protein stability, function and subcellular localization, it is
very likely that Naa60p will emerge as a key regulator for several
proteins. Future investigations will aim at elucidating these specific
Naa60p substrates.
Figure 6. Knockdown and overexpression of hNaa60p affects N-terminal acetylation in HeLa cells. A. HeLa cells cultivated in 13C6
15N4 L-
arginine were transfected with control vector and cells cultivated in 12C6 L-arginine were transfected with phNAA60-V5. After 48 hours of transfection
the cells were harvested, lysed and subjected to COFRADIC and MS and MS/MS- analysis. MS spectra of the peptide 1MKGKEEKEGGAR12, originating
from the STIP1 homology and U-box containing protein1 is shown. The protein is more acetylated when hNaa60p is overexpressed (32% Na-
acetylated) as compared to the control (18% Na-acetylated). Aliquots were processed by SDS-PAGE and Western blotting using anti-V5 and anti-b-
tubulin antibodies. B. Control cells cultivated in 12C6 L-arginine were transfected with 50 nM siNon-targeting control, and cells cultivated in
13C6
15N4
L-arginine were transfected with 50 nM sihNAA60 pool. After 84 hours of transfection the cells were harvested and subjected to COFRADIC and MS
analysis. MS spectra of the peptide 1MVPGSEGPAR10, originating from the protein Mediator of RNA polymerase II transcription subunit 25 is shown.
The peptide was partially acetylated in both control (26% Na-acetylated) and knockdown setup (17% Na-acetylated), however the peptide was less
Na-acetylated when the levels of hNaa60p was reduced. Aliquots were processed for SDS-PAGE and Western blotting using anti-hNaa60p and anti-
actin antibodies.
doi:10.1371/journal.pgen.1002169.g006
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Materials and Methods
N-terminal dipeptide frequency analysis for H. sapiens,
D. melanogaster, and S. cerevisiae
The random dipeptide frequencies (n = 400) were estimated by
Monte Carlo sampling of one randomly selected decapeptide per
protein in the databases of; Homo sapiens, Drosophila melanogaster and
Saccharomyces cerevisiae (UniProt/SwissProt entries (version 2011-
05)). After 100 sampling rounds, the mean and standard deviation
for each dipeptide were estimated. Thereafter, the N-terminal
dipeptide frequency of all decapeptides from position 2 to 11 were
calculated, and the obtained frequencies compared with the
random frequencies. The corresponding species-specific z-score,
reflecting the amino acid dipetide frequency differences between
the protein N-terminal and overall protein sequence were
calculated as follows:
AA freq (N-term)-AA freq (random)
AA stdev (random)
~AA z-score
Searching for novel human NATs
Sequences of the known human catalytic NAT units/subunits,
hNaa10p (P41227), hNaa11p (Q9BSU3), hNaa20p (P61599),
hNaa30p (Q147X3) and hNaa50p (Q9GZZ1), were used in the
search of novel human NATs by making use of NCBI BLAST
(blastp) queries (search set: ‘Swiss-Prot protein sequences’
restricted to organism: ‘Homo sapiens’ and otherwise the
predefined parameters). Besides the known human NATs, there
was in particular one significant hit, the uncharacterized NAT15
(Q9H7X0), which held sequence similarity to all query NATs
with E-values between 361026 and 0.24. NAT15 is an
automatically annotated name due to the presence of a N-
acetyltransferase domain (pfam00583) in the protein sequence.
When using hNaa30p and hNaa50p as query sequences, NAT15
scored even better than some of the known human NATs
(hNaa20p and hNaa10p/hNaa11p/hNaa20p, respectively).
When using hNaa30p as query sequence, some other human
proteins scored equally well as NAT15: NAT8 (Q9UHE5),
NAT8B (Q9UHF3), NAT8L (Q8N9F0) and ATAC2/CRP2BP
(Q9H8E8) with E-values ranging from 761025 to 0.034.
However, all these candidates were biochemically characterized
as members of the GNAT family (pfam00583) with functions
distinct from protein N-terminal acetylation. NAT8 is a cysteinyl-
S-conjugate N-acetyltransferase catalyzing the last step of
mercapturic acid formation while NAT8B is a likely pseudogene
of NAT8 [44]. NAT8L catalyses the synthesis of N-acetylaspar-
tate [45] and ATAC2 catalyses lysine acetylation on histone H4
[46]. Thus, NAT15 was the only uncharacterized protein with a
significant similarity to the known human NATs (Figure 2) and
was therefore further pursued.
Figure 7. NAT-activity of recombinant hNaa60p towards synthetic N-terminal oligopeptides. MBP-hNaa60p was incubated with the
indicated oligopeptide substrates (200 mM) and acetyl-Coenzyme A (300 mM) in acetylation buffer for 35 minutes at 37uC. Peptide acetylation was
determined by RP-HPLC peptide separation. The NATs responsible for acetylating the different peptides are shown. Question marks indicate that no
NAT has yet been identified to acetylate these peptides. *SYSM represents the ACTH N-terminus which is an artificial in vitro substrate of NatA. The
four first amino acids in the oligopeptides are indicated, for further details see Materials and Methods.
doi:10.1371/journal.pgen.1002169.g007
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Construction of plasmids
Plasmid encoding V5-tagged NAT15/hNaa60p (Gene ID:
79903) used for mammalian expression was constructed from
human HEK293 cDNA by use of Transcriptor Reverse
Transcriptase (Roche). The PCR product containing the CDS
plus four 59 nucleotides (gaga) was inserted into the TOPO TA
vector pcDNA 3.1/V5-His TOPO Invitrogen) according to the
instruction manual. An E. coli expression vector encoding MBP-
His-tagged hNaa60p was constructed by subcloning hNAA60 from
phNAA60-V5 to the pETM-41 vector using the Acc65I and NcoI
Figure 8. dNaa60p is required for chromosome segregation during anaphase. Control dsRNA treated cells (A,D,F,H,J and L). dNAA60 dsRNA
treated cells (B,E,G,I,K and M). dNAA60-depleted cells exhibited chromosome segregation defects during anaphase (A–C). These defects included
lagging chromosomes (K, highlighted by asterisk) and chromosome bridges (B and G, highlighted by asterisk). Quantification of chromosome
segregation defects in dNAA60-depleted cells (n = 278) and control cells (n = 179) (***p,0,001 Student’s test) (C). Histone 3 phosphorylated on Serine
10 (red), a-tubulin (green) and DNA (blue). dNAA60-depleted cells showed no significant defects in the localization of both Cnn and Cid proteins (D–
G). Both control and dNAA60-depleted cells exhibited bypolar spindles with correct alignment of chromosomes at the metaphase plate (D,E).
Anaphase cells with chromosome segregation defects in dNAA60-depleted cells showed no obvious defects in Cnn and Cid localization (F,G). a-
tubulin (red), Cid (green) and Cnn (blue). Control and dNAA60-depleted cells exhibit proper chromosome alignment during metaphase with no
detectable defects in the actin and microtubule cytoskeleton (H,I). dNAA60-depleted cells undergoing anaphase with chromosome segregation
defects also showed a normal actin and microtubule cytoskeleton (J,K; details show histone 3 phosphorylated on serine 10 staining). dNAA60-
depleted cells in interphase show no detectable defects regarding the actin and microtuble cytoskeleton (L–M). Actin (red), a-Tubulin (green) and
Histone 3 phosphorylated on Serine 10 (blue).
doi:10.1371/journal.pgen.1002169.g008
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Figure 9. The major pathways of protein N-terminal processing in higher eukaryotes. N-termini of which the iMet is followed by one of
the small amino acids, Ser-, Ala-, Thr-, Val-, Gly-, Cys-, and Pro- often undergo iMet cleavage performed by a methionine aminopeptidase (MAP). These
N-termini, with the exception of Pro-, are often further acetylated by NatA, or in the case of Histone H2A and H4, by NatD (Hole K. et al., unpublished).
However, this group of N-termini may also be acetylated by NatF. Met-Asp-, Met-Glu- and Met-Asn- are acetylated by NatB. Actins are further
processed in one or more steps by unidentified Actin aminopeptidases (Act AP). The acidic actin N-termini are then acetylated by at NAT, presumably
NatA [38]. Hydrophobic Met-Leu-, Met-Ile- and Met-Phe- are acetylated by NatC, but also by NatF as well as by NatE in vitro, suggesting potential
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Special processing for Actins 
sites. pETM-41-dNAA60, encoding the predicted fruit fly Naa60p
was made by subcloning the CG18177 CDS from pOT2-
CG18177 (clone LD27619 from the Drosophila Genomics
Resource Centre, Indiana University) to pETM-41. pETM-41
was generously provided by G. Stier, EMBL, Heidelberg. A yeast
expression vector, pBEVY-U-hNAA60 encoding untagged
hNaa60p was constructed by subcloning hNAA60 from
phNAA60-V5 to the pBEVY-U vector [47] using the BamHI and
SalI sites.
E. coli protein expression and purification
The plasmid pETM-41-hNAA60 or pETM-41-dNAA60 was
transformed into E. coli BL21 StarTM (DE3) cells (Invitrogen) by
heat shock. A 200 ml cell culture was grown in LB (Luria Bertani)
medium to an OD600 nm of 0.6 at 37uC and subsequently
transferred to 20uC. After 30 min of incubation, protein
expression was induced by IPTG (1 mM). After 17 h of
incubation, the cultures were harvested by centrifugation and
the pellets stored at 220uC. E. coli pellets containing recombinant
proteins were thawed at 4uC and the cells lysed by sonication in
lysis buffer (1 mM DTT, 50 mM Tris-HCl (pH 7.5 or 8.3 for
MBP-dNAA60p and MBP-hNAA60p, respectively), 300 mM
NaCl, 1 tablet EDTA-free protease Inhibitor cocktail per 50 ml
(Roche)). Following centrifugation, the cell extracts were applied
on a metal affinity FPLC column (HisTrap HP, GE Healthcare,
Uppsala, Sweden). MBP-hNaa60p and MBP-dNaa60p were
eluted with 300 mM Imidazole in 50 mM Tris (pH 7.5 or 8.3
for MBP-dNAA60 or MBP-hNAA60, respectively), 300 mM NaCl
and 1 mM DTT. Fractions containing recombinant protein were
pooled and further purified using size exclusion chromatography
(SuperdexTM 75, GE Healthcare) until apparent purity as analysed
by Coomassie stained SDS-PAGE gels. The protein concentra-
tions were determined by OD280 nm measurements.
In vitro peptide library-based NAT assay using hNaa60p
and dNaa60p
Preparation of proteome derived peptide libraries. Proteome-
derived peptide libraries were generated from human K-562 cells.
Cells were repeatedly (36) washed in D-PBS and then re-
suspended at 76106 cells per ml in lysis buffer (50 mM sodium
phosphate buffer pH 7.5, 100 mM NaCl, 1% CHAPS and
0.5 mM EDTA) in the presence of protease inhibitors (Complete
protease inhibitor cocktail tablet (Roche Diagnostics, Mannheim,
Germany)). After lysis for 10 min on ice, the lysate was cleared by
centrifugation for 10 min at 16,0006 g and solid guanidinum
hydrochloride was added to the supernatant to a final concentra-
tion of 4 M. The protein samples were reduced and S-alkylated,
followed by tri-deuteroacetylation of primary amines and digestion
with trypsin as described previously [48,49]. The resulting peptide
mixtures were vacuum dried. The dried peptides were re-dissolved
in 500 ml 50% acetonitrile. The sample was acidified to pH 3.0
using a stock solution of 1% TFA in 50% acetonitrile and further
diluted with 10 mM sodium phosphate in 50% acetonitrile to a
final volume of 1 ml. This peptide mixture was then loaded onto
an AccuBONDII SCX SPE cartridge (Agilent Technologies,
Waldbronn, Germany) and SCX separation (SCX fractionation 1)
of Na-blocked N-terminal peptides (and C-terminal peptides) from
Na-free peptides was performed as described previously [48,50].
The flow-through containing the Na-blocked N-terminal peptides
and C-terminal peptides was discarded and the SCX-bound
fraction (containing the Na-free peptides) was collected by elution
with 4 ml of 400 mM NaCl and 10 mM sodium phosphate in
40% of acetonitrile (pH 3.0). Eluted peptides were vacuum dried
and re-dissolved in 1 ml of HPLC solvent A (10 mM ammonium
acetate in 2% acetonitrile, pH 5.5). C18 solid-phase extraction
(SPE desalting step) of the Na-free peptides was performed by
loading the peptide mixture onto a AccuBONDII ODS-C18 SPE
cartridge (1 ml tube, 100 mg, Agilent Technologies). This
cartridge has a binding capacity of 1 mg of peptides and thus
for each mg of material, a separate cartridge was used. Prior to
sample loading, the cartridges were washed with 2 ml of 50%
acetonitrile and then washed with 5 ml of HPLC solvent A.
Sample loading was followed by washing the C18 cartridge with
5 ml of 2% acetonitrile. Peptides were eluted with 3 ml of 70%
acetonitrile and subsequently vacuum dried.
In vitro peptide library-based NAT assay. 100 nmol of the
desalted Na-free peptide pool was reconstituted in acetylation
buffer (50 mM Tris-HCl (pH 8.5), 1 mM DTT, 800 mM EDTA,
10% glycerol) together with equimolar amounts of a stable isotope
encoded variant of acetyl-CoA, 13C2-acetyl CoA, (99%
13C2-acetyl
CoA, ISOTEC-Sigma (lithium salt)) and 1 nmol of enzyme (i.e.
recombinant hNaa60p or dNaa60p) was added to a final reaction
volume of 1 ml. The reaction was allowed to proceed for 1 h at
37uC and stopped by addition of acetic acid to a 5% final
concentration. SPE was then performed as described above.
NAT oligopeptide-substrate recovery and RP-HPLC based
separation. Peptides starting with pyroglutamate were unblocked
prior to the second SCX fractionation step. Here, 25 ml of
pGAPase (25 U/ml) (TAGZyme kit, Qiagen, Hilden, Germany)
was activated for 10 min at 37uC by addition of 1 ml of 50 mM
EDTA (pH 8.0), 1 ml of 800 mM NaCl, and 11 ml of freshly
prepared 50 mM cysteamine-HCl. 25 ml of Qcyclase (50 U/ml,
TAGZyme) was then added to the pGAPase solution. The dried
peptides were re-dissolved in 212 ml of buffer containing 16 mM
NaCl, 0.5 mM EDTA, 3 mM cysteamine, and 50 mM aprotinin.
The activated pGAPase and Q-cyclase mixture was added to the
peptide sample and the mixture (275 ml total volume) was
incubated for 60 min at 37uC. 275 ml acetonitrile was then added
and the sample was acidified to pH 3 using a 1% TFA stock
solution in 50% acetonitrile. The sample was further diluted with
10 mM sodium phosphate in 50% acetonitrile to a final volume of
1 ml. SCX enrichment of Na-blocked N-terminal peptides was
performed as described [48] (SCX fractionation 2). The SCX
fraction containing the newly blocked N-terminal peptides was
vacuum dried and re-dissolved in 100 ml of HPLC solvent A. To
prevent oxidation of methionine between the primary and
secondary RP-HPLC separations (and thus unwanted segregation
of methionyl peptides [51], methionines were uniformly oxidized
to sulfoxides prior to the primary RP-HPLC run by adding 2 ml of
30% (w/v) H2O2 (final concentration of 0.06%) for 30 min at
30uC. This peptide mixture was injected onto a RP-column
(Zorbax 300SB-C18 Narrowbore, 2.1 mm (internal diame-
ter)6150 mm length, 5 mm particles, Agilent Technologies) and
the RP-HPLC separation was performed as described previously
[48]. Fractions of 30 s wide were collected from 20 to 80 min after
sample injection (120 fractions). To reduce LC-MS/MS analysis
time, fractions eluting 12 min apart were pooled, vacuum dried
and re-dissolved in 40 ml of 2% acetonitrile. In total, 24 pooled
redundancy between these NATs. Met-Met-, Met-Lys- and Met-Gln- are acetylated by NatF and potentially other NATs. Information about Met-His-,
Met-Arg-, Met-Trp- and Met-Tyr- is limited, but it is likely that some of these N-termini are acetylated as well, by NatF and perhaps NatC.
doi:10.1371/journal.pgen.1002169.g009
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fractions per setup were subjected to LC-MS/MS analysis (see
below).
LC-MS/MS analysis. LC-MS/MS analysis was performed
using an Ultimate 3000 HPLC system (Dionex, Amsterdam,
The Netherlands) in-line connected to a LTQ Orbitrap XL mass
spectrometer (Thermo Electron, Bremen, Germany) and, per LC-
MS/MS analysis, 2 ml of sample was consumed. LC-MS/MS
analysis and generation of MS/MS peak lists were performed as
described [52]. These MS/MS peak lists were then searched with
Mascot using the Mascot Daemon interface (version 2.2.0, Matrix
Science). The Mascot search parameters were set as follows.
Searches were performed in the Swiss-Prot database with
taxonomy set to human (UniProtKB/SwissProt database version
2010_05 containing 20,286 human protein sequences). Trideu-
tero-acetylation at lysines, carbamidomethylation of cysteine and
methionine oxidation to methionine-sulfoxide were set as fixed
modifications. Variable modifications were trideutero-acetylation,
acetylation and 13C2-acetylation of protein N-termini and
pyroglutamate formation of N-terminal glutamine. Endoprotei-
nase Arg-C/P (Arg-C specificity with arginine-proline cleavage
allowed) was set as enzyme allowing no missed cleavages. The
mass tolerance on the precursor ion was set to 10 ppm and on
fragment ions to 0.5 Da. The estimated false discovery rate by
searching decoy databases was typically found to lie between 2 and
4% on the spectrum level [48]. Quantification of the degree of N-
Ac was done as previously explained [18].
In vitro N-terminal acetylation assay using purified
MBP-hNaa60p and synthetic peptides
Purified MBP-hNaa60p (500 nM) was mixed with selected
oligopeptide substrates (200 mM) and 300 mM of acetyl-CoA in a
total volume of 50 ml acetylation buffer (50 mM Tris (pH 8.5),
800 mM EDTA, 10% glycerol, 1 mM DTT) and incubated at
37uC for 35 min. The enzyme activities were quenched by the
addition of 5 ml of 10% TFA. Peptide acetylation was quantified
using RP-HPLC as described previously [23].
Synthetic peptide sequences
Peptides were custom-made (Biogenes) to a purity of 80–95%. All
peptides contain 7 unique amino acids at their N-terminus, as these
are the major determinants influencing N-terminal acetylation. The
next 17 amino acids are essentially identical to the ACTH peptide
sequence (RWGRPVGRRRRPVRVYP) however; lysines were
replaced by arginines to minimize any potential interference by Ne-
acetylation. Oligopeptide sequences:
SYSM-RRR (ACTH (aa138–161, P01189): [H] SYSMDH-
FRWGRPVGRRRRPVRVYP [OH]; MDEL-RRR (NF-kkB p65,
Q04206): [H] MDELFPLRWGRPVGRRRRPVRVYP [OH];
MLGT-RRR (hnRNP H, P31943): [H] MLGTEGGRWG-
RPVGRRRRPVRVYP [OH]; MAPL-RRR (Prot phosphatase 6,
O00743): [H] MAPLDLDRWGRPVGRRRRPVRVYP [OH];
MLGP-RRR (hnRNP F, P52597): [H] MLGPEGGRWGRPVG-
RRRRPVRVYP [OH]; SESS-RRR (High mob. gr. prot A1,
P17096): [H] SESSSKSRWGRPVGRRRRPVRVYP [OH]; MKKS-
RRR (Septin 9, Q9UHD8): [H] MKKSYSGRWGRPVGRRRRPV-
RVYP [OH].
Yeast strain generation and cultivation for in vivo
N-terminal acetylation analysis
The S. cerevisiae MATalpha strain BY4742 (Euroscarf) was
transformed with pBEVY-U or pBEVY-U-hNAA60 and transfor-
mants were selected on plates lacking uracil. The two strains
generated, BY4742-pBEVY-U (yeast normal) and BY4742-
pBEVY-U-hNAA60 (yeast+NatF), were cultivated in 300 ml
synthetic medium lacking uracil (Sigma) to an OD600nm of ,3.
After harvesting, cells were washed twice in lysis buffer (50 mM
Tris, 12 mM EDTA, 250 mM NaCl, 140 mM Na2HPO4
(pH 7.6) supplemented with a complete protease inhibitor mixture
tablet (1 tablet per 100 mL) (Roche Diagnostics) and glass beads
were added before several rounds of vortex/ice (106). One
milliliter of lysis buffer was used for a pellet resulting from 300 mL
of yeast culture. The lysates were centrifuged at 50006 g for
10 min and the retained supernatants were analyzed by
COFRADIC analyses. Aliquots were analysed by SDS-PAGE
and Western blotting using anti-hNaa60p. Solid guanidinium
hydrochloride was added to a final concentration of 4 M in order
to inactivate proteases and denature all proteins. Subsequently,
proteins were reduced and alkylated simultaneously, using
TCEP.HCl (1 mM final concentration (f.c.)) and IAA (2 mM
f.c.) respectively, for 1 h at 30uC. Subsequent steps of the N-
terminal COFRADIC protocol were performed as described
previously [48]. Aliquots were analysed by SDS-PAGE and
Western blotting using anti-hNaa60p.
Human cell culture and transfection
HeLa cells (epithelial cervix adenocarcinoma, ATCC CCL-2)
were cultured in Glutamax-containing DMEM medium supple-
mented with 10% dialyzed foetal bovine serum (Invitrogen,
Carlsbad, CA, USA), 100 units/ml penicillin (Invitrogen) and
100 mg/ml streptomycin (Invitrogen). Cells were grown in media
containing either natural (12C6) or
13C6
15N4 L-arginine (Cam-
bridge Isotope Labs, Andover, MA, USA) [53] at a concentration
of 80 mM (i.e. 20% of the suggested concentration present in
DMEM at which L-arginine to proline conversion was not
detectable for HeLa cells). Cells were cultured for at least six
population doublings to ensure complete incorporation of the
labeled arginine. Human K-562 cells (ATCC CCL-243) were
grown in Glutamax-containing RPMI-1640 medium supplement-
ed with 10% foetal calf serum, 100 units/ml penicillin and
100 mg/ml streptomycin. Cells were cultured at 37uC and in 5%
CO2.
Plasmid transfections were performed using Fugene6 (Roche)
according to the instruction manual. siRNA transfections were
performed using Dharmafect 1 (Dharmacon). In the overexpres-
sion experiment, 10610 cm dishes of cells cultivated in 13C6
15N4
L-arginine were transfected with control vector and cells
cultivated in 12C6 L-arginine were transfected with phNAA60-
V5. Cells were harvested 48 hours post-transfection. Aliquots
were analysed by SDS-PAGE and Western blotting using anti-V5
(Invitrogen) to confirm efficient overexpression (See Figure 6A).
In the knockdown experiment, 10610 cm dishes of control
control cells cultivated in 12C6 L-arginine were transfected with
50 nM si-non-targeting control (D-001810, Dharmacon) and cells
cultivated in 13C6
15N4 L-arginine were transfected with 50 nM
sihNAA60 pool (D-014479, Dharmacon). After 48 hours of
transfection, the medium was replaced by new SILAC medium
containing 5 mM zVAD-fmk. After 84 hours, cells were harvest-
ed, lysed and subjected to COFRADIC analysis as described
previously [18]. Aliquots were analysed by SDS-PAGE and
Western blotting using anti-hNaa60p (Custom made affinity
purified rabbit antibody targeting a peptide corresponding to aa
69–82 of hNaa60p, Biogenes) to confirm efficient knockdown
(See Figure 6B). Each sample of the knockdown- and overex-
pression experiments resulted from 10610 cm dishes of cells and
was processed further for N-terminal COFRADIC analyses as
described previously [18].
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Quantification of the degree of Na-acetylation
The ratios of Na-acetylation for all N-termini were quantified
using MASCOT Distiller. The extent of Na-acetylation was
calculated after extracting the corresponding peak intensities
(extracted from the resulting rov-files). The modified peptide
sequences were used to calculate the theoretical isotope peak
distribution using the MS-isotope pattern calculator (http://
prospector.ucsf.edu). For both variants (i.e., in vivo Na-acetylated
(peak at m/z) and in vitro 13C2D3-N
a-acetylated (peak at m/z+5 Da)),
the predicted intensity of the 5th contributing isotope was subtracted
from the measured intensity of the corresponding monoisotopic
peak of the other overlapping isotopic envelopes in order to correct
for overlapping isotopic envelopes. Only the corresponding highest
scoring MS/MS-spectra were withheld and inspected to evaluate
the calculated Na-acetylation degree (in case of inconsistencies,
whenever possible the second, third or next highest scoring MS/
MS-spectra were inspected to evaluate the calculated Na-acetylation
degree, if inconclusive the status was set as ‘‘N.D.’’). When unclear
MS-spectra were observed, the N-Ac status was also documented as
‘‘N.D.’’. When no clear isotopic envelope was present for one of the
possible variants, the status was set at 0% and 100% or 100% and
0% respectively. Further, if the Na-acetylation calculated was#2%
of$98%, the overall N-Ac status was accounted for as being free or
fully N-Ac respectively.
When comparing the degrees of Na-acetylation from two
independent control experiments (with the degrees of Na-
acetylation of more than 1,000 unique N-termini calculated) and
taking into account a [x210%, x+10%] interval around the
calculated x-value (the x-value being the degree (%) of Na-
acetylation for the calculated data point in one dataset), the p-
value was calculated to be p,0.01, indicating that upon setting
these limits, less than 1% of all measured N-Ac values differed
more than 10%. Therefore, a significant variation in the degree of
Na-acetylation was set to 10% or more. In the case of free N-
termini identified in a control setup however, significance was set
to 5% since in this case two isotopic envelopes could clearly be
distinguished.
RNA interference and immunofluorescence microscopy
of Drosophila Dmel2 cells
Dmel2 cells were cultured at 25uC and RNAi was performed
according to standard procedures. To deplete dNaa60 (CG18177),
Dmel2 cells were separately transfected with two different double-
stranded RNAs (dsRNA) corresponding to fragments of dNaa60
defined by the set of primers (Forward-1) CAACAAACA-
CAGTGCGCC and (Reverse-1) CACATTTCGATAGGGTTT-
GATTTC or (Forward-2) GACTCGATGGGTCGTTCCGC
and (Reverse-2) GTGGATGGCCGCCGTTAAT. GFP-targeting
dsRNA was used as control. Each primer incorporates a T7 RNA
polymerase binding site. All PCR products were used as template
to synthesize dsRNA by use of the T7 RiboMAX Express kit
(Promega). Drosophila Dmel2 cells were grown in SFM Medium
(GIBCO) supplemented with 16 glutamine and 16 PenStrep
(GIBCO). Cells were counted and diluted to 26106 cells/ml in
SFM medium supplemented with glutamine. Cells were incubated
during 1 h with 40 mg for each dsRNA at a concentration of 1 mg/
ml. After 1 h incubation with dsRNA, 3 ml of SFM media
supplemented with glutamine and PenStrep (GIBCO) was added
back. After 93 h dsRNA treatment, 26106 cells were added to
coverslips by 1 h incubation at 25uC. Cells were fixed with 4%
formaldehyde, 0.03 M PIPES, 0.11 M HEPES, 0.01 M EGTA
and 4 mM MgSO4 for 10 min, followed by two washes in 16
PBS. Permeabilization and blocking was performed for 1 h with
PBS-TB (PBS, 0.1% Triton X-100, 1% fetal bovine serum).
Primary antibody incubations were done in blocking solution for
2 h at room temperature or overnight at 4uC, followed by three
5 min washes in PBS-TB. Secondary antibody incubations were
performed as described for the primary antibodies, including three
5 min washes. Primary antibodies included mouse anti-a-tubulin
DM1A (1:500; Sigma), rabbit anti-pSer10-Histone H3 (1:500;
Upstate Biotechnology), chicken anti-Cid (1:500; kindly provided
by David Glover’s laboratory) and rabbit anti-Cnn (1:500; kindly
provided by Jordan Raff). F-actin was stained with rhodamine-
conjugated phalloidin (Sigma) and DNA was stained with DAPI at
1:1000 (stock concentration 1 mg/ml), with the addition of 5 mg/
ml RNAse A. Visualization of fixed cells was performed using a
Delta Vision Core System (Applied Precision) using a 1006
UplanSApo objective and a cascade2 EMCCD camera (Photo-
metrics). Images were acquired as a series of z-sections separated
by 0.2-mm intervals. Deconvolution was performed using the
conservative ratio method in softWoRx software. Phenotypic
quantification was performed using a regular Epifluorescent
microscope Leica DMRA2.
Supporting Information
Figure S1 Amino acid frequencies at position 2 of hNaa60p and
dNaa60p substrates. Bar charts of the amino acid frequencies at
the 2nd position in the Met- (black bars) and Leu-starting (red bars)
oligopeptide substrates identified in proteome-derived peptide
library screens of hNaa60p (upper panel) and dNaa60p (lower
panel).
(TIF)
Figure S2 dNAA50 but not dNAA60 dsRNAi treated cells arrest
in mitosis. Graph showing mitotic index in control, dNAA60 and
dNAA50 dsRNA treated Dmel2 cells. Mitotic index is the
percentage of cells positive for phospho-Histone H3 (pSer10).
(TIF)
Table S1 List of 868 unique N-terminal peptides (start position 1
or 2) identified in the proteome of the control yeast strain and/or
the yeast strain expressing hNaa60p.
(DOC)
Table S2 List of 1,497 human N-terminal peptides (start
position 1 or 2) identified in the hNaa60p overexpression or
knockdown experiments in HeLa cells.
(DOC)
Table S3 Relating the occurrence of N-Ac and different N-
termini in yeast and humans. An unbiased estimation of N-Ac for
all methionine-starting yeast (6613) and human SwissProt entries
(20102) (SwissProt version 57.8) was performed based on the
nature of the N-terminal amino acids and the N-terminal
acetylation status uncovered in this study.
(DOC)
Table S4 List of the 72 unique in vivo hNaa60p substrate N-
termini identified in yeast. S4A. hNaa60p yeast substrate N-
termini (44) which were completely unacetylated in the control
setup analyzed. S4B. hNaa60p yeast substrate N-termini (28)
which were partially N-Ac in the control setup analyzed.
(DOC)
Table S5 List of N-termini affected in their N-Ac status by
knockdown or overexpression of hNaa60p in HeLa cells.
(DOC)
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